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ABSTRACT

1). The effect of temperature, P450 inhibitors (pyrazole and imidazole),
sulphydryl reagents (iodoacetamide and N-ethyl maleimide) and
glutathione on the activation of CCl4 in rat liver microsomes was
studied. Spin trapping of CCI3 ', covalent binding of CCl4 to protein and
CCl4-dependent MDA formation were used as indices of CCl4
metabolism. Formation of PBN-CCI3 ' adduct, 14CCl4 covalent binding to
protein and CCl4-dependent :MDA production were dependent on
temperature range from 15-40°C. The transition temperature was at
26.7 -27 .5°C when the activation was measured by formation of PBNCCl3 ' adduct and specific 14CCl4 covalent binding. The transition
temperature was found to be 34.3°C when CCl4-dependent MDA
production was taken as the index of the activation of CCI4. Pyrazole,
imidazole and iodoacetamide inhibited CC14-dependent MDA formation
only at high concentrations (10-20 mM), whereas glutathione showed a
strong inhibitory effect on CCl4-stimulated lipid peroxidation. MDA
formation was nearly 100°;6 inhibited by 1 roM GSH. GSH also delayed
the onset of lipid peroxidation. N-ethyl maleimide (NEM) exerted
biphasic effects on CCl4-dependent MDA formation. The lower
concentration of NEM (0.5 mM-l mM) reduced the :MDA prodUction,
while the higher concentration of NEM (5-10 mM) enhanced the MDA
formation.
2). Ribonucleotide reductase was partially purified from juvenile
normal rat liver. The enzyme was purified 30 fold after DEAE-cellulose
chromatography. The CDP reductase activity in tissues with different
growth states or rates was compared. The enzyme activity was
developed well in juvenile rat liver, regenerating liver and hepatoma
(cells), while the enzyme activity was undetectable in adult rat liver
and sham-operated rat liver. The enzyme activity in Yoshida cells was
3-fold of the activity in Morris 5123tc tumours. Dithiothreitol (DIT)
activated the activity of CDP reductase from 48h and 60h regenerating
liver, but DIT did not activate the enzyme activity of juvenile 'normal
rat liver. The possible mechanism of the activation of enzyme activity by
DIT was discussed and a mechanism of regulation of the
ribonucleotide reductase activity in regenerating liver was suggested.
3). The effect of the lipid peroxidation product 4-hydroxynonenal
(HNE) on CDP reductase from juvenile normal rat liver was
investigated. HNE inhibited the CDP reductase activity. The inhibition
was dependent on the concentration of HNE and the incubation time.
The enzyme activity was reduced 500/0 by 0.1 roM HNE. The inhibitory
effect of HNE was irreversible. DIT protected the enzyme against HNE
suggesting that HNE inhibited the activity of ribonucleotide reductase
from rat liver through the mechanism of blockage of functional SH
groups in the enzyme protein.
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1. INTRODUCTION

Carbon tetrachloride (CCIJ is a classic hepatotoxin that has been
shown to be activated by enzymic processes to a reactive intennediate.
Lipid peroxidation is involved in some of the damaging actions of CCI4 .
Lipid peroxidation is a free radical mediated process and during the
process of lipid peroxidation, a variety of products are produced.
Among these products, 4-hydroxyalkenals have a very important
biological activity. They have effects on DNA synthesis and cell
proliferation. Ribonucleotide reductase is a key enzyme for DNA
synthesis: it catalyzes the conversion of ribonucleotides to
deoxyribonucleotides which are DNA precursors. It is well established
that the activity of the enzyme correlates closely with tissue and cell
growth. This introduction is divided into three sections, the activation
of CCl4 and CCl4 -induced lipid peroxidation, the biological activity of
4-hydroxyalkenals and ribonucleotide reductase.

1

1. 1 PART I

ACTIVATION OF CARBON TETRACHLORIDE AND
LIPID PEROXIDATION

Carbon tetrachloride

(CCl~

is a very toxic substance that can

cause liver injury in many species with a predictable dose-dependence.
It is readily aVailable in pure form and its toxic effects have been

studied for many years. The concepts emerged from such studies are
helpful for understanding of biochemical mechanisms of other
hepatotoxins (Slater, 1984; Slater et al., 1985; Cheeseman et al.,
1985).

1. 1. 1 Activation of CCI,!

1. 1. 1. 1 Activation of CCl4
Although the damaging actions of CCl4 on the liver were
recognised in 1930s, it only was in the 1960s that a fundamental
theory was established that CCl4 has to undergo metabolic activation
in order to exert its full range of hepatotoxic effects. The mechanism
depended on the metabolism of CCl4 in the hepatic endoplasmic
reticulum to a free radical product capable of initiating lipid
peroxidation (Slater, 1966; Slater et al., 1985: Cheeseman, et al.,
1985).
CCl4 is activated through interaction with the NADPHcytochrome P450 electron transport chain, which is located in the
endoplasmic reticulum in many types of cell and involves the
flavoprotein NADPH-P450 reductase and cytochrome P450 together in a
phospholipid environment (Slater, 1984). The activation of CCl4
proceeds reductively. The first intermediate of the activation of CCl4 is
believed to be a trichloromethyl radical (CCl3 ') (Slater,
2

1966,1982:

Slater et al .. 1985).
CCl4 + e - - In principle, the electron donor is NADPH and the electrons are
transferred via cytochrome P450 reductase to cytochrome P450 (see Fig.
1.1.1).

The free radical of CCI3 · is very reactive and can undergo several
secondary reactions (see Fig. 1.1.2). It reacts very quickly with oxygen
to yield the trichloromethyl peroxyl radical (CCI3 0 2 ·) which is even
more reactive than CCI3 · and is believed to be the species that initiates
lipid peroxidation (Slater et al .. 1985). The CCI3 · radical is very
efficient in forming stable covalent bonds with suitable molecules;
proteins and lipids are frequent targets (Slater, 1982; Slater et al.,
1985).

CC13 · cannot be measured directly but can be detected using
ESR spectroscopy with the spin trap phenylbutyl nitrone (PBN)
(Albano et al., 1982; Slater et al., 1985). PBN can react with reactive
free radicals, like CC13 · to form a relatively stable spin-adduct which is
detectable by ESR (see Fig. 1.1.3). The spin-trapping of CCI3 · by PBN,
along with the covalent binding of radiolabelled CCl4 to microsomal
macromolecules and CCl4 -induced lipid peroxidation are useful
methods to measure CCl4 activation indirectly (Cheeseman et al.,
1985).

The site of activation of CCl4 is probably at cytochrome P450. As
reviewed by Cheeseman et al. (1985), the conclusion of the role of
cytochrome P450 in CCl4 action was drawn from the evidence outlined
below: 1) after depletion of cytochrome P450 by CoCl2 ,
3

NADPH -

FP, -

..... CYT. PL.50

n

PUFA

1

Fig. l.1.1 Activation of CCl4 through the NADPH-P 450
electron transport chain
FP: flavoprotein (NADPH-P450 reductase)
(Modified from Slater, 1982)
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allylisopropylacetamide and cobalt protoporphyrin in vivo, the
metabolism of CCl4 in vitro is decreased; 2) the reconstituted systems
containing the components of mixed-function oxidase (MFO) system do
not metabolise CC14 unless the hemoprotein is included; 3) CC1 4
activation is stimulated by the induction of cytochrome P450 by drugs
such as phenobarbitone, ethanol, benzene, or imidazole; 4) the
covalent binding of CC1 4 to microsomal protein is largely to cytochrome
P 450 molecules. Using purified enzymes, NADPH-cytochrome P450
reductase and cytochrome P450' Wolf et al. (1980) demonstrated that
the enzyme responsible for the metabolic activation of CCl4 is
cytochrome P450 rather than NADPH-cytochrome P450 reductase.
Cytochrome P450 can catalyse the reduction of CC1 4 , but NADPHcytochrome P450 reducatse alone cannot reduce CC14 .
However, the studies with classical inhibitor of the MFO system
have yielded equivocal results concerning the precise locus of CCl4
activation along the microsomal electron transport chain. The MFO
inhibitors, p-chloromercuribenzoate (pCMB), SKF 525A. CO,
menadione and metyrapone have little effect on CC14 activation. This
may be because CC14 is not a typical substrate of P450 and its
metabolism depends on a specific P450 isoenzyme that can be induced
by several drugs (Cheeseman et al., 1985). For example, both
phenobarbital (PB) and 3-methylcholanthrene (MC) can induce P450'
but metabolism of CC1 4 is enhanced only by PB-induction. MC-induced
microsomes are equivalent to micro somes from untreated animals
(Frank et al., 1982). The work of Noguchi et al. (1982) also
demonstrates that the metabolism of CC14 to CC13 ' radical is not a
general property of the multiple forms of cytochrome P450 in
microsomes of phenobartital-induced rats. It was limited to a particular
form. the 52,000 dalton P450 cytochrome which is the first
7

polypeptide to disappear in liver micros ames treated with CCI4 .
Johansson and Ingelman-Sundberg (1985) indicated that the ethanolinducible form of liver microsomal cytochrome P450 (P450

lIEI)

was

responsible for CCl4-induced lipid peroxidation. P450 lIEI can be
induced by ethanol in rabbits liver and imidazole or pyrazole in rat
liver. In reconstituted membrane system this type of P450 was a 100fold more effective catalyst of CCl4 metabolism than either of the
cytochrome P450

LM2

or P450 LM:4' Lauriault et al. (1992) have the same

conclusion that ethanol inducible P450 lIEI is a major catalyst of the
microsomal metabolism of CCI4. Antibody to P450 lIEI markedly inhibits
the metabolism of CCI4 .
There are other indications that the activation of CC14 is closely
associated with P450' Administration of CCl4 into the peritoneum
produces necrosis mainly in the centrilobular zone of the liver (Slater
et al., 1985). Very recent work of Azri et al. (1992) confirms this
observation. Using precision-cut slices of liver as the experimental
material, they further examined the damage to rat liver by CCI4. They
observed that significant leakage of glucose-6-phosphate
dehydrogenase and j3-glucuronidase from centrilobular hepatocytes
occurred 9h following CCl4 administration. The content of the
enzymes that are native to periportal (lactate dehydrogenase and
sorbitol dehydrogenase) was unchanged in the same slices over the
duration of the experiment. A major contribution to this lobular
location of injury is the distribution of cytochrome P450' It is known
that cytochrome P450 is more concentrated in the centrilobular
regions of rat liver than in the periportal regions (Gooding et al., 1978;
Slater et al., 1985).
Covalent binding of 14CC14, adduct formation with the spin trap
PEN and CC1 4-stimulated lipid peroxidation in vitro are generally
8

correlated With the tissue distribution of P450 (Slater et al., 1985). 4and 14-day-old rats are not as capable as adults in their ability to
metabolize CCl4 measured by binding of 14CCl4 to microsomal protein
and lipid (Cagen and Klaassen, 1980). The concentration of
cytochrome P450 in new born rat liver microsomes is 2-3 times lower
than in adult rat liver (Benedetto, 1981). With microsome preparations
from kidney, lung, brain. testis and adrenal, no significant activity for
the CCl4 -stimulated peroxidation or of 14CCl4 covalent binding was
found (Benedetto et al., 1981; Kornbrust and Mavis, 1980). The
concentration of P450 in microsomal suspensions from these tissues is
very low in comparison With liver (Benedetto et al., 1981).
The above discussion is particularly concerned with activation of
CCl4 in microsomes. More recently, it has been observed that CCl4 can
be activated to CCI3· in rat liver mitochondria (Tomasi et al., 1987). It
is found that incubation of liver mitochondria in a medium containing
succinic acid, ADP, PBN and in the presence of CCl4 resulted in the
formation of a PBN -spin adduct and lipid peroxidation measured by
conjugated diene production. Inhibitors of microsomal monooxygenase
at high concentrations, SKF 525A (1 mM), metyrapone (0.2 mM) and
p-CMB (0.1 mM) did not affect prodution of CCI3·. However, inhibitors
of the respiratory chain such as antimycin A and KCN decreased freeradical formation. Tomasi et al. suggested that the mitochondrial
electron -transport chain was responsible for the activation of CCl4 and
cytochrome a3 was involved in the reduction process, probably by a
mechanism similar to that of cytochrome P450-mediated activation.

1. 1. 1. 2 Factors influencing the activation of CCl4
Many factors, such as the activity of the drug -metabolizing

9

enzymes, temperature, oxygen concentration and hormones can affect
the activation of CCl4 and therefore influence the liver injury induced
by CCl4.
As early as 1966, McLean and McLean showed that the

hepatotoxic action of CCl4 was increased by prior induction of the
drug-metabolizing enzyme system. Since cytochrome P450 is the site
of activation of CCl4, any effect which modifies P450 activity will
influence the activatiQn of CCl4. Cytochrome P450 is a collective term
for a large family of hemoproteins associated with the metabolism of
drugs (Nebert and Negishi, 1982). P450 may function as a
monooxygenase, a dioxygenase, an oxidase and as a peroxidase (Bast
and Haenen, 1990).
The acute lesion (fatty degeneration and necrosis) can be
modified by various pretreatments that affect the activity of the
NADPH-cytochrome P450 chain (Slater, 1984). Induction of microsomal
cytochrome P450 by drugs such as phenobarbital, ethanol, isopropanol,
benzene and imidazole enhances the activation of CCl4 and increases
its ability to cause lipid peroxidation in liver microsomes. These
drugs can induce isoenzymes of liver microsomal cytochrome P450
(Cheeseman et al., 1985; Noguchi et al., 1982; Ingelman-Sundberg and
Jomvall, 1984; Johansson and Ingelman-Sundberg, 1985; Hung, et al.,
1983). Ethanol treatment of rats caused a 25-fold induction of the
microsomal CCl4-dependent lipid peroxidation. Imidazole and pyrazole
enhanced the CCl4-induced lipid peroxidation in rabbit liver
microsomes by 4-5-fold (Johansson and Ingelman-Sundberg, 1985).
In some cases, inhibition of activity of the cytochrome P450
system leads to suppression of the activation of CCI4. Although
"classical" inhibitors of cytochrome P450 like SKF 525A. CO and
metyrapone have little effect on the activation of CC1 4 at lower
10

concentration as discussed above, high concentrations of these
inhibitors still show the effect of reducing CCl4-stimulated lipid
peroxidation or 14CCl4 covalent binding to protein or spin trapping of
CCI3 ' in rat liver microsomes (Cheeseman et al., 1985). Metyrapone at
4 mM still had no effect on Fe2 + stimulated peroxidation, but lipid
peroxidation induced by CCl4 was inhibited by 930/0 (Kornbrust and
Mavis, 1980). For more examples, several other drugs are mentioned
here to show inhibition of CCl4 activation due to decrease in the
cytochrome P450 activity. pCMB (200 nmol/mg protein) produced a
900/0 loss of P450 activities and caused a similar reduction in the extent
of peroxidation induced by CCI4, although it had little or no effect on
the cytochrome P450 reductase (Kornbrust and Mavis, 1980). Cobaltic
protoporphrin IX (CPP) profoundly decreased the level of cytochrome
P 450 in rat liver microsomes; consequently, the associated mixedfunction oxidase systems were equally depressed and activation of CCl4
was much lower in liver microsomes from CPP-treated rats
(Cheeseman et al., 1984). Methoxsalen (8-methoxypsoralen) is one of
the psoralen derivatives (Labbe et al., 1987). Cytochrome P450 content
and monooxygenase activities decreased by 60-900/0 in mice
administrated with methoxsalen (250

~mol/Kg).

Covalent binding of

14CCl4 to protein and CCl4-induced lipid peroxidation were also
inhibited by the same extent. However, lipid peroxidation mediated by
reduced endogenous iron was not modified by methoxsalen showing
that this drug does not act as a free radical scavenger but prevents CCl4
activation by decreasing cytochrome P450 activity ( Labbe et al., 1987).
Silymarin is an extract from the wild thistle Si{y6um mananum( L.) Gartneri
(Letteron et al., 1990). Silymarin has been shown to protect animals
against various hepatotoxins including CCI4. It inhibits CC1 4-mediated
lipid peroxidation in mouse liver in vivo evidenced by exhalation of
11

ethane and in mouse liver microsomes in vitro shown by :MDA
production. Treatment of silymarin also decreases the covalent binding
of 14CCl4 to microsomal protein in vivo and in vitro. The inhibition
mechanism is apparently due to its inhibition of some mono oxygenase
activity (Letteron, et al., 1990). Thiol drug diethydithiocarbamate
(DEDC) and its two metabolites, disulfiram (DS) and carbon disulfide
(CS2) markedly decreased the activity of aniline hydroxylase, pnitroanisole-O-demethylase and pentoxyresorufin-O-dealkylase in rat
liver microsomes (Lauriault et al., 1992). Hepatocytes isolated from
rats treated with DEDC or DS and CS2 were resistant to CCl4-induced
cytotoxicity and lipid peroxidation.
The concentration of 02 influences the activation of CCI4.
Kieczka and Remmer (1981) observed that in rat liver microsomes
14CCl4 binding to protein and lipid increased continuously with
decreasing oxygen concentrations. However, CCl4-induced MDA
formation showed an atypical oxygen dependency with a maximum at
about 7% 02 and a minimum at about 15% 02' De Groot and Noll (1988
a, b) investigated this subject extensively. They also found that the
CCl4-mediated lipid peroxidation was strongly dependent on the
oxygen partial pressure (p02)' In NADPH -reduced microsomes it was
maximal at p02 around 5 mmHg and markedly decreased at p02 below
and above this value. In hepatocytes it was maximal at p02 of 7 mmHg.
They proposed that this optimum curve resulted from the fact that the
formation of CCl3 ' radicals at the haem moiety of cytochrome P450 is
inhibited by 02 while the formation of CCI3 OO' and the propagation
stage of lipid peroxidation require the participation of 02' The
reductive activation of CCl4 by cytochrome P450 takes place at the
same site 02 normally becomes activated, so the activation of CCl4 is
inhibited by

°2,

12

Changes in body temperature may affect the activation of CCl4
and protect liver injury induced by CCl4 (Slater, 1984). Temperature
reduction can be made a great protection against CCl4-mediated liver
injury. Marzi et ale (1980) reported that a chlorpromazine (CPZ)
induced reduction in body temperature of SOC prevented CCl4 induced
hepatic necrosis at 24h. They suggested that CPZ delayed the onset of
the process but did not prevent its final intensity since CPZ did not
inhibit the covalent binding of 14CCl4 to cellular constituents or CCI4induced lipid peroxidation. Reddrop et ale (1983) observed that
promethazine inhibited CCl4 -stimulated lipid peroxidation in vivo when
added in very low concentrations. The synergistic effects of
promethazine and CCl4 in reducing the body temperature of rats may
be one of particular Significance to the protective action of
promethazine. Administration of promethazine gives a long-lasting 23°C reduction in core temperature and this can be expected to lower
the rate of metabolism of CCI4. Villarruel et ale (1990) made a similar
observation. They found that thioridazine (TDZ) could partially prevent
necrogenic effects in rat liver after administration of CCl4 at 24h. The
protective effect of this drug was partly due to its reduction of the body
temperature in CCl4-treated animals during the initial 24h. Lower body
temperature decreases the rate of CCl4 metabolism.
Cytochrome P450 can be phosphorylated in a cAMP-dependent
fashion (Mkrtchian et al., 1990). It is found that cAMP dependent
phosphorylaytion increases the NADPH dependent production of
malondialdehyde. The cytochrome P450 inhibitor cyanide abolishes this
activity. This observation implies a mechanism of increase in lipid
peroxidation in response to hormonal signals (Mkrtchian, et al., 1990).
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1. 1. 2. CCl 4 -stimulated lipid peroxidation and its pathological role
One of the most important consequences of the activation of CCl4
is initiation of lipid peroxidation as a damaging reaction of potentially
great significance in cytotoxicity. Lipid peroxidation is described as an
oxygen-dependent. autoxidative degradation of fats, particularly
polyunsaturated fatty acids (PUFA). It is a chain reaction initiated and
propagated by free radicals (Pryor, 1976). It comprises three stages:
initiation, propagation and termination. The initiation stage occurs
when a radical species abstracts one hydrogen from a PUFA to fonn a
lipid radical. This lipid radical will then spontaneously react with
oxygen to generate a lipid peroxyl radical. The second stage is a chain
reaction leading to propagation. Finally, tennination occurs when two
radicals react together producing lipid peroxides or when scavengers
such as vitamin E act by interrupting this chain reaction. These
peroxides can reinitiate the radical chain reactions if they breakdown
to further radical species in the presence of a transition metal. They
can also undergo rearrangements and cleavages generating different
compounds. The whole process can be outlined as shown in Fig. 1.1.4
taking the polyunsaturated fatty acid linolenic acid (18:3 ( n-3)) as an
example and is fully described for CCl4 -induced lipid peroxidation
below.
First CCl4 is activated by the hepatic NADPH-cytochrome P450
system to CCI3 ·. Second CCI3 ' radical reacts quickly with oxygen to
yield the trichloromethyl peroxyl radical CCI3 OO·. Because CCI3 OO'
reacts much faster with a PUFA (such as arachidonate) than does CCI3 '
it has been suggested that lipid peroxidation is preferentially initiated

in the endoplasmic reticulum by CCI3 OO' rather than CCI3 ·. Third,
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ALDEHYDES, KETONES

Fig. 1.1.4 Scheme representing the peroxidation of linolenic acid
(18:3 (n-3)) induced by hydroxyl radicals
(Adapted from Vaca et al., 1988)
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CCI3 OO- reacts with PUFA in the endoplasmic reticulum and other
hepatocellular membranes by abstraction of a hydrogen atom from
PUFA to initiate the formation of lipid radicals (PUFA-)_ Lipid radicals
interact with molecular oxygen to form the lipid peroxyl radicals
PUFA- + 02 --..... PUFA0 2This peroxyl-radical can oxidise its neighbouring molecules by
hydrogen abstraction either from another molecule of PUFA or from
some other hydrogen donor (XH) to form hydroperoxides and new
radicals

PUFA0 2- +XH

---...

PUFAOOH + x-

In this way a chain reaction involving PUFA· is propagated - In the
presence of transition metal ions, the hydroperoxides and lipid peroxyl
radicals breakdown to form a complex variety of products
PUFA0 2-, PUFA0 2 H, metal ions ----.
... alkanes
alkanals
alkenals
4-hydroxyalkenals
etc.
(Slater, 1984; Slater and Cheeseman, 1987).
It has been proved that CCl4 induces lipid peroxidation in the

livers of various species including rat, hamster, guinea-pig, chicken
and mouse (Cheeseman, 1982 b; Lee et al., 1980)_ Liver microsomes of
rabbit are resistant to lipid peroxidation in vitro. However, CCl4
administration to rabbit in vivo promoted lipid peroxidation in their
liver microsomes in vitro (Bernacchi et al., 1983). Rat liver microsomes
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and hepatocytes have been used as the useful model of studying toxic
effect of CCl4 (Slater and Sawyer. 1971 a. b. c; Poli et al .. 1987; Slater

--

and Cheeseman. 1987).

Lipid peroxidation is involved in many biochemical and biological
events such as the aging process. the various diseases and the toxic
effects of certain xenobiotics (Slater. 1984; 1987; 1988). It is generally
accepted that lipid peroxidation may be important in some types of
tissue injury.
Studies with liver microsomes and hepatocytes have clearly
demonstrated that lipid peroxidation has a crucial role in the toxic
effect of CCl4 on the liver (Slater et al., 1985; Poli et aI., 1987). Lipid
peroxidation is strictly related to several CCl4 -induced damaging
actions. namely reduction of cytochrome P450 level (Glende et al.,
1976). alteration of the activity of enzymes including glucose-6phosphatase (Poli and Gravela. 1982), protein kinase C (Poli et al.,
1988 b; Pronzato et aI., 1990), Glycerol-3-phosphate acyltransferase
(Thomas and Poznan sky. 1990), effect on several subcellular
organelles and induction of liver necrosis.
Glende et al. (1976) measured cytochrome P450 level and
aminopyrine demethylase and glucose-6-phosphatase activities in
suspensions of microsomes recovered after metabolism of

14 CCl 4

under

anaerobic conditions. Massive covalent binding occured in the absence
of oxygen. The level of cytochrome P450 and the activities of
aminopyrine demethylase and glucose-6-phosphatase were virtually
unaffected by covalent binding in the anaerobic system, but they were
markedly depressed by lipid peroxidation in an aerobic system.
Poli and Gravela (1982) and Poli et al. (1989 a) reported that
glucose-6-phosphatase was inactivated by the treatment of hepatocytes
with CCl4 . There was a direct relationship between the degree of lipid
17

peroxidation and the degree of the enzyme inactivation. Promethazine
completely prevented the decrease in this enzyme activity and strongly
inhibits CCl4 -induced lipid peroxidation in liver microsomes and liver
cells. Promethazine is known to have protective activity in relation to
CCl4 -induced liver necrosis. The main effect of promethazine on CCI4 mediated damage in microsomal and isolated hepatocytes is by
scavenging CCI3 OO' free radicals that would initiate lipid peroxidation.
It has no inhibitory effect on covalent binding of CCl4 (Cheeseman,

1982 a; Poli et al., 1989 b). Therefore, the inactivation of glucose-6phosphatase was not result of covalent binding of CCl4 to the enzyme
protein but the result of lipid peroxidation (Poli and Gravela, 1982;
Poli et al., 1989 b). De Groot et al. (1985, 1986) have the same
conclusion that CCI3 ' radical does not damage glucose-6-phosphatase
directly. They found that NADPH/CCI4 induced lipid peroxidation in
microsomes and decrease of glucose-6-phosphatase activity only
occurred in the presence of

°

2:

under anaerobic conditions no lipid

peroxidation and no alteration in enzyme activity occurred.
Furthermore, Benedetti et al. (1980) could demonstrate that 4hydroxynonenal, a product of lipid peroxidation, was capable of
inactivating glucose-6-phophatase possibly by reacting with essential
thiol groups.
Protein kinase C (PKC) is an important transmembrane signal
transduction system of many short- and long-term cellular responses
including cell proliferation and transformation. Poli et al. (1988 b) and
Pronzato et al. (1990) observed that hepatocyte PKC activity was
inhibited by CCI4 . Preincubation of hepatocytes with Trolox protected
both cytosolic and microsomal PKC activity. Trolox completely
inhibited CCl4 -induced lipid peroxidation but did not affect the
covalent binding of CCl4 to hepatocyte proteins. It is indicated that
18

CC14 -induced lipid peroxidation inhibited PKC. Moreover, since the
degree of inhibition of both PKC activity in microsomes and cytosol was
the same, it is suggested that the effect of CC14 on PKC could be
mediated by a factor able to diffuse from the site of activation of CC14 in
the membranes of the endoplasmic reticulum to the cytosol. It was
shown that products of lipid peroxidation, 4-hydroxyhexenal, 4hydroxyoctenal and 4-hydroxynonenal inhibit the PKC activity.
Glycerol-3-phosphate acyltransferase (GPAT) is a enzyme of
biosynthesis of glycerolipids. The results of Thomas and Poznan sky
(1990) showed that CC14 inactivated GPAT in microsomes in the

presence of NADPH. At the same time lipid peroxidation occurred.
Addition of promethazine substantially recovered the lost of GPAT
activity indicating that lipid peroxidation plays a role in inactivation of
microsomal GPAT. Adding 1 mM DTI at the end of incubation
protected the enzyme activity, therefore the sensitive SH groups might
be damaged during lipid peroxidation, probably by products of lipid
peroxidation.
Damage to protein synthesis was involved in CC14 tOxiCity to rat
liver slices and related to CC14 -induced lipid peroxidation (Fraga et al.,
1989). CC14 -induced lipid peroxidation and inhibition of protein

synthesis occurred concurrently.
CC14 -mediated lipid peroxidation has been shown to be involved,
at least partly, in the several examples of CC14 -induced subcellular
organelles damage. Examples are liver mitochondrial swelling and
uncoupling of oxidative phosphorylation: inhibition of the uptake of

c::a2+ by liver microsomes, severe impairment of plasma membrane
structure resulting in the leakage of intracellular enzymes;
interference with the lipoprotein assembly and maturation in the
formative side of liver Golgi apparatus (Poli et al., 1987; 1990).
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The ultimate consequence of inactivation of enzymes and
alteration of functions of subcellular organelles induced by CC14 mediated lipid peroxidation might be cell death. At present, the
prevailing opinion is that lipid peroxidation plays an essential role in
causing acute liver necrosis induced by CC14 . With isolated hepatocytes
lipid peroxidation is shown long before the appearance of signs of cell
damage such as the loss of Trypan Blue staining and leakage of
cytoplasmic enzymes (Slater, 1985). Both lipid peroxidation and cell
injury are prevented by the addition of antioxidants. For example, low
concentrations of CC14 (0.1-0.15 mM) stimulate early lipid
peroxidation. The initial cell death evidenced by the leakage of lactate
dehydrogenase or transaminase happens much later. Antioxidants such
as promethazine and vitamin E block the lipid peroxidation and
prevent the hepatocyte damage (Smith et al., 1983; Poli et al., 1988 a;
Mourelle et al., 1989).
The mechanism of injury induced by lipid peroxidation is
attributed to three aspects.
First, primary reaction due to the interaction of reactive free
radicals produced during lipid peroxidation with the surrounding
system. It has been shown that reactive free radicals are able to
produce chemical modifications and damage to proteins, lipids, and
nucleotides (Slater, 1984). The consequence of these modifications is
wide spread disturbances of cellular metabolism.
Second, the toxic and pharmacological effect of products of lipid
peroxidation. This mechanism is more important. Highly reactive free
radicals are easily trapped in their microenvironment by virtue of their
high chemical reactivity. However, the products of lipid peroxidation,
like lipid hydroperoxides, aldehydes and 4-hydroxyalkenals can diffuse
conSiderable distances. These products have toxic and pharmacological
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activities. therefore they can spread disturbances throughout the cell
and even into the extracellular domain (Slater. 1984; Willis, 1980).
This mechanism is probably particular important for CCl4 tOxiCity. It
has been shown by Kombrust and Mavis (1980) that microsomal lipid
peroxidation induced by CCl4 is highly focal and limited, involving only
about 10% of the available membrane fatty acids. The reason for this is
a loss of the capacity of microsomes to activate CCI4 • attributed to
inhibition of cytochrome P450 by lipid peroxidation. Amplification of
the toxic consequences of lipid peroxidation is achieved by the
products moving from sites of lipid peroxidation on the endoplasmic
reticulum to other parts of the cell. Evidence of this is given by Poli et
al. (1988 b) and Pronzato (1990). As already mentioned they observed
that PKC activity in microsomes and cytosolic was inhibited in
proportion to CC14 -induced lipid peroxidation. They suggested that
prod ucts of lipid peroxidation which are able to diffuse from the site of
activation of CCl4 to the cytosol were responsible for the inactivation of
PKC.
Third. disorganization of the membrane results from lipid
peroxidation. Peroxidation of membrane lipids leads to a number of
changes in membrane structure and composition, such as decreases in
the unsaturation/ saturation ratio in membrane phospholipids, changes
in the chain-length percentage distribution of fatty acids, and covalent
crosslinks between adjacent lipid and protein molecules which are
accompanied by increases in the molecular order of the membrane and
decreases in its flUidity. Various membrane functions such as selective
permeability, enzyme activity, and ion transport are impaired by lipid
peroxidation (Slater, 1978: Pryor, 1980). De Groot et al. (1985, 1986)
found that lipid peroxidation induced by iron or CC14 could lead to the
loss of microsomal latency estimated by measuring the activity of
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nucleoside diphosphatase and this only occurred when lipid
peroxidation had reached a certain extent. Beyond this threshold lipid
peroxidation led to severe disintegration of the microsomal membrane
resulting in a loss of its selective penneability. The loss of latency
evoked by lipid peroxidation was comparable to the loss of latency
induced by detergent. They implied that inactivation of glucose-6phosphatase activity may relate to the loss of integrity of the
microsomal membrane apart from the effect of products of lipid
peroxidation. Glucose-6-phosphatase is a integral microsomal enzyme:
the enzyme activity largely depends on an intact lipid bilayer.
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1. 2.

PART II BIOLOGICAL EFFECT OF 4-HYDROXYALKENALS

Lipid peroxidation is involved in a range of pathological and
biological events such as aging, certain diseases, tumour initiation and
promotion and the cytotoxicity of certain xenobiotics (Slater, 1984,
1987). A complex variety of products are generated during the process
of lipid peroxidation. Some of them have important biological activities.
Among them are the 4-hydroxy-2,3-trans-alkenals series. This is
represented by 4-hydroxypentenal (HPE), 4-hydroxyoctenal (HOE), 4hydroxyhexenal (HHE) and 4-hydroxynonenal (HNE) (Esterbauer,
1991). HNE represents 950/0 of the aldehyde production (Benedetti et
al., 1980). The structure of these 4-hydroxyalkenals is shown in Fig.
1.2.1. This class of products, especially HNE, has received particular
attention because of their multiple biological activities.

1. 2. 1 Chemical reactivity
A striking chemical feature of 4-hydroxyalkenals is the fact that
at neutral pH they react avidly with SH groups in both proteins and low
molecular weight thiols such as glutathione, cysteine and coenzyme A.
The reaction product initially formed is a saturated aldehyde with the
glutathione residue bound by a thio-ether linkage at carbon atom 3.
This primary aldehyde then becomes a very stable cyclic hemiacetal
which is the main (950/0) end product in aqueous solution (see
Fig.1.2.2) (Esterbauer, 1991; Benedetti and Comporti, 1987). The
reaction rates of HNE with glutathione are:
forward reaction ( HNE + GSH ~ adduct)

1.09 M- 1 s-1

reverse reaction (adduct - - HNE + GSH) 9.6 x 10-7 M- 1 s-1
8.85 x 10- 7 M-1

equilibrium constant

(Esterbauer, 1981). If isolated proteins and enzymes containing SH
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groups are incubated with 4-hydroxyalkenals. the number of aldehyde
molecules bound to the protein equals the number of SH groups lost
during the incubation (Benedetti and Comporti. 1987). Apart from
cysteine. 4-hydroxyalkenals can react with other amino acid residues.
like lysine. histidine. serine and tyrosine (Esterbauer et al., 1991;
Uchida and Stadtman, 1992). Under certain conditions (slightly
alkaline pH, of 8.8, high concentration of the reactants 10 mM) 4hydroxyalkenals can react with nearly all amino acids.

1. 2.2. Cytotoxicity

Unlike reactive free radicals. 4-hydroxyalkenals have a relatively
long life-time and can diffuse appreciable distances and thereby extend
the cellular damage far from the site of initial toxin activation or even
escape from the cell (Slater, 1987; Benedetti, et al., 1981). Therefore,
such products generated in situ should not merely be considered as
remnants or end-products of lipid peroxidation processes but rather as
a kind of "second toxic messenger" which mediate and/or potentiate
the damage initiated by primary free radicals (Slater, 1987).

1. 2. 2. 1. Inhibitory effects on enzyme activity

A wide range of enzymes on the Table 1.2.1 have been reported
to be inhibited by HNE.
The high reactivity of HNE with glutathione implies that HNE
formed in biological systems, such as peroxidising microsomes will
preferentially attack molecules with SH groups. All inhibitory effects of
4-hydroxyalkenals on enzymes investigated so far can be explained by
the inactivation of functional SH groups (Benedetti and Comporti,
1987, Esterbauer. et al., 1988). The fact that most actions are inhibited
by the previous addition of thiols in the incubation medium, whereas
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Table 1.2.1. Inhibition of enzyme activity by HNE

Enzyme

Source

HNE conctn. - range

Reference

(~M)

Adenylate cyclase

rat liver
plasma membranes

13.4 - 26.8

Dianzani et al.. 1982
Paradisi et al .• 1985

S-adenosylmethionine
decarboxylase

Yoshida ascites
hepatoma cells

250 - 1000

Dianzani et al.. 1982

Glucose-6-phosphatase

rat liver microsomes
hepatocytes

Glyceraldehyde-Pdehydrogenase

Ehrlich ascites
tumour cells

150 - 250

Esterbauer et al.. 1991

and.f3- DNA
polymerases

Yoshida ascites
hepatoma cells

210 - 460

Wawra et al.. 1986

5· -nucleotidase

rat liver
plasma membrane

06- me thylguanine
DNA methyl transferase

human bronchial
fibroblasts

-100

Eckl and Esterbauer. 1989

Protein kinase C

rat hepatocytes

-100

Poli et al.. 1988b
Pronzato et al .. 1990

N

"'-J

(l-

- 450
- 250

1300 - 4600

Benedetti et al .• 1980

Dianzani et al.. 1982. 1989
Paradisi et al .. 1985

amino acids are generally inactive, paints in favour of this explanation
(Schauenstein. 1982). HNE discriminates between different types of
thiols. When acting in vitro on Ehrlich ascites tumour cells at
concentrations exceeding 3 mM. the entire subcellular content of
nonprotein thiols (which mainly consists of glutathione) is consumed
by reaction with the hydroxyalkenals. whereas only 500/0 of the soluble
cell protein thiols react (Schauenstein. 1982). This can explain the
mechanism whereby low molecular weight thiols protect protein-thiols
against HNE. Further evidence for the explanation that the inhibitory
effect of HNE on enzyme activity is due to blockage of enzyme SH
groups is that HNE binds to microsomal protein in vivo and in vitro and
the binding mechanism is very likely to involve reaction with SH
groups in the protein (Benedetti. et al .• 1982). Furthermore, the
binding capacity of aldehyde to the protein is responsible for the
inactivating capacity of the aldehyde (Benedetti et al., 1984). The lower
binding capacity found for 4,5-dihydroxydecenal as compared to HNE
correlated with its lower inactivating ability on microsomal glucose-6phosphatase. Recently polyclonal and monoclonal antibodies which
specifically recognize HNE-modified proteins have been established.
Immunocytochemical staining with such antibodies give a direct
evidence that HNE-modified proteins are in fact formed in animals in
vivo (Esterbauer et al .. 1991).

Other enzymes. not listed in Table 1.2.1 such as hexokinase and
lactate dehydrogenase are also inhibited by 4-hydroxyalkenals
(Esterbauer et al., 1988). Mitochondral NAD-dependent aldehyde
dehydrogenase and glucose-6-phosphate dehydrogenase might be
inhibited by 4-hydroxyalkenals too. Kanazawa and Ashida (1991)
reported that the two latter enzymes were inhibited by low-molecular
weight component of products of linoleic acid peroxidation; the major
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components in low-MW were aldehydes.
HNE had a biphasic, dose- and time-dependent effect on
adenylate cyclase in rat liver plasma membranes. Very low doses
strongly stimulated the enzyme activity after 2 and 5 min of
incubation, whereas a progressive, time- and dose-dependent
inhibition was observed afterwards. HNE (0.1 JlM) elicited the highest
enhancement without inhibition whereas 26.8 JlM was immediately
inhibitory (Paradisi et al., 1985; Dianzani et aI., 1990).

1. 2. 2. 2. Inhibitory effect on DNA, RNA and protein synthesis

HNE inhibits protein synthesis, as observed in liver cells (250
JlM), Ehrlich ascites tumour cells (140 JlM), rabbit reticulocyte lysate
(480 ).lM) (Esterbauer et al., 1991), cells from guinea pig epidermis
(guinea pig keratocytes) (100-200 JlM) (White and Rees, 1984), human
diplOid fibroblasts (1-100 ).lM) (Michiels and Remade, 1991) and
bovine aortic endothelial cells (30 ).lM) (Radu and Moldovan, 1991). It
was reported that [14C]-valine incorporation into isolated hepatocytes
was inhibited by 300/0 at 100 ).lM and by 70% at 250 ).lM HNE added in
the incubation medium (D ianz ani , 1982). The inhibitory activity of
HNE was about 10 times more effective than that of HPE. Treatment
of guinea pig keratocytes in culture with HNE, incorporation of 3Hleucine into protein was inhibited by 50-60% at 100 ).lM HNE (White
and Rees, 1984). At 30 ).lM, HNE produces a gradual decrease in
protein synthesis in bovine aortic endothelial cells during short (2-4h)
incubations, followed by return to the control level at 6-8h (Radu and
Moldovan, 1991). The protein synthesis was measured by 14C-Ieucine
incorporation. It is suggested that the inhibition of protein synthesis in
the reticulocyte lysate of rabbit is primarily due to an impairment of
the protein synthetic machinery, probably by an interaction of the

29

carbonyl compounds with sulphydryl groups essential for protein
synthesis (Benedetti, 1981). In support of this explanation, White and
Rees (1984) observed that cysteine protects protein synthesis in
guinea pig keratocytes against HNE. Addition of 400

~M

cysteine to the

culture medium in the presence of 200 JlM of HNE gave complete
protection whereas if the cultures were pretreated with cysteine
followed by washing, no protection against the subsequent addition of
HNE was obtained.
One of the important effects of HNE is its inhibitory effect on
nucleic acid syntheSiS. It is found that HNE stops or reduces DNA
synthesis in Ehrlich ascites tumour cells (150-250 JlM) (Schauenstein,
1982; Hauptlorenz, et al., 1985), guinea pig keratocytes (100 JlM)
(White and Rees, 1984), Yoshida ascites hepatoma cells (40 JlM)
(Wawra et al., 1986), malaria parasites (50

~M)

(Clark et al., 1987),

human diplOid fibroblasts (0.1 JlM) (Michiels and Remacle, 1991),
human lymphocytes 000-300 JlM) (Tessitore et al" 1987), and K562
and HL-60 human leukemic cells (1 JlM) (Barrera et al., 1991). The
inhibition of DNA synthesis was shown by the reduced incorporation of
labelled thymidine or hypoxanthine into DNA. In cells from guinea pig
epidermis (guinea pig keratocytes) inhibition of RNR syntheSiS
(measured by 3H -uridine incorporation) was more sensitive to HNE
treatment than protein synthesis whereas DNA synthesis was the most
sensitive to HNE (White and Rees, 1984). In Ehrlich ascites tumour
cells, the reduction of labelled thymidine incorporation actually
results from the inhibition of tie novo DNA synthesis but not from an
inhibition of the thymidine uptake. This was demonstrated by DNA
pulse label experiments and 8 6 Rb uptake experiments (Hauptlorenz, et
al., 1985).
It is suggested that HNE affects DNA synthesis due to inhibition
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of some enzyme activity essential for DNA synthesis, for example DNA
polymerases, and again the blockage of the SH groups by HNE plays an
important role (Hauptlorenz, et al., 1985). This assumption is
supported by the fact that low concentrations of HNE selectively attack
protein SH groups contained in the nucleus. Whilst 3 mM HNE
discriminates between non-protein and protein thiols as mentioned
above, less than 0.2 mM HNE can diSCriminate between cytoplasmic
and nuclear protein thiols: the latter are more sensitive to
hydroxyalkenals than those of the cytoplasm. For example, after
incubation of Ehrlich ascites tumour cells with HNE (0.2 mM) for 30
min, cytoplasmic protein thiols decrease only 1.70/0 whilst nuclear
soluble proteins thiols decrease 27%) (Schauenstein, 1982). When
EATC are incubated with 200 JlM HNE, DNA synthesis is inhibited up
to 900/0 after 30 min incubation, but respiration of the cell remains
practically unaffected and glycolySis is inhibited only by some 150/0.
Respiration and glycolysis are controlled by SH enzymes. This fmding
is in accordance with the above observation (Schauenstein, 1982).
There is another possibility of inhibition of DNA synthesis by
HNE. The inhibition may result from block of some signalling events
that are necessary for progression through the G 1 phase since HNE
can alter the cell cycle as described below (Barrera, et al., 1991 a).

1. 2. 2. 3. Altering cell cycle and mitOSis
4-hydroxyalkenals are able to disturb cell cycling.
Dianzani (1982) reported that HPE influences the cell cycle of
ascites AH-130 Yoshida hepatoma cells in vivo during the exponential
phase of growth. At a dose of 25 mg/kg and 50 mg/kg, HPE
significantly increase the mean DNA synthetic period (S-phase) and
decreases the number of cells participating in the cell cycle, especially
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at the lower dose. Moreover. HPE decreased the peak of the mitotic
wave, suggesting an impairment of the S-phase.
Poot et aI., (1988) studied the disturbance of cell proliferation by
HNE in close detail. Using amnitotic flUid fibroblast-like cells and
human diplOid skin-derived cells they found that HNE (10-20 )lM)
caused an accumulation of cells in the G 1 and G2 phase. This is due to
the fact that HNE provokes a retardation of the transit of the cells from
GO to G 1 and a rapid rate of exit from GO / G 1 and S phase but

diminished rate of exit from G2. Additionally, HNE eliCited a
permanent arrest in the G2 phase of the first cell cycle and in the G 1
phase of the second cell cycle even if added to quiescent cell culture.
These results indicate that HNE might cause proliferating cells to
enter a quiescent state (Poot et aI., 1988).
4-hydroxyalkenals are able to affect microtubules. Microtubules,
together with microfilaments and intermediate filaments, are the
major cytoskeleton components of mammalian cells. They playa role in
the secretory processes, the distribution of cell organelles and the
movement of chromosomes during mitosis (Olivero et al., 1990). It is
observed that HNE affects the cellular distribution of microtubules
(Olivero et al., 1990). At a low concentration (10 JlM) HNE slightly
affects microtubules in 3T3 fibroblasts, which became smaller than
their normal counterparts and the microtubule network appeared to be
formed of short fibres. After treatment with 100 JlM HNE cytoplasmic
microtubules disappeared. This effect of HNE may result from
preventing tubulin polymerization or by provoking microtubule
depolymerization. Tubulin is a main functional protein of microtubules.
It was found that incubation of purified tubulin with HNE caused a

reduction, both in the rate and the extent of polymerization. The
inhibition showed a direct relationship between the amounts of HNE
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and the degree of inhibition. The maximum inhibitory effect (780/0) was
observed at 1mM of HNE (Olivero et al., 1990). Similar results were
obtained by Miglietta et al. (1991). They observed that 0.5 mM HNE
inhibited polymerisation of microtubular protein in calf brain in vitro.
The mechanism of the inhibition may be the interaction of HNE with
SH groups of tubulin since the inhibition was prevented by addition of
cysteine. SH groups are fundamental for the polymerization of tubulin
(Dianzani. 1982; Olivero et al .. 1990; Miglietta et al.. 1991).

1. 2. 2. 4. Damage to DNA and DNA function
. It has been demonstrated that free radicals induce DNA damage
{l?J

in liver systems. So far there is no direct evidence that 4hydroxyalkenals damage DNA or influence DNA function, however,
recently there is increasing information that suggests lipid
peroxidation is an important event in free radical induced DNA damage
and products of lipid peroxidation may play an important role (Vaca,
1988; Esterbauer. 1990). Several examples are given below to show the
relationship between lipid peroxidation and damage of DNA and DNA
function.
A high dietary level of polyunsaturated fats in the absence of
vitamin E resulted in decreased hepatic DNA template activity. It is
presumed that peroxidative damage to the DNA occurred since DNA
template activity of rats fed less polyunsaturated fats and vitamin E was
normal (Summerfiedd and Tappe!, 1984).
DNA isolated from liver slices after incubation with 1 mM t-butyl
hydroperoxide (t-BOOH), 1 mM BrCCl3 or 50

~M

ferrous iron for 2h

was damaged. The enhancement of ethidium bromide fluorescence by
DNA from treated slices was decreased. Meanwhile. the TBARS
released into the incubation medium from liver slices was increased.
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DNA damage and TBARS release were both time dependent. In this
experimental system BrCCl3 did not induce significant DNA damage
and was the weakest TBARS inducer. Butylated hydroxytoluene (BIIT)
at 1 mM inhibited both DNA damage and TBARS production. These
results indicate that lipid peroxidation and DNA damage in liver slices
were concurrent (Fraga and Tappe!, 1988).
When mitochondria of rat liver were incubated in an in vitro lipid
peroxidation system (NADPH-ferrous chlOride) marked lipid
peroxidation occurred. DNA isolated from these mitochondria had a
completely different Agarose gel electrophoresis pattern. The lipid
peroxidation and DNA damage are not protected by scavengers of
superoxide ani-en, hydrogen peroxide and hydroxyl radicals. However,
alpha -tocopherol protected against both lipid peroxidation and
mitochondrial DNA damage (Hruszkewycz, 1988).
Transforming activity of plasmid pBR 322 DNA, as assayed by
transforming

T..

coei CSR 603 was inactivated by incubation of DNA with

the reaction mixture for NADPH -dependent lipid peroxidation of
liposomes. The inactivation was dependent on the extent of the lipid
peroxidation as determined by measuring the production of TBARS.
The DNA was broken by the incubation. ·OH scavengers exhibited only a
weak effect on the formation of DNA strand breaks, but did not inhibit
lipid peroxidation. The chloroform extracts from peroxiding liposomes
caused inactivation of the transforming activity of plasmid DNA, but did
not induce DNA strand breaks. These results indicate that the factor
which inactivates the transforming activity is not a free radical since it
could be extracted into chloroform, whereas the factor producing DNA
breaks might be free radical intermediate since it was not extractable
with chloroform (Akasaka, 1986).
As illustrated in Fig. 1.2.3 damage to DNA may be produced in
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the various steps of lipid peroxidation. The third mechanism would be
represented by the reaction of DNA with the variety of non-radical
products of the lipid peroxidation process. These reactions lead to
modification of nucleobases and to severe structural deterioration of
DNA (Vaca et al., 1988). However, the interaction of products of lipid
peroxidation with DNA has been disputed in the literature. According
to Akaska (1986) in a system consisting of plaSmid pBR 322 DNA and
[U-14C]-arachidonic acid-containing liposomes, no binding of
peroxidation products of the radiolabelled fatty acid to DNA was
observed. On the other hand, Vaca and Harms-Ringdahl (1989 a, b)
reported that the products of lipid peroxidation do interact with
chromatin inside the cell nucleus. Using rat liver nuclei labelled with
3H -arachidonic acid which is a main substrate for lipid peroxidation,
Vaca and Harms-Ringdahl (1989 a, b) found that the product of lipid
peroxidation induced by ascorbate-Fe 2 + and NADPH-ADP-Fe2 +
interacted with DNA and nuclear proteins. Inhibition of lipid
peroxidation by the iron chelator Desferrioxamine B prevented the
association of peroxidation products to nuclear macromolecules.
One of the lipid peroxidation products, malondialdehyde can
interact with DNA. Its damage to DNA and genotoxicity have been
extensively studied in vivo and in vitro (Vaca et al., 1988; Esterbauer et al.,
1991). It is possible that 4-hydroxyalkenals also react directly with

DNA but to my knowledge no experimental evidence has been shown.
There is only indirect evidence that suggest this class of product of
lipid peroxidation may associate with DNA. The fonnation of
fluorescent products from the interaction of peroxidizing lipid with
DNA has been characterized in a series of studies (Vaca et al., 1988). A
fluorescence spectrum was observed when DNA was reacted with
peroxidizing arachidonic acid. This spectrum was different from that
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obtained from the reaction between MDA and DNA. The results
indicated that reactive carbonyls other than MDA, formed during the
peroxidation of arachidonic acid, may also react with DNA. A similar
experiment was performed by Frankel et al. (1987). They examined
the fluorescence formation between DNA and a series of aldehydes,
carbonyl compounds and other products obtained by thermal and
catalytic (in presence of ferric chloride and ascorbic acid)
'decomposition of pure methyl linolenate hydroperoxides. They found
that the aldehydes gave the most reactive intermediates with DNA. In
addition, it is observed that HNE can react with deoxyguanosine in vitro
at pH 7.4 to form cyclic ad ducts (Winter et al., 1986) indicating that
HNE has the ability of alkylating DNA (Witz 1989). Recently, it is
observed that a potential activated metabolite of HNE, 2,3-epoxy-4hydroxynonenal (EH) modifies DNA and RNA. Endogenous HNE may be
metabolised to form EH in vivo (Sodum and Chung, 1991). Reaction of
EH with RNA and Single-strand DNA yielded different proportions of
adenosine and guanosine adducts. In contrast to the single stranded
nucleic acids, reaction with native DNA produced only deoxyguanosine
adducts. In double-stranded DNA, yields of adduct were considerably
lower than in single-stranded DNA or RNA (Sodum and Chung. 1991).

1. 2. 2. 5. Lethal effects on cells
Apart from the cytoxicity of 4-hydroxyalkenals discussed above,
these compounds also alter respiration, Ca2+ uptake, phosphate
transport, cytochrome P450 and levels of cellular glutathione and onset
of lipid peroxidation (Esterbauer. 1988; Esterbauer et al.. 1991). These
toxiC effects can induce cell injury, suppression of cell growth and cell
death.
Cadenas et al. (1983) reported that HNE at 0.6-2.4 mM
37

enhanced oxygen-induced low-level chemiluminescence and ethane
and n-pentane formation by hepatocytes. HNE at 2 mM enhanced these
toxic indices over 7 -fold. HNE also caused a rapid loss of cellular
glutathione in the form of a glutathione conjugate with the alkenal
when it was added to a suspension to hepatocytes. White and Rees
(1984) found that HNE at 0.5-1.5 mM initiated lipid peroxidation in
rat liver microsomes.
Morphological changes were also observed in the cells injured by
HNE. Normal cultured hepatocytes have a polyhedral shape and 1-2
prominent nuclei, and all cells are well attached to the surface of the
dishes (Eckl and Esterbauer, 1989; Esterbauer et al., 1990). After
treatment of cultures with 100 IlM HNE for 3h, a large number of
spherical cells with an intense granular structure and pycnotic nuclei
appeared. These cells also appeared to have lost contact with the
surface. The cells did not recover from this damage and 24h later all
the cells were dead. With higher concentrations (0.3-0.5 mM) of HNE
it is observed that guinea pig keratocytes (cells from guinea pig
epidermis) rounded up and became detached within Ih of treatment
(White and Rees, 1984).
The inhibition of cell growth is shown by decreases in cell
number and viability. HNE at 1 IlM decreased human diplOid fibroblasts
viability by 20% compared with control. At 100 IlM of HNE, the cell
viability was totally lost (Michiel and Remacle, 1991). K562 cells
growth was strongly inhibited by 100 IlM HNE. With treatment of cells
with HNE for Ih, the cell number did not increase during 6 days
culture period and was only 25°;6 of control. The viability of treated -cell
culture lost 30% (Barrera et al., 1991 b).
High concentrations of HNE can eventually cause the death of
the cell. Ehrlich ascites tumour cells were killed by 3 mM HNE
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(Schauenstein, 1982).
Table 1.2.2 shows the concentration of HNE and time of
treatment acutely toxic for mammalian cells. Most of the HNE effects
described as inhibitory and toxic to cells are at relatively high
concentrations, i.e. in the range of 0.1-10 mM. It seems most unlikely
that this high concentration of hydroxyalkenals exists in biological
systems, except perhaps in cell membranes (see below). The levels of
HNE that can be expected in normal tissues are in the range of about
0.1-3

~

(Esterbauer et al., 1989), and under conditions of oxidative

stress the HNE concentration can increase to 5-10 J.lM. Normal rat
liver for example contains 0.5-2.5 J.lM nmol HNE/ g wet tissue, and
under vitamin E deficiency this figure may increase to 5.4 nmol/ g wet
tissue (Esterbauer et al., 1990). The intracellular steady state
concentration of HNE in CCl4 -intoxicated hepatocytes was found to be
about 7 J.lM (Poli et al., 1985).
The main reason for the need of relatively high concentrations to
get an inhibition of the function in vitro is probably the fact that
biological fluids contain a large amounts of masking substances
preventing the contact of HNE with the enzyme targets. It is shown by
the fact that when the aldehydes are assayed on purified enzymes,
their active concentration decreases conSistently (Dianzani, et al.,
1990).
Another reason may be the fact that aldehydes are quickly
catabolized by cells and cell particles. Liver cell suspensions can
tolerate exposure to a constant concentration (10 J.lM) of toxiC
aldehydes (Poli et al., 1989 a). Incubation of isolated rat liver cells with
HNE resulted in a rapid loss of the aldehyde from the incubation
mixture as measured by h.p.I.c. Within 1 min 92 0/0 of 0.1 mM and 500/0
of 1.0 mM HNE were consumed by 2 x 106 cells/mI. The rate of HNE
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Table 1.2.2 CytotoxiCity of HNE towards different cell types
Cell Type

LDso. Time

isolated rat hepatocytes

1000 J-LM, 1h

culturated rat hepatocytes

100 J-LM. 20 h

intraperitoneal Ehrlich ascites
tumor cells
culturated Ehrlich ascites tumor
cells
Chinese hamster ovary
cells
umbilical vein endothelial
cells
human skin fibroblasts

500

glutathione synthetase deficient
skin fibroblasts
fibroblasts in logarithmic
growth
fibroblasts growth
arrested

( Adapted from Esterbauer et al., 1991 )
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J-L~1,

2h

100 J-LM, 6 h
100 J-LM, 1.5 h
25 J-LM, 3 h

> 40 J-LiY1. 1 week
20 J-LM, 1 week
18 J-LM, 20 h
5 J-LM, 20 h

loss increased linearly with the cell number over the range 5 x 104 -5 x
105 cells/ml (Esterbauer et al., 1985).
On the other hand, the concentration of HNE may be very high in
cell membranes. It is observed that aldehydes derived from lipid
peroxidation are unequally distributed between the lipid and aqueous
phases. Therefore, it is possible that liposoluble compounds such as
HNE might reach concentrations in the membrane environment
higher than those detected in whole cells. It is assumed that the
membrane concentration of HNE is in the range of 4.5-100 JlM; this is
enough to inhibit several enzyme functions and it has been proposed
that HNE might attack critical target proteins within the lipid bilayer
(Poli, et al., 1987).

1. 2. 3. Genotoxicity
The genotoxic activities of 4-hydroxyalkenals were investigated
in Chinese hamster cells (Brambilla et al., 1988). Sister-chromatid
exchange increased after treatment with HPE, HHE, HOE, while HNE
and 4-hydroxyundecenal had a weak, although statistically Significant,
effect. The concentration of 4-hydroxyalkenals was 20-60 JlM. DNA
fragmentation increased after exposure to the five 4-hydroxyalkenals
tested. The genotoxicity of HNE was also observed in rat hepatocytes
(Eckl and Esterbauer, 1989; Esterbauer et al., 1990). After incubation
with 0.1-10 JlM HNE for 3h, the percentage of cells with micronuclei,
the frequency of chromosomal aberration and number of sisterchromatid exchanges were significantly increased in primary cultures
of rat hepatocytes. HNE at 10 JlM or below is not cytotoxiC towards the
culture hepatocytes. Therefore the observed genotoxic effects are
indeed induced by the aldehyde itself and not by some unknown factor
produced by severely damaged or dying cells.
41

Mutagenicity of HNE was observed in V79 Chinese hamster lung
cells at the hypoxanthine-guanine phosphoribosyltransferase locus. It
was found that at the concentrations ranging from 10-45 J.1M, HNE
induced a dose-dependent increase in the number of mutations to the
6-thioguanine resistance (Vaca, 1988; Eckl and Esterbauer, 1989).
Clastogenic factors (CF) are chromosome-damaging materials in
plasma of irradiated persons and patients with so-called spontaneous
chromosomal instability. CF have a molecular weight lower than 10,000
Da. Exposure of human lymphocytes or Chinese hamster cells to
superoxide-generating systems can produce CF. CF are produced or
released by cells. In a recent report by Emerit et al. (1991) it was
shown that when cultures of human lymphocytes exposed to
hypoxanthine and xanthine oxidase (02 ·-generating system) CF were
induced. HNE was formed in 500/0 of CF induction samples, while it
was absent in all control samples. After addition of as low as 0.1 IlM
HNE in the culture, clastogenic activity was observed. So it was
suggested that HNE is a clastogenic component of CF.
In direct contrast to reports of its mutagenicity, HNE has shown
its ability to inhibit the mitogenic effect of another mitogen (Kiss et al.,
1992). In fibroblasts the mitogenic effects of sphingosine involves a
rapid rise in the cellular content of phosphatidic acid (PtdOH). It is
observed that in fibroblasts (NIH 3T3 cells), HNE selectively inhibits
sphingosine-stimulated phospholipid hydrolysis resulting in the
inhibition of Ptd OH formation (Kiss et al., 1992).

1. 2. 4. Effect on cell proliferation
HNE and other 4-hydroxyalkenals possess the capacity of
blocking cell proliferation at concentrations where lethal effects are
low or absent. Schauenstein (1982) and Hammer et al. (1988) reported
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that HNE inhibited Ehrlich ascites tumour cell (EATC) proliferation.
After incubation of EATC in vitro with 0.16 mM HNE for 120 min, the
cell viability did not differ essentially from control cells, but when
treated cells were reimplanted into healthy mice, considerable
inhibition of tumour growth occurred: 90% of animals remained
absolutely tumour-free after 10 days, and 100/0 of the animals showed
considerable inhibition of tumour growth. No animal showed
unchanged tumour growth. Hauptlorenz et al. (1985) also observed that
during exposure of cultured EATC to concentration of 10-20 )lM HNE,
the proliferation was strongly inhibited. These concentrations of HNE
do not affect cell viability and membrane integrity as measured by the
Trypan Blue exclusion method and rubidium uptake. Barrera et al.
(1991b) found that repeated treatment of the HL-60 human
promyelocytic cell line with HNE (1 )lM) caused a strong inhibition of
cell growth without affecting cell viability. Moreover, HNE treatment
induced differentiation of HL-60 cells. HL-60 cells can be induced to
differentiate terminally into either monocyte/macrophage-like cells or
granulocytes by a variety of chemical agents. Like a common inducer of
HL-60 cell differentiation, DMSO, HNE induced chemiluminescence
prodUction, phagocytosing capabilities and enzymatic changes.
There are several possibilities that may explain the inhibition of
cell proliferation induced by HNE:
(1) Inhibition of the DNA polymerase system and DNA synthesis
(Schauenstein, 1982; Hauptlorenz, et al .• 1985). DNA polymerase ex is
an SH-containing enzyme, which can be blocked by sulphydryl reactive
agents including a,

~-unsaturated

aldehydes, such as HNE. However,

isolated DNA polymerase a is rather resistant to HNE (ID 50 = 21 )lM).
it is therefore unlikely that inhibition of cell proliferation and overall
synthesis of DNA results from inhibition of the DNA polymerase system
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(Esterbauer et al., 1991).
( 2 ) Disturbance of the cell cycle (Poot et al., 1988: Miglietta, et
al., 1991) and alteration of the microtubular system (Olivero et al.,
1992). As mentioned above, HNE arrests cells in G2 and G 1 phase,
delays onset of proliferation due to a retardation of the transit of the
cells from GO to G 1 and prolongs the G 1 phase. This severe
disturbance of the cell cycle indicates that HNE-treated cells show a
diminished DNA synthesis and a diminished rate of proliferation.
( 3 ) Interference of the expression of certain genes (Dianzani et
al., 1990).
The property of HNE interfering with the gene expression was
displayed at very low concentrations. HNE specifically blocks c-myc
oncogene expression by a human erythroleukemic cell strain (K 562)
cultivated in vitro. This effect occurs at concentrations of 0.1-1 JlM and
is accompanied by the increase of the expression of the gamma-globin
gene (Dianzani, et al., 1990). The c-myc protein is involved in the
regulation of cellular multiplication.
Low concentration of HNE has also been suggested to reduce
ornithine decarboxylase (ODe) gene transcription (Barrera et al.,
1991a). ODe is the first regulatory enzyme in the biosynthesis of
polyamines. It plays a key role in proliferation both of normal and
neoplastic cells and its induction seems to be a universal mechanism
of growth stimulation by hormones, drugs and tumour promoters. It
has been reported that the inhibition of ODe activity is associated with
a block in cell cycle progreSSion at the G 1 phase. Barrera et al. found
that HNE at 1-10 JlM inhibits the induction of ODe activity in
leukaemic cells by foetal serum. Since HNE did not affect the half-life
of ODe and the same HNE concentration did not inhibit ODe activity
when added to cytosol, they suggested that HNE affects ODe synthesis
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and may act by reducing ODC mRNA transcription.
The mechanism involved in the regulation cell differentiation
still remains relatively obscure (Barrera, 1991 b). It seems that HNEinduced HL-60 cell differentiation is related to regulation of gene
expression. HNE inhibits c-myc gene expression in K562 cell. The
down regulation of this gene is a common feature of several
differentiation processes (Barrera, 1991 b). Induction of HL-60 cell
differentiation by DMSO enhanced synthesis of heat shock proteins
(Barrera, 1991 a). This effect has also been observed after treatment of
hepatoma cells with HNE (Cajone and Bernelli-Zazzera, 1989). It is
reported that treatment of HeLa cells with HNE has the same effect as
heat shock in causing the appearance of a protein that binds to the
sequence of DNA specific for the induction of heat-shock gene
expression (Cajone et al., 1989).
However, in contrast to the inhibitory effect on proliferation of
cells, HNE exhibits some stimulatory effects on gene expression and
cell proliferation.
AscorbiC acid has shown to stimulate collagen synthesis via
stimulation of pro collagen gene transcription. Chojkier et al., (1989)
reported that lipid peroxidation and aldehydes induced by ascorbic
acid and iron accumulated in culture cells may be necessary for the
stimulation of Type I collagen synthesis and collagen a( 1) gene
transcription in cultured AF2 human fibroblasts. They observed that
cOincubation of cells with ascorbic acid and a-tocopherol blocked the
production of TBARS, malonaldehyde-protein adducts and 4-HNEprotein adducts as well as ascorbic acid stimulated-collagen production
indicating that products of lipid peroxidation mediated the ascorbic
acid-induced stimulation of collagen gene expression. They suggested
that protein ad ducts formed with aldehydes derived from peroxidation
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such as HNE may play a role in the increased transcription of the
collagen gene.
Adenylate cyclase and phosphatidylinositol-4,5-bisphosphate
(PIP2 )-phospholipase C (PL-C) are effecter enzymes coupled, through
regulatory G proteins. to specific membrane receptors for hormones
and growth factors. Their reaction products (cAMP for adenylate
cyclase, diacylglycerol (DG) and inositol triphosphate (IP3) for PL-C)
play a prominent role in the control of cell division and proliferation.
HNE at very low concentrations stimulate both of these two enzymes
(at higher concentration, HNE inhibits adenylate cyclase, see Table
1.2.1). 0.1-1

~M

for adenylate cyclase in Fisher rats liver plasma

membrane, 0.01-1

~M

for PL-C in rats liver (Dianzani, et al., 1990,

Rossi, et al., 1990) and 0.01

~M-1~M

for PL-C in plasma membranes

isolated from rat neutrophils (Rossi et al., 1991).
Moreover, HNE (0.001-1

~M)

reduces junctional communication

(JC) among bOvine aortic endothelial cells in culture. JC is reduced
progressively with increasing concentration of HNE. The decrease in
JC does not seem related to general. unspecific inhibition of protein
syntheSiS. At concentrations between 0.001-1

~M.

there is no

reduction in protein synthesis for up to 8h treatment with HNE.
Intercellular communicating junctions are conSidered to be important
for cellular homeostasis, regulation of cell growth and differentiation.
Loss of JC, may help transformed cells to escape from growth control.
Reduction of JC is conSidered to be a general mechanism, among
others, for promotion of uncontrolled cellular proliferation (Radu and
Moldovan, 1991).
Clearly. there are contradictory reports concerning the effect of
HNE on cell proliferation and this topiC needs further investigation to
resolve this contradiction.
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From the discussion above, it can be seen that 4-hydroxyalkenals,
particularly HNE, have two different effects depending on the
concentration. At 10-100 J.lM or above HNE cause acute and unspecific
cytotoxic effects, such as inhibition of DNA-, RNA- and protein
synthesis and leading to cell death. At 0.1-1 J.lM or below, HNE exhibits
physiological functions, modulation of cell proliferation/differentiation
by affecting associated enzyme activity and gene expression. HNE is a
product of lipid peroxidation and under conditions of oxidative stress
the concentration of HNE in tissues can increase to 5-10 J.lM
(Esterbauer et aI., 1989). The membrane concentration of HNE may
reach 100 J.lM (Poli et al., 1987). At this concentration HNE will show
its toxic effects. In fact some cytoxicities of HNE, such as inhibition of
glucose-6-phosphatase activity, reduction of P450 content and
alteration of Ca2 + uptake are observed under the condition of lipid
peroxidation induced by chemicals, for example CCl4 . Lipid
peroxidation also exists in normal tissues at very low level. The
physiological concentration of HNE ranged from 0.1-3 J.lM (Esterbauer,
1990; Esterbauer et al., 1989). At this concentration level, HNE plays a
role in the control of cellular proliferation/differentiation. It has been
suggested that lipid peroxidation has a very important role for control
of cell proliferation (Cheeseman et al., 1986; Slater 1988). The fact
that HNE has a regulatory function on cell proliferation supports this
hypothesis.
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1.3 PART III

RIBONUCLEOTIDE REDUCTASE

1. 3. 1 Ribonucleotide reductase of i£scfiericfiia cofi and mammals

Ribonucleotide reductase (ribonucleoside diphosphate reductase,
EC 1.17.4.1.) and ribonucleoside triphosphate reductase (EC 1.17.4.2.)
catalyse the conversion of all ribonucleotides into their corresponding
deoxyribonucleotides. Since the pool of deoxyribonucleoside
triphosphates is relatively small compared to the rate of DNA
synthesis, ribonucleotide reductase is considered to playa critical role
for DNA synthesis, maintaining an adequate and balanced supply for the
direct precursors of DNA (Thelander and Reichard, 1979; Lammer and
Follmann, 1983; Cory, 1989).
Based upon substrate specificity and cofactor requirements, the
reductase can be classified into three types. The first type reduces
ribonucleoside diphosphates and is best represented by the enzyme
from i£scfiericfiia cofi ('E. coa). This type of enzyme is also found in
mammals, higher plants and in some fungi (Thelander and Reichard
1979; Wright et al., 1989; Lammers and Follmann 1983). The second
type of enzyme reduces ribonucleoside triphosphates, requires 5 ~ deoxyadenosylcobalamin as a factor which is represented by the
enzyme from Lacto6acif{us feicfimanni (Carell and Seeger, 1980). The third
type is characteristic of '13aci![us megaterium and 1\..fiizo6ium me[ifate. This
enzyme requires deoxyadenosylcobalamin as the co-factor but reduces
the ribonucleoside diphosphates (Thelander and Reichard, 1979,
Carell and Seeger, 1980). There is another type of enzyme in which
manganese is involved in ribonucleotide reduction (Lammer and
Follmann, 1983).
48

1.3.1.1. I£sclieridiia coli enzyme

The well characterized ribonucleotide reductase from 'E. coli is
composed of two non-identical proteins Bl and B2, both required for
activity (see Fig. 1.3.1). Protein B2 (Mr=78,000) contains two identical
polypeptide chains

(~~),

that do not dissociate except under

denaturing conditions. Each chain contains a non-haem iron centre
and an oxidized tyrosine free radical which is essential for the
enzymatic reaction (Reichard and Ehrenberg, 1983; Atkin, et al.,
1973). This radical is derived from a tyrosyl residue of the polypeptide
chain and is stabilised by the iron centre. The radical can be
recognized by a sharp peak at 410nm in the optical spectrum and a
characteristic electron paramagetic resonance (EPR) signal (Thelander
and Reichard, 1979; Sjoberg and Reichard, 1977). Protein Bl
(Mr= 160,000) is a dimer of polypeptides (aa#) which are identical in
size but appear to differ in their N-terminal amino acid sequence. Bl
contains two apparently identical binding sites for substrates (CDP,
UDP, GDP and ADP) and four sites for allosteric effectors. Of four
allosteric effector sites, two sites ('h' sites) bind dATP with high
affinity and, in addition, bind ATP, dGTP, and dTTP and determine
substrate specificity of the enzyme. The remaining two sites ('1' sites)
bind dATP with low affinity and, in addition, only bind ATP and govern
the overall activity of the enzyme (Thelander and Reichard, 1979;
Reichard and Ehrenberg, 1983). The active enzyme contains B 1 and
B2 in a 1: 1 stOichiometry. The catalytic site of the holoenzyme is at the
interface of the two proteins comprised of residues from both subunits
with B 1 contributing redox-active sulphydryl groups that donate the
electrons necessary for the reduction and B2 contributing the tyrosine
free radical and the non haem iron (Thelander and Larsson, 1976;
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B1

0

1 site: ATP
dATP
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h site: ATP
dATP
dGTP
dATP
A Substrate
binding site
Oxidized tyrosine
free radical

B2

Fe2 + non-haem
iron centre
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M1

0

ATP
dATP

<>

ATP
dTTP
dGTP
dATP

A Substrate
binding site

Oxidized tyrosine
free radical

M2

Fe2 + non-haem
iron centre

Fig. 1.3.1 Model for

'E.

coG and mammaUan ribonucleotide reductase

(a) 'E. co.G enzyme; (b) mammalian enzyme
(Modified from Wright, 1989 and Whitfield and Youdale, 1989)
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Thelander and Reichard, 1979; Lin et al., 1987). The cross-linking
data support a model in which both of the p-subunits interact closely
with only one of the two ex subunits (Mathews et al., 1987). C-terminal
ends of the B2 protein are involved in the interaction with the Bl
protein (Climent et al., 1991).

1.3.1.2. The mammalian enzyme
Mammalian ribonucleotide reductase appears to resemble the 'E.

cofi enzyme with respect to its substrate, iron and free radical
involvement. Studies on the enzyme from Ehrlich ascites hepatoma
tumour of mice (Cory et al., 1978), rat Novikoff hepatoma (Moore,
1977), human lymphoblast cell line (Molt-4F) (Chang and Cheng,
1979), rabbit bone marrow (Hopper, 1972), calf thymus (Thelander et
aI., 1980; Engstrom, et al., 1979), mouse fibroblast 3T6 cell (Larsen et
aI., 1982), and rat regenerating liver (Youdale and MacMances, 1979;

Youdale rt al., 1982) have revealed that several properties of the
mammalian enzyme are Similar to those of the enzyme obtained from
'E. corio

In mammalian cells, the enzyme consists of two non-identical
subunits called Ml and M2. These two components have functions
equivalent to the B 1 and B2 proteins of the 'E. cofi reductase (Cory et
aI., 1978, 1979; Thelander and Reichard, 1979; Thelander et aI.,

1985; Nutter and Cheng, 1989) (see Fig. 1.3.1). Protein Ml is a dimer
and it contains two kinds of effector binding sites, one kind specific
for ATP or dATP (activity site) and the other kind capable of binding
ATP, dATP, dTIP and dGTP (specificity site), but only one catalytic site
which forms, or becomes functional when Ml subunits couple with M2
subunits. There is no indication of the presence of high- and low51

affinity binding sites for dATP (Thelander et al., 1980). The M2 protein
is a dimer too and it contains two non-haem iron centres and a tyrosyl
free radical essential for activity (Thelander et al., 1985; Ochiai et al.,
1990). Both iron and radical centre seem to be the same as in the
bacterial protein (Thelander et al., 1985; Akerblom et al., 1981;
Graslund et al., 1982). Molecular weights of the intact enzyme and
separated components of some mammalian reductases were
summarised by Nutter and Cheng (1989) (see Table 1.3.1).

1.3.1.3. Mechanism of ribonucleotide reductase reaction
In 1£. cofi and mammalian cells the reduction of the four
ribonucleotides occur at the diphosphate level, (NDP to dNDP) and
involves the replacement of a hydroxyl group by a hydrogen. It appears
likely that the enzyme reaction involves a direct replacement of the
hydroxyl group at carbon 2# of NDP by a hydrogen (Thelander and
Reichard, 1979; Lammer and Follmann, 1983). In addition to the
ribonucleotide reductase, two small proteins, thioredoxin and
thioredoxin reductase, which is a flavoprotein, also participate in the
reduction process as hydrogen carriers. The electrons are originally
from NADPH (Thelander and Larsson. 1976; Thelander and Reichard,
1979). The scheme for the ribonucleotide diphosphate reduction in 1£.
cofi is shown in Fig. 1.3.2. Reduced thioredoxins do not directly donate

H to a substrate but first reduce an enzyme disulphide bridge. During
enzymic catalysis, the B 1 subunit alternates between two forms, the
active dithiol form and the inactive disulphide form, which is
continuously regenerated by thioredoxin (Sjoberg and Reichard, 1977;
Lammer and Follmann, 1983). There are at least 4 redox-active
cysteine thiols in the reductase B1. The role of thiol residues in the
reductase catalYSiS is much more complex: two pairs of thiols are
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Table 1.3.1 Molecular weights of mammallan ribonucleotide reductase and their components
Component
Source

Holoenzyme

Effector-binding (Ml)

Non-haem iron (M2)

Rat NovikofI ascites

200,(XX) - 250,<xx> •

Regenerating rat liver

280,OOOt

180,000 •
90,000 #
45,000 #, t (CDP reduction)

120,000 t

100,000 EB

75,000 + 47,000 #
100,000 EB

84,000 #

55,000 #

98,000 EB
84,000 #

110,000 • , EB
58,000 #

127,<XX>§

81,000 §

Human lymphoblast
0'1
W

210,000

EB

Calf thymus

Mouse Ehrlich
tumour
Mouse
lymphc&lrcana

340,00 § (CDP reduction)
254,000 § (ADP reduction)

95,000 §

89,000 #

Methodological criteria: • gel filtration, # SDS-polyacrylamide gel electrophoresis, EB sedimentation velocity,
§ sedimentation eqUilibrium, t molecular exclusion high perfonnance liqUid chromatography.
(Adapted from Nutter and Cheng, 1989)
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Fig. 1.3.2 Reduction of ribonucleotide diphosphate to deoxyribonucleotide
diphosphate in 'E corio
(Adapted from Thelander and Reichard, 1979)

involved in catalysis, one being responsible for substrate reduction and
the other for shuttling reducing equivalents from the external reducing
system into the active site (Ashley and Stubbe, 1989). The role of the
B2 free radical in the substrate reduction is not very clear, but it
directly participates in the catalytic process together with the
oxidation-reduction active dithiols of Bl (Thelander and Larsson,
1976; Sjoberg and Reichard, 1977; Ashley and Stubbe, 1989).
A single 1£. coCi reductase reduces all four ribonucleotides
(Thelander and Reichard, 1979; Cory, 1989). The mammalian
enzymes, on the other hand, seem to be more complicated. Youdale et
al (1982) proposed that there are four different Ll (or Ml) subunits
each specific for the reduction of a particular ribonucleotide (ADP,
UDP, CDP and GDP) attached to one L2 (or M2) subunit in rat liver. A
similar conclusion suggesting that there may be more than one kind of
Ml subunit in rat liver comes from Whitfield (1989) who observed that
the Ml C-terminal anti-serum inhibits CDP-reductase activity almost
completely in extracts from 24h regenerating liver, but this anti-serum
does not affect ADP reductase activity. Carter and Cory (1989) found
that elevated CDP and ADP reductase activity in hydroxyurea-resistant
cells (hydroxyurea is a specific inhibitor of the reductase, see below)
are not coordinately increased indicating that the two enzymes are not
identical. Based on the observations of the enzyme from Ehrlich
hepatoma tumour cells, mouse L cell lines, and CRO cell lines, Cory
and Fleischer (1982 a) suggested that the intact mammalian reductase
is made of a non-haem iron component (M2) that is common to all
substrates and an effector-binding component (Ml) which is specific
for each substrate. There are conflicting conclusions. Chang and Cheng
(1979) reported ADP- and CDP- reductase activity may exist in the
same enzyme of human lymphoblast cells (Molt-4F) but have different
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active sites. With the enzyme from calf thymus, Ericksson (1979)
claimed that only one enzyme catalyses the CDP, UDP, GDP, and ADP
reduction. However, their data are not sufficient for the conclusion that
the four substrate are all reduced by the same enzyme (Cory and
Fleischer, 1982 a).

1.3.1.4. Location of the enzyme
Although it was once postulated that the ribonucleotides were
reduced in the nucleus, using immunohistochemical and subcellular
fractionation techniques it has been demonstrated that the enzyme is
exclusively localised in the cytoplasm and the activity is present in the
cytoplasm (Elford et al., 1972; Chang and Cheng, 1979; Hansson et al.,
1986; Kucera and Paulus, 1986).

1.3.2 Relationship between ribonucleotide reductase activity and the
growth of tissues and cells

The levels of deoxyribonucleoside triphosphates in cells are very
low. It is found that the dNTP pools are suffiCient to support DNA
synthesis for only 1-5 min (Elford. 1974). Therefore. the reductive
conversion of ribonucleotides to deoxyribonucleotides is believed to be
a crucial and rate-controlling step in the pathway leading to the
biosynthesis of DNA and the enzyme that catalyses the reduction.
ribonucleotide reductase is conSidered to play a key role in cell
division and its activity closely correlates with the tissue growth
(Elford, 1970,1972; Takeda and Weber, 1981).

1.3.2.1 Activity in proliferating tissue
Based on research into the relationship between reductase
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activity and growth rate of hepatomas. Elford et al. (1970; 1972) found
an excellent correlation between tumour growth rate. which is defined
as the average time required for the development of a viable
transplantable tumour. and the activity of the reductase (see Fig. 1.3.3).
Differences of 200-fold in enzyme specific activity exist between the
very fast- and the slow-growing hepatomas. The experiments of Takeda
and Weber (1981) support this finding. They showed that the
reductase activity is markedly increased in hepatomas compared to the
normal liver and the rise in activity correlates pOsitively with the
growth rate of the tumours.
A strong correlation between the enzyme activity and tissue
proliferation is also found in the profile of the enzyme activity during
neonatal development in several rat organs. Rat foetal liver extract has
a very high level of enzyme activity. At the time of birth. there is a
sharp decrease in activity. One week after birth there is only a very
small amount of activity remaining. 1/20 of the newborn liver activity
and only 1/200 of the 18-19-day foetal liver extract activity. No activity
can be detected in adult rat liver. In developing rat spleen. the
•

maximum activity occurs at a time when the onset of white cell
production is initiated. at six days after birth. In the developing rat
thymus. the enzyme is very low at the time of birth and then rapidly
increases. The maximum peak of activity occurs at about the time that
the thymus is able to colOnise the lymphoid system and synthesize a
new pattern of immunoglobulins (Elford. 1972). The activity of the
enzyme is also markedly increased in regenerating liver (King and
Lancker. 1969; Elford. 1974; Cory and Fleischer, 1982 b; Takeda and
Weber. 1981). The main events preceding cellular division and cellular
multiplication after partial hepatectomy are DNA synthesis. which in
the rat starts at 18h post operation. and mitosis which starts 6h later
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Fig. 1.3.3 Relationship between tumour growth rate
and ribonucleotide reductase activity
(Adapted from Elford, 1972)
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(King and Lancker, 1969). According to Elford (1974) there is no
detectable activity in normal rat liver, or in 5h, 12h, and 18h
regenerating rat liver. However, appreciable activity is seen 24h after
hepatectomy and is further increased after 36h.
Further evidence for the close involvement of reductase in
replication is provided by the organ distribution of this enzyme activity.
Among 14 different tissues of the rat the activity is highest in the
organs of active cell renewal: namely, in the thymus, bone marrow,
spleen, mucosa of small intestine, and colon mucosa. In other organs
activity is only found in trace amounts in the brain and adipose tissue
(Takeda and Weber, 1981).

1.3.2.2. Activity during cell cycle
Many investigations have uncovered a critical association between
the mammalian reductase activity and cell growth. There is a strict
relationship between the measured reductase levels and the fraction of
the cell population that is replicating DNA (Turner et al., 1968). The
activity of the enzyme has been shown to vary in cells at different
phases of the cell cycle. The enzyme activity is low in resting cells
during GO-G 1 and increases dramatically just prior to and during
periods of DNA synthesis, S phase, and then returns to a low basal
level near the end of S phase (Eriksson and Martin, 1981; Cheranne
and Caldini, 1986; Rubin and Cory, 1986).
The mammalian enzyme is composed of two proteins M 1 and
M2. The proteins are associated but can be separated into two inactive
components which constitute an enzymatically active complex when
recombined. In contrast to the enzyme in 'E.

co[~

the two subunits of

the mammalian reductase are not coordinately increased and
decreased during the cell cycle (Lammers and Follmann, 1983; Nutter
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and Cheng, 1989). Although it is in agreement that the two subunits of
mammalian enzyme are not coordinately expressed, there are two
opposite conclusions concerning which subunit is the controlling or
limiting component for enzyme activity in G 1 when holoenzyme is low.
Cory and Fleischer (1982 b) reported that in Ehrlich ascites
tumour cells, the decrease in CDP reductase activity which
accompanies decreased proliferation in vivo, is correlated with the
decrease in the effector-binding component (Ml) since the addition of
this component to cell-free extracts stimulated CDP reductase activity,
and the addition of non-haem iron content component (M2) had no
effect. Rubin and Cory (1986) found that in L1210 murine leukemia G1
phase cells, addition of exogenous effector-binding subunit markedly
increased the level of CDP reductase activity indicating an excess of the
non-haem iron subunit and a limiting amount of the effector-binding
subunit. Whitfield et al (1989) demonstrated that in regenerating rat
liver cells functional M2 subunits start accumulating rapidly around 2h
before the onset of DNA replication. Only when the M2 subunits reach
a certain level do M1 subunits appear and combine with waiting M2
subunits to form the active reductase holoenzyme needed for DNA
replication. Thus, from these results it is suggested that the Ml
subunit controls the level of reductase holoenzyme.
By contrast, another group of experiments show that Ml is in
excess and the enzyme is controlled during the cell cycle by the level
of M2 protein. The increased overall enzyme activity in cells from the
S phase of the cell cycle is shown to be due to an increased M2 protein
activity, and the M1 protein is practically constant in G 1 and S phase
cells. When mouse S49 lymphoma cells are arrested by

B~cAMP

(N6,02_dibutyryI3'-5'-monophosphate) in the G1 phase, addition of
M 1 protein gave no stimulation of the reductase activity from treated
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cells but the addition of M2 protein resulted in a stimulation of the
t

activity indicating that the decreased enzyme activity in

B~

cAMP-

treated G I-arrested cells is mainly due to the limiting M2 protein
t

activity. When a population of dividing cells was subfractionated as
follows:
(i) 900/0 cells in G 1
(ii) 310/0 cells in G 1 and 680/0 cells in S/G2

(iii) 950/0 cells in S/G2
the specific activity of M 1 protein was found to be similar in all 3
fractions and close to that of an unfractionated population however
t

t

the specific activity of protein M2 is very similar in fraction (ii) and
(iii) but in the fraction (i) it is decreased to approximately one-third
t

(Eriksson and Martin 1981). In hydroxyurea-resistant M2-overt

t

producing mouse mammary tumour TA3 cells the concentration of the
t

M2-specific tyrosyl radical increases when cells pass from the GO/G1
phase to the S phase of the cell cycle. Using two independent methods
to obtain a synchronized cell population centrifugal elutriation and
t

isoleucine starvation it was found that both Sand G2 cells contain high
t

levels of protein M2 whereas very little is found in GO / G 1 cells
t

(Erissson et al. 1984). In bovine kidney MDBK cells, no correlation
t

was observed between the protein level of M 1 which was determined
by the use of a two-site monoclonal antibody-enzyme immunoassay and
the number of cells in the S phase. Instead, M1 protein is constant
through the cell cycle. However, M2 protein increases in S phase in
parallel with an increase in reductase holoenzyme activity. Addition of
an excess of pure Ml gave no stimulation of the enzyme activity.
Addition of purified M2 protein resulted in a pronounced stimulation
of enzyme activity (Engstrom, et al., 1985). These studies suggest that,
at least in these cultured cell lines, the M2 protein is limiting for
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ribonucleotide reductase activity during the cell cycle (Wright, 1989).
Other evidence that supports the view that M2 controls the enzyme
activity come from Strandart et al (1985, 1986) who showed that
unfertilised clam and sea urchin maintain a pool of functional M 1
subunits and a pool of untranslated M2 mRNA which translate only
after fertilisation.
Mann et al. (1988) defined the kinetic feature of M1 expression
related to transitions into, within, and out of the cell cycle by directly
studying its expression during a variety of cell kinetic events. They
observed that the M1 subunit is continually

expressed by rapidly-

cycling cultured cells throughout the cell cycle. The level in G 1 is even
slightly higher than in later parts of the cell cycle, whereas quiescent
(GO) cells have virtually no Ml. Their data further reinforce the view

that M1 protein levels do not limit activity during G l. These results
indicate that when proliferation ceases, M1 falls in these 'out of cycle'
cells. This is in agreement with the result that protein M 1 is not
present in all cells, it is only present in proliferating cells of rat tissues
(Engstrom et al., 1985). A similar observation was made by Whitfield et
al., (1989). They observed that cells in intact rat liver make functional
M 1 protein only when replicating DNA. When quiescent, or after
finishing DNA replication the liver produces a fragment of the
functional M1 protein. This fragment in the quiescent, intact liver is
not functional.
However, the precise relationship between the changes in the
M 1 and M2 level during the cell cycle has not yet been determined
(Sato and Cory, 1986).
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1. 3. 2. 3

The relationship between other enzymes associated with
DNA metabolism and cell proliferation

Apart from ribonucleotide reductase, other enzymes are involved
in pyrimidine and purine metabolism, such as thymidylate synthetase,
thymidine kinase, uri dine kinase, and uridine
phosphoribosyltransferase etc. However, ribonucleotide reductase plays
a pivotal role in the biochemical programme of proliferation. Elford et
al. (1970) indicated that although thymidine kinase is markedly
elevated in the hepatomas and that the increases are related to growth
rate, discrepancies were observed and this enzyme is a salvage pathway
enzyme and not a

ae novo synthetic one.

The activity of thymidylate

synthetase appears elevated in hepatoma tumours, but the degree of
correlation between this enzyme activity and growth rate of the tumour
is quite limited, especially in the rapidly growing tumour (Elford et al.,
1970). The largest measurable difference in thymidine kinase and
thymidylate synthetase activities between the fast-growing, poorly
differentiated tumours and slow-growing, well-differentiated tumours,
are less compared with the difference in ribonucleotide reductase
activity, only about 20-fold in the case of thymidylate synthetase and
50-fold in the case of thymidine kinase (Elford, 1972). Ribonucleotide
reductase activity in fast-growing tumours is 200-fold higher than the
enzyme activity in slow-growing tumours. Takeda and Weber (1981)
observed that when cells are freshly plated and allowed to grow for a
96h period, ribonucleotide reductase is the first enzyme activity to
rise at 6h among the enzymes mentioned above. The only other
parameters measured that rise as early as 6h after plating are the
incorporation of cytidine and deoxycytidine into macromolecules.
These results indicate that the correlation of the ribonucleotide
reductase activity with DNA synthesis and tissue growth rate is much
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closer than the other enzymes associated with DNA synthesis.
Additionally, the physiological reducing complex, thioredoxin/
thioredoxin reductase is also shown not to be the rate-limiting factor
accounting for the large differences in the reductase activity observed
between the various hepatomas (Elford, 1972).

1. 3. 3. Regulation of ribonucleotide reductase activity

Ribonucleotide reductase from all sources so far examined
exhibits complex control by different mechanisms of regulation from
holoenzyme activity level to the molecular level.

1. 3. 3.1 Product feed back regulation
The enzyme activity has been shown in both mammalian and
bacterial systems to be regulated in a very strict allosteric fashion by
nucleoside 5' -triphosphates and nucleoside 5' -diphosphates that can
serve as positive and negative effectors (Thelander et al., 1980;
Eriksson et al., 1981; Cory, 1973; Cory et al., 1985 b; Hards and
Wright, 1984). There are two genetically independent regulatory
domains on the protein M1 molecule, one responsible for regulating
substrate specificity of the enzyme and the other for regulating its
overall activity (Erikson et al., 1981) (see Table 1.3.2).
The most widely cited regulatory model for the mammalian
reductase is that described by Thelander and Reichard (1979) and
Thelander et al. (1980). According to this model, the regulation of
enzyme activity is proposed to occur as follows. The holoenzyme is
activated when ATP causes the formation of an M1 dimer containing
two kinds of effector sites and one kind of catalytic site. When ATP
occupies both of the effector sites, the M1 catalytic site switches to its
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Table 1.3.2 Regulation of E. coli and mammalian ribonucleotide
reductase by ribonucleoside triphosphate

Activity site
Binds
ATP

Specificity site

Effects

Binds

Substrate reduced

ATP

activation

CDP
}

dATP

inhibition

dATP

UDP

dTIP

GDP

dGTP

ADP

(Adapted from Eriksson et al., 1981)
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CDP/UDP reductase mode. However, when the increasing amount of

dTIP formed from dUDP eventually displaces ATP from one of the M1
effector sites, the catalytic site switches from its CDP IUDP reductase
mode to its GDP reductase mode. The increasing amount of dGTP
displaces dTIP from the effector site and stops GDP reduction by
Switching the catalytic site to its ADP reductase mode. Finally, the
cycle or pulse ends when dATP displaces ATP from one
of the effector sites and switches off the enzyme. However. this model
was constructed using data obtained with cell-free extracts, and there
are indications that in vivo regulation of the enzyme may not entirely
agree with this model. Using an intact cell assay system, Hards and
Wright (1984) modified the model. They suggested that GTP, or
perhaps dCTP, should be included in the model for the enzyme
regulation (for activation of CDP and ADP reduction). Since it is
indicated that mammalian reductase consists of one of four distinct M 1
subunits plus one M2, in the new modified model, it is assumed that all
four possible M 1 subunits would possess a Similar regulatory site to
which dATP binds to inhibit enzyme activity. Each subunit should also
possess a nucleoside specific site but, unlike the in vitro model, it is
proposed that each Ml subunit can bind only those nuc1eotides which
activate the particular substrate it binds. Cory et al., (1985 b)
demonstrated that nucleoside

5~ -diphosphates

and the direct products

of the enzyme reaction, deoxynucleoside 5-diphosphates can also serve
as positive and negative effectors respectively. dNDPs act as noncompetitive inhibitors with respect to the substrate.
The question arises whether the difference in reductase activity
between the various tissue and cell phases are the consequence of an
alteration in the enzyme from an inactive to active state as mediated by
allosteriC agents. or whether they represent an increase in enzyme
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synthesis. Takeda and Weber (1981) suggested that it is unlikely that
the enzyme activity in rapidly proliferating tissues is controlled by
modulation of the enzyme activity by feedback inhibitors. In most
mammalian systems the inhibition of purified enzyme activity achieved
by dNTPs was not verified in the actual cellular concentration of these
metabolites. In normal, regenerating and newborn rat liver and in
slowly and rapidly growing hepatomas, there is a growth-rate-related
increase in the levels of dATP, dGTP, and dTTP. The concentrations
required to inhibit 500/0 of the activity of CDP reductase from
regenerating liver and rapidly growing hepatoma are much higher than
those normally found in tissues. Thus, Takeda and Weber proposed that
the activity of reductase in the liver and in hepatoma is controlled
chiefly by the amount of the reductase present in the cell. Elford et al ..
(1970) believed that the gross changes in enzyme activity observed in a
series of hepatoma tumours represent different rates of enzyme
synthesis and degradation in response to the cell requirement for DNA
synthesis rather than response to an alteration in the state of the
enzyme from an inactive to an active state. The allosteric control
probably exerts a fine control on the reaction by assuring that a
balanced supply of deoxyribonucleotides is synthesized and preventing
an excess supply of free deoxyribonucleotides since excess
deoxyribonucleoside triphosphates are cytotoxic to cells (Cory, 1989).
However, Albert and Gudas (1985) claimed that the increased
reductase activity seen in mouse T-Iymphoma S49 S phase cells
compared with G 1 arrested cells is not due to a large induction of the
synthesis of either the M1 or M2 subunit. Allosteric control of the
enzyme accounts for some changes in dNTP pools, or enzyme activity
during the cell cycle. especially in G 1 phase.
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1. 3. 3. 2

Regulation through free radical activation

The enzyme activity of protein M2 depends upon the presence of
the tyrosyl radical. The regeneration of the radical is an intrinsic
property of M2 protein provided that iron, dithiothreitol and oxygen
are present (Thelander et al., 1983;1985). The thymus enzyme might
not permanently contain a free radical species but instead forms such a
species only during the reaction (Engstrom et al., 1979). These facts
imply that cells may have a mechanism for controlling reductase
activity by generating the free radical of M2. Two experiments support
this proposal. Using a cell line (mouse fibroblast 3T6) resistant to
hydroxyurea, Akerblon et al. (1981) and Graslund et al. (1982)
observed a 20-fold increase in M2 tyrosine free radical content
compared to that seen in non-resistant cells, but only about a 3-fold
increase in the amount of M2 protein indicating that part of the
increase of enzyme activity is due to the modulation of the free radical.
Probast et al. (1989) observed that the radical concentration in
cultured Ehrlich ascites cells decreased under hypoxia and increased
again upon re-aeration. At the same time, CDP reductase activity
changed in the same way as the radical concentration: CDP reduction
was greatly diminished and reactivated respectively under hypoxia and
re-aeration. However, it is suggested that normally there is no pool of
radical-free M2 protein present in cells (Eriksson et al., 1984;
McClarty et al., 1987 b). There is still no concrete evidence whether
the balance between radical containing and radical-free enzyme
reflects an additional regulatory mechanism.

1. 3. 3. 3

Regulation through the changes of the level of enzyme
protein

It is suggested that perhaps in the cell the components of the
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reductase do not exist as a tightly bound entity because the subunit
components of the enzyme are dissociable (Cory and Fleischer, 1979).
This may be an important factor in the regulation of this enzyme in the
intact cell. This suggestion plus the fact that M1 and M2 can exist
independently in the cell cycle indicate that M 1 and M2 are able to be
regulated differently in the cell. In recent years, some studies concern
in particular the molecular regulation of M1 and M2. Usually these
studies have used a valid model, hydroxyurea-resistant mutant cells,
since these cells have an elevated activity of ribonucleotide reductase
and the increased enzyme activity is related to an increase in the
enzyme level rather than to marked alterations in activity (Choy et al.,
1988; McClarty et al., 1987 a,b; Hurta and Wright, 1990 a, b; Bjorklund
et al., 1990). Mutants altered in the reductase activity would be
val uable tools for analyzing the complex structural, regulatory, and
functional properties of the mammalian enzyme (Wright, 1989). In
general, compared with wild -type cells, M 1 protein and M2 protein
levels are increased in the mutant cells though the increase in the M2
level is much higher than in Ml. For example, hydroxyurea-resistant
mutant mouse L cells contain apprOximately 50-fold more M2 than its
wild-type counterpart whereas M1 protein is over-produced 2-3-fold
in mutant cells compared to wild-type cells (McClarty et al., 1987 a, b).
Both protein increases are accompanied by corresponding elevation in
the levels of mRNA for both subunits and increased rates of
transcription of both genes. Usually the M2 mRNA transcript was
dramatically overproduced in the mutant cell while only the most
highly resistant lines show increases in M1 mRNA as well (McClarty et
al., 1987 a, b; Choy et al., 1988; Hurta and Wright, 1990 a,; Albert et al.,
1990). The increased level of M2 mRNA is frequently associated with
amplification of the M2 gene. In contrast, M1 gene amplification in
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hydroxyurea resistant cell lines appears to occur only rarely, and seems
to be associated with the most highly drug resistant cells, for example
in the cells which are resistant to 15 and 30 mM hydroxyurea
(McClarty et al., 1987a; Wright, 1989; Hurta and Wright, 1990 b).
Moreover, Ml and M2 protein levels are further elevated when the
drug (hydroxyurea) is present, i.e. mutant cells grown in the presence
of hydroxyurea contain more M 1 and M2 protein than the same cells
grown in the absence of the drug. However the levels of M 1 and M2
mRNA are essentially unchanged when the mutant cell line is grown
under two different conditions, one is presence of HU and the other is
absence of HU (McClarty et al., 1987 a; 1988). These results suggest
that these kinds of change in M 1 and M2 proteins occur by a posttranscriptional mechanism, such as an increase in half-life or through
an increase in protein biosynthetic rate (Choy et al., 1988). It is
observed that when mutant cells are cultured in the presence of
hydroxyurea, the half-lives of both proteins Ml and M2 are increased
by approximately 2-fold but the increase in the rate of M1 and M2
biosynthesis occurs slowly. The level of protein M2 rises much more
rapidly than protein M1 (McClarty et al., 1988). These observations
show that multiple mechanisms are involved in the regulation of the
two proteins of the enzyme.
The regulation of M 1 and M2 protein levels through the changes
of mRNA concentrations seems to be a common mechanism for a
increase of enzyme activity in hydroxyurea -resistant mutant cells for
achieving resistance to hydroxyurea (McClarty, 1987 a, b). Perhaps this
is also an important regulation mechanism which accounts for both the
S phase dependent reductase activity expressed as the cell pass
through the cell cycle, and the enzyme elevation in rapidly dividing
tissues. From the results of measuring the levels of M 1 and M2 mRNA
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during the cell cycle in centrifugally elutriated cells and cells
synchronized by isoleucine or serum starvation, it has been shown that
the levels of both transcripts are very low or undetectable in GO / G 1
phase, have a pronounced increase as cells progress into S phase, and
then decline when cells progress into G2 + M phase (Bjorklund et al.,
1990). Many investigations have shown that

ae novo synthesis of the

reductase is a major contributor for the increase of the enzyme activity
in rapidly proliferating tissue since the protein synthesis inhibitor
prevented expected increases in enzyme activity during the neonatal
development of spleen and thymus in the rat (Elford , 1972) and when
cells approached S phase (Lammers and Follmann, 1983).

1. 3. 4 Inhibition of ribonucleotide reductase activity

1. 3. 4. 1 Chemical inhibitors

The complex structure and molecular mechanism of the
reaction of ribonucleotide reductase enzymes make them vulnerable to
many kinds of disturbances (Lammers and Follmann, 1983). The
enzyme from all sources is easily inhibited by one or more of the
following inhibitors.
i) inhibitors which destroy or hinder generation of the radical.

ii) inhibitors which affect the metal ion which has structural
or catalytic function.
iii) inhibitors which affect the effector-binding component (M1
or B 1) or specially inactivate the catalytically-active dicysteine
system.
iv) inhibitors which block the substrate or the effectornucleotide binding sites and require a functional enzyme.
v) inhibitors which cause disturbance of the native protein
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structure which is important for activity.
Several different compounds have been shown to be relatively
specific inhibitors of ribonucleotide reductase (see Fig. 1.3.4).

i) Free radical scavengers and inhibitors of free radical formation

( a ) Hydroxyurea (HU)
HU is a known antineoplastic drug employed in clinical
chemotherapy for solid tumour as well as acute and chronic leukemia
and a widely used tool for reversible inhibition of replicative DNA
synthesis in cell synchronization in vitro and in vivo (Lammers and
Follmann, 1983; Wright, 1989). It is a highly specific and extenSively
studied inhibitor of ribonucleotide reductase. It is generally agreed
that its mechanism of action is by scavenging and destrOying the
tyrosine free radical of the M2 or B2 subunit of the reductase. In
studies using homogeneous

'E. coCi

reductase in vitro. Atkin et ale (1973)

observed that the drug was shown to scavenge and destroy the radical
of protein B2 resulting in an inactive enzyme. Meanwhile the iron is
not removed nor apparently affected in any way by the treatment with
HU. The experiments of Larsen et al. (1982) gave further support that
the free radical in protein B2 is the target of HU. Using a model system
using the free radical salt,

(S03S)2NO' ,

replacing the tyrosine free

radical of the reductase, they found that there was a positive
correlation between the free radical scavenging ability of HU and its
analogues, and the ability to inhibit ribonucleotide reductase activity. In
an analogous mode of action such as with the bacterial enzyme, HU also
acts as a radical scavenger of the tyrosyl radical of the M2 subunit of
mammalian reductase as well (Lammers and Follmann, 1983). After
incubation of HU-resistant, M2 overproducing mouse fibroblast 3T6
cells with 50 mM HU for 15 min. The EPR spectrum of free radical
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,',

disappeared completely (Akerblom et al., 1981). When HU-resistant
mutant mouse L cells were grown in the presence of HU the free
radical concentration decreases dramatically compared with the same
cell line grown in the absence of drug. This is the result of HU
destrOying the M2 tyrosyl free radical, leading to the loss of the EPR
signal (McClarty, 1987a).
The reductases from regenerating liver (King and Lancker,
1969), calf thymus (Engstrom et al., 1979), human cells (Chang and
Cheng, 1978; Larsen et al., 1982), mouse cells ( Akerblom et al.,
1981), 'E..coli (Atkin et al., 1973). bacteriophage T4 (Yeh and Tessman,

1978;

Vant~t

Riet et al., 1979 ) are all inhibited by HU. Reduction of

CDP, ADP, and GDP by different mammalian enzymes is as sensitive to
HU (IC 50 = 2-4 x10-4 M) as is the 1£. cofi enzyme (Lammers and
Follmann, 1983). HU inhibits the homogeneous calf thymus enzyme in
a concentration dependent fashion. The activity is inhibited 900/0 by
1mM HU (Engstrom, et al., 1979). This degree of inhibition is very
similar to that observed with homogeneous 1£. cofi reductase (Engstrom
et al., 1979). The M2 activity in HU-resistant mouse fibroblast 3T6
cells is increased 30-fold. The reductase isolated from such cells
shows the same sensitivity towards HU inhibition as the enzyme from
normal cells (Akerblom et al., 1981). However, mouse TA3 cells,
selected for resistance to HU, also overproduce the M2 subunit of the
reductase and the enzyme from such cells is more resistant to HU than
the enzyme from parent cells (Larsen et al., 1982). The mechanism of
HU inhibition is different for enzymes from different sources. The
effect of HU on the thymus enzyme is reversible (Engstrom et al.,
1979). After removal of the drug by gel filtration, the enzyme regained
its original activity. Like the intact calf thymus reductase, isolated M2
of thymus enzyme was affected reverSibly by treatment with HU
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(Thelander et al., 1980). The same, reversible inactivation of the
reductase occurred during preincubation of T4 enzyme or its isolated
subunits with HU (Bergland and Sjoberg 1979). However this
reversible effect is in strong contrast to what happens with the
enzymes from Ehrlich ascites tumour cells and 1£. coli. HU inhibits 1£. coa
enzyme in an irreversible -fashion (Atkin et al., 1973; Thelander and
Reichard, 1979). For the partially-purified reductase from Ehrlich
ascites tumour cells, HU is an irreversible inhibitor (Cory et al., 1978;
Cory and Fleischer, 1979).
The reductase of phage T4 and 1£. coli is a single enzyme
controlling the reduction of four common nucleotides: CDP, ADP UDP
and GDP. The effect of HU on each reduction activity of T4-infected
cells has been investigated. Yeh and Tessman (1978) found that HU
inhibited reduction of the four common substrates in T4' but HU had
considerably smaller effect on the reduction of UDP and GDP than on
the reduction of CDP and ADP. Contrary to this, Bergland and Sjoberg
(1979) found that HU was a potent inhibitor of the reduction of all four
ribonucleotide substrates in phage T4; the differences between the four
substrates were negligible. The same investigations were performed on
the enzymes from

'E. coli

and human cells. Bergland and Sjoberg

reported (1979) that there is no difference in the effect of HU on
reduction of GDP and CDP in

'E. co{i.

Chang and Cheng (1978) reported

that CDP reductase activity from human cells (Molt-4F and KB cells)
was more sensitive to inhibition by HU than was ADP reductase activity.
HU inhibits DNA synthesis in eukaryotic cells and also in
prokaryotes. This effect is mediated via inhibition of ribonucleotide
reductase leading to decreased dNTP pools (Skog et al., 1987; Yeh and
Tessman, 1978). A consequence of the depletion of the necessary DNA
precursors is inhibition of cellular growth (Platz and Sjoberg, 1984). In
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most mammalian cells, HU concentration of about 2x10- 3 M prevents
DNA replication, cell proliferation, and in vitro ribonucleotide reduction
(Lammers and Follmann, 1983). HU at 200}.lM will inhibit the growth
of L1210 cells in culture (Sato et al .. 1982). In the presence of 60}.lM
of HU, the growth rate of mouse S49 T-Iymphoma and human CEM Tlymphoblastoid cells was diminished by about 250/0 (Skog et al .. 1987).
Therefore, HU has been widely used in chemotherapy to inhibit the
growth of neoplastic cells, especially in the treatment of leukemia (Yeh
and Tessman, 1978).

( b ) Other inhibitors
2,3-dihydro-1H-pyrazolo-(2,3-~-imidazole

(IMPy) is a relatively

potent and selective inhibitor of DNA synthesis without affecting RNA
or protein synthesis. It inhibits the reductase from HEP-2 cells and
L1210 cells (Cory and Fleischer. 1980; Goddard et al., 1987). The
results from Cory and Fleischer indicate that the site of the IMPY
target is on M2. The ADP reductase activity was inhibited to a greater
extent than was CDP reductase activity by IMPY and the inhibition is
irreversible. IMPY is also shown to be a inhibitor of HSV-1 reductase,
but the effect is reversible (Spector and Jones. 1985).
Guanazole inhibits the mammalian enzyme by a mechanism
Similar to HU. acting as a radical scavenger and destroying the tyrosine
free radical of protein M2 (Larsen et al .. 1982). The inhibitory effect of
guanazole on the mammalian enzyme (human epidermoid carcinoma
cells) is 10-fold more effective than on the HSV-1 enzyme (Spector
and Jones. 1985).
Thiosemicarbazone derivatives comprise the most active
inhibitors of the mammalian enzyme (Lammers and Dollmann. 1983).
Formylisoquinoline thiosemicurbazone (MAIQ) and 1-formylisoqui76

nolinethiose thiosemicarbazone (IQ-1) are more potent inhibitors than
HU on human cell reductase activity and cell growth (Chang and
Cheng. 1978). MAIQ is at least 100 times more active than HU (Carter
and Cory. 1989). In the presence of oxygen both of them can destroy
the tyrOSine free radical of the M2 subunit of purified calf thymus
reductase (Thelander and Graslund. 1983). This is in consistent with
the observation using Ehrlich tumour enzyme that only the addition of
exogenous M2 subunits to the MAIQ-treated intact enzyme and the
enzyme from the MAIQ-treated cells can restore enzyme activity (Cory
and Fleischer. 1979). Although MAIQ and IQ-1 act directly on the M2
su bunit. they may have different mechanisms of inhibition of the
reductase compared with HU (Carter and Cory. 1989). The iron
chelates of these two drugs are the active form of the inhibitor rather
than the drugs themselves (Thelander and Graslund. 1983; Moore and
Startorelli. 1989).
The aminoguanidine (HAG) derivatives are inhibitors of CDP
reductase activity of L1210 cells (Cory et al .. 1985 a; Matsumoto et al ..
1990; Weckbecker et al" 1988). These derivatives. which have a core
structure resembling HU. are supposed to act through the same
mechanism as HU (Matsumoto. et al .. 1990). However. the reduction
activity in extracts from drug-treated L1210 cells was not restored by
the addition of either exogenous non-haem iron or effector-binding
subunits (Cory et al .. 1985 a).
EDTA acts as an inhibitor of the enzyme only at high
concentrations (Lammers and Follmann. 1983). and this effect is due
to the inhibition of the enzyme regeneration. Once the radical-iron
centre is formed. the enzyme seems to be stable to EDTA (Thelander.
et al .• 1983).
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ill Inhibitors affecting iron centre
(1-aziridinyl)-2,4-dinitrobenzamide (CB1954) inhibits the
enzyme from Walker carcinoma in rats. At the same concentration of
CB 1954, the degree of inhibition of the enzyme was proportional to
the enzyme concentration in the assay. This suggests that the cytosolic
protein contains a fIxed number of enzyme sites that are titrated out by
CB 1954. The inhibition is irreversible and from structure-activity
studies it is likely that the amide group becomes bound to the enzyme,
possibly by chelation of iron ion (Tisdale and Habberfield, 1980).

iii) Inhibitors of component Ml or Bl

Oxidized inosine (in ox) is one of the periodate-oxidized
dialdehyde derivatives. It inhibits Ehrlich tumour CDP reductase. The
inhibitory effect of inox on CDP reductase is stronger than on ADP
reductase activity and the inhibitory mechanism of inox is probably
irreversible (Cory et al., 1976). Cory and Fleischer (1979) reported
that addition of exogenous M1 can restore the enzyme activity which is
decreased by inox, and suggested that inox inactivates the M 1 subunit.
Cisplatin is one of the most widely used anticancer drugs.
Cisplatin inhibits the CDP reductase from 'E. cofi. Under anaerobic
conditions, using the dithiol-reduced form of the enzyme it was found
that ribonucleotide reductase is extremely sensitive to cisplatin.
Inhibition was essentially instantaneous and irreversible. Inhibition
occurs specifIcally by reaction of cisplatin with the dithiol at the active
site and other dithiol pairs in the B 1 subunit (Smith and Douglas,
1989).
The intact enzyme from Ehrlich tumour cells loses the activity by
treatment with the sulfhydryl agent, pCMB and NEM . The effectorbinding subunit is much more reactive with these agents (Sato and
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Cory, 1986).

Iv) Inhibitors requiring functional enzyme
Unlike the inhibitors discussed above, 2'-chloronucleoside 5'_
diphosphates cytidine (CcIDP) and 2' -azidonucleoside cytidine (CzDP)
comprise another class of ribonucleotide reductase inhibitor that
requires a functional enzyme (both subunits) to generate the inhibitor.
Thelander and Larsson (1976) have extensively studied CclDP and
CzDP effect on 'E. coli enzyme. CclDP inactivates the Bl subunit. The
inactivation of B 1 showed an absolute requirement for active B2 and is
prevented by normal substrate CDP. The interaction of CclDP with the
enzyme is controlled by allosteric effectors in the same way as the
binding of CDP. So the interaction occurs at the substrate binding site
of the enzyme. CclDP irreversibly modifies the active dithiols in Bl.
CzDP inactivates protein B2, the activity of protein B 1 was not
decreased by CzDP. In the absence of functional Bl, no inactivation of
B2 occurs. The inactivation is due to the selective destruction of the
free radical of B2. CDP protects protein B2 against CzDP-inactivation.
In inactivating the reductase both CclDP and CzDP behave like
irreversible enzyme inhibitors. Since the enzyme had to be in an active
conformation in order to be inactivated by CclDP and CzDP, it is
suggested that a reaction product of CclDP or CzDP, but not the
compounds themselves inactivated Bl or B2, i.e. CclDP and CzDP are
suicide inhibitors (Thelander and Larsson,1976). CzDP also decreased
the calf thymus ribonucleotide reductase, but it acts as a reversible
inhibitor competitive with the normal substrate, CDP (Engstrom et al ..
1979). Similarly the inactivation of CDP reductase of T.. coG. by 2'methylene-5' -diphosphate cytidine (CmdDP) and

2' -methylene

uridine(UmdDP) appears to be irreversible. CDP reductase is capable of
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catalyzing the interconversion of both compounds to a reactive species
capable of enzyme inactivation (Baker et al., 1991).
The reductase isolated from rat NOvikoff tumour is inhibited by
arabinonucleotides. aADP acts as a competitive inhibitor with respect
to substrate indicating it interacts with the substrate sites. The enzyme
from T.. cou also interacts with arabinonucleoside triphosphates at the
triphosphate-specific effector sites: aATP is a potent inhibitor, but
aCTP stimulates substrate reduction (Ludwig and Follmann, 1979).

v) Inhibitors causing disturbance of the protein structure

The nonapeptide YAGAVVNDL, which in sequence is identical to
the C-terminus of HSV component 2, can inhibit HSV ribonucleotide
reductase in vitro, and the inhibition is accompanied by a dosedependent diSSOCiation of the enzyme subunits. These data imply that
the nonapeptide inhibits enzyme activity by competing with
component 2 for a critical binding site and effectively prevents the
formation of the active holoenzyme (Pierrette et al., 1987; McClements
et al., 1988). The peptide corresponding to the C-terminal region of
the B2 subunit inhibits the enzymatic activity and binds to the B 1
subunit indicating that the peptide inhibits 'E. eoa enzyme by binding to
the heterodimer interface in competition with the B2 subunit
(Bushweller and Barttelt, 1991; Climent et al., 1991). This type of
inhibition is also found to occur in the mammalian enzyme. The NUacetyl derivative of FTLDADF which represents the C-terminal
heptapeptide of component 2 of the mouse enzyme is a potent
inhibitor of calf thymus ribonucleotide reductase (Yang, et al., 1990).

1. 3. 4. 2

Natural inhibitors

There are also some common natural inhibitors such as negative
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allosteric effectors dATP, dTTP, and to a lesser extent, dGTP
(Lammers and Follmann, 1983), RNA (Cory, 1973), proteases (Sato and
Cory, 1986), some phenolic metabolites isolated from mushroom
(Fitzgerald et al., 1984) and gossypol from cotton seed oil (McClarty et
al., 1985).
RNA markedly inhibits ribonucleotide reductase from mouse
Ehrlich ascites tumour cells, at concentrations which could be of
physiological significance, (I50 = 5

)lM).

The inhibition appeared to be

dependent on the base composition of the RNA (Cory, 1973). The
enzyme is inhibited by tRNA and rRNA from Ehrlich ascites cells, by
yeast tRNA and by poly (C). Poly (I), poly (G) and poly (U) are only
slightly inhibitory. Poly (A) does not inhibit the enzyme activity.
The activity of CDP reductase from Ehrlich tumours was rapidly
lost from the intact enzyme treated with trypsin. This is due to the
great sensitivity of the non-haem iron subunit to trypsin. When the
trypSin-treated enzyme was supplemented with exogenous non-haem
iron subunit, conSiderable reductase activity was restored. On the other
hand, the effector subunit was more sensitive to chymotrypsin than
was the non-haem iron subunit, and the loss of reductase activity in the
intact enzyme was due to the specific loss of the effector-binding
subunit (Sato and Cory. 1986).
y-L-Glutaminyl-4-hydroxybenzene is a substance that has been
implicated in the induction of sporulation in the common mushroom.
It inhibits the enzyme from L1210 leukemia cells reversibly and this
inhibition is responsible for inhibition of DNA synthesis in the L1210
cell line (Fitzgerald et al.. 1984).
Gossypol is in relatively common use in several countries as a
male contraceptive and may be useful as an antitumour agent. Gossypol
is a potent inhibitor of the reductase activity of mouse L cell on the
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reduction of CDP and ADP (McClarty et al .. 1985).

1. 3. 4. 3

Physical effectors

Some physical effectors also decrease the enzyme activity. The
Ml subunit of the Ehrlich tumour enzyme loses its activity rapidly at
55°C while M2 is remarkably stable (Sato and Cory. 1986). The wholebody y-irradiation of mice with a dose of 6 Gy and the whole-body Xirradiation of 18h post-partially-hepatectOmised rats causes a decrease
in enzyme activity (Avakyan. 1987; King and Lancker. 1969).

Ribonucleotide reductase plays a critical role in DNA synthesis.
4-hydroxynonenal inhibits DNA synthesis and affects cell proliferation.
It has been found that the level of lipid peroxidation is very low in

dividing tissues and cells (Slater et. al.. 1990). Therefore, this thesis
relates studies into the activity of ribonucleotide reductase in
regenerating liver; livers taken from rats at different stages of
development and cells from hypatomas were also studied. The
inhibitory effect of the lipid peroxidation product, HNE on
ribonucleotide reductase was also investigated. This thesis also details
investigation into the activation of CCl4 as an agent capable of inducing
lipid peroxidation.
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2. MATERIALS AND METHODS

2. 1 MATERAL

Reagents were purchased from the following suppliers:
BDH Chemicals Ltd., Poole, England: Thiobarbituric acid (TBA) ,

sucrose, magnesium chloride, ethanol, ether, chloroform,
trichloroacetic acid (TCA) , toluene, potassium chloride, sodium
carbonate, cupric sulphate, acetic acid, potassium hydroxide,
ammonium sulphate, perchloric acid, metaphosphoric acid,
ethylenediaminetetra acetic acid disodium (EDTA-Na2), sodium
chloride, sodium hydroxide, hydrochloric acid, disodium hydrogen
orthophosphate, potassium dihydrogen orthophosphate, potassium
tartrate, Folin & Ciocalteu's phenol reagent, tri-sodium citrate (Na3citrate), sodium dodecyl sulphate (SDS)' glycerol, 2-.13mercaptoethanol.
Sigma Chemical Company Ltd: Bovine serum albumin, Trizma

base (Tris) , glucose-6-phosphate, acetamide, glutathione (GSH),
dimethyl sulphoxide (DMSO), imidazole, pyrazole, N-ethyl maleimide
(NEM),iodoacetamide, dithiothreitol (DTI), ATP, 2'-deoxycytidine 5'monophosphate (dCMP), 5,5'-dithiobis (2-nitrobenzoic acid) (DTNB),
phosphate-buffered saline (PBS), acrylamide, N,N'-methylene-bis
acrylamide, N,N ,N' ,N' -tetramethylethylene-diamine (Temed),
Bromophenol blue, glycine, Brilliant Blue G-colloidal, MES (2-[Nmorpholino]ethanesulfonic acid), high molecular weight standard
protein mixture, N-a-p-tosyl-I-Iysine chloromethyl ketone (TLCK),
Trypsin inhibitor (type II-S : Soybean), DEAE-cellulose (fine mesh),
Dowex 50W-(+H) (200-400 mesh), Sephadex-G25, CM-sephadex C-25
(40-120 Jl).

Phannacia: ATP-Agarose (AGATp1N Type 3).
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Calbiochem: Flake polyethylene-glycol (Aquacide III).
NEN Research Products: Proteosol. Econofluor.
Packard, Canberra Company: Opti -fluor.
Bethesda Research Laboratories, Inc: Ammonium persulphate.
Boehringer Mannheim GmbH: NADP (sodium salt), glucose-6phosphate dehydrogenase.
Amersham International PIc.: 14C-CCI4,

(5-3H)cytidine 5'-

diphosphate, ammonium salt (3H-CDP) (18.4 ci/m mol).
4-hydroxy-trans 2,3-nonenal (HNE) was kindly provided by
Professor H. Esterbauer, Institute fur Biochemie, University of Graz,
Austria.

Male Wistar rats from Harlan Olac Ltd. were used in all
experiments. The animals had access to food and water ab libitum.
The animals for regenerating liver were housed for a minimum of
three weeks under a strict lighting regimen of an inverse 12 hour
light: 12 hour dark cycle with food only available for 8h in the dark
period. All partial hepatectomy operations were performed under light
anaesthesia by the procedure of Higgins and Anderson (1931) and
always at 7:00 pm. In each case the left and right lobes, equivalent to
approx. 2/3 of the original weight of the liver were removed. For each
operation 4-10 rats (250-320g body weight) were used. When
ribonucleotide reductase was to be prepared from the regenerating
and sham livers the animals were sacrificed at 12 hourly intervals
following the operation. In the sham group only the minor lobes were
taken.
Yoshida ascites hepatoma cells were maintained by
transplantation every 5 days into the abdomen of male Wistar rats.
Cells were passaged by removing 1 ml of ascitic fluid from the host rat
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and injecting the cell suspension into the next carrier animal. The
cells were harvested at the end of the passage period. The cell
suspension was centrifuged at 800 x g for 5 min. and the supernatant
was discarded. The cell pellet was washed 3 times with phosphatebuffered saline (PBS). The viability of cells was always

~

900/0.

MOrris Hepatoma 5123tc solid tumours were obtained from S. M.
Clutton, Department of Biochemistry, BruneI University. Tumours were
transplanted in male Buffalo rats (bred in BruneI University) every 21
days by injecting 0.5 g of minced tumour material into the thighmuscle of rats.
Cultured Yoshida ascite hepatoma cells were obtained from
Dr. Marie-Luce Carrie, Department of Biochemistry, BruneI University.
Cells were cultured in MEM medium at 37°C. The culture medium was
changed every 1-2 days.

2.2 METHODS

Preparation of micro somes from rat liver
The rats used for making microsomes were males of the Wistar
strain, 7 weeks-old and 200-220g body weight. Rats were starved
overnight prior to the preparation of microsomes. Livers were removed
immediately after the rats were killed by cervical dislocation, weighed
and put into ice-cold 0.25M sucrose solution. After washing with
0.25M sucrose. livers were minced using scissors and rinsed further
with 0.25M sucrose to remove blood. The minced livers were
homogenized in 0.25M sucrose (1 :4-5, w Iv) using a loose-fitting
Potter-Elvehjem (glass-Teflon) homogeniser. The homogenate was
centrifuged twice at 14.000 x g (MSE-18) for 10 min. The pellet was
discarded and the supernatant was centrifuged at 165,000 x g (MSE-
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65) for 40 min. The pellet was rinsed with 0.1 M Tris/HCI (pH 7.4)
and then gently homogenised in the same buffer by hand using a small
glass homogeniser. The microsomal pellet was collected by
centrifugation at 165,000 x g for 25 min. and stored at -70°C (Slater
and Cheeseman, 1987).

Lipid peroxidation initiated by CCl 4 /NADPH in rat liver microsomes
In this system the NADPH was generated using glucose-6phosphate, NADP+ and glucose-6-phosphate dehydrogenase, so the
stock solution of lipid peroxidation incubation mixture contained 83.5
mM KCI, 37 mM Tris/HCI (pH 7.4), 5.5 mM glucose-6- phosphate

(sodium salt), 0.25 mM NADP+ (sodium salt), 106 mM acetamide and
8 international units of glucose-6-phosphate dehydrogenase. The
microsomal pellet was resuspended in ice-cold 0.15M KCI, so that 1
ml of suspension contained microsomes equivalent to 19 wet weight of
original liver. The standard 3 ml reaction mixture contained 2.2 ml
stock solution, 0.3 ml microsomal suspension, 0.5 ml H2 0 or test drug
solution under study and 10

~l

CCI4 . The reaction was started by

adding the microsomal suspension with or without addition of 10 ~ of
a CCl4 solution in dimethyl sulphoxide (CCI4 /DMSO, 1 :4, v Iv) to the
tube fitted with a ground glass socket and stopper containing stock
solution. The incubation was carried out in a water bath at the required
temperature for 15 min. with gentle shaking and in the dark. (Slater
and Sawyer, 1971 a; Slater and Cheeseman, 1987).
To stop the reaction, 6 ml of 10% TCA was added to the medium
at the end of incubation. After leaving on ice for 15 min. the mixture
was centrifuged at 800 x g for 10 min. and 2 ml of supernatant was
taken for assay of content of MDA
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Malonaldehyde (MDA) estimation
To estimate the MDA content, 2 ml of protein-free sample was
mixed with 2 ml of 0.67% thiobarbituriC acid and heated at 100°C for
10 min. The absorbance of the solution was read at 535 nm using a
Beckman DU -62 spectrophotometer. The MDA content was calculated
using the molar extinction coefficient of 1.49 x 105 M-1 cm -1 (Slater
and Cheeseman, 1987).

Extraction of PBN ICCI 3 · produced during lipid peroxidation induced by
CCl 4 in rat liver microsomes
The standard reaction mixture in this experiment was essentially
the same as that used for the general lipid peroxidation induced by
CCl4 in rat liver microsomes except 0.5 ml 18 mM PBN was used
instead of 0.5 ml H 2 0. The fmal concentration of PBN was 3 mM. The
reaction was started by the addition of the microsomal suspension with
or without CCI4/DMSO and took place in the dark at certain
temperatures between 20-40°C for 15 min. Ice-cold toluene (1 ml) was
mixed well with the reaction mixture at the end of incubation. The
upper phase of toluene containing PBN/CCI3 · was separated by
centrifugation at 800 x g for 10 min. and immediately frozen in liqUid
nitrogen for later analysis by ESR spectroscopy.

Covalent binding of 14C-CC1 4 to rat liver microsomal protein
The method was essentially the same as that used for the general
CCl4-induced microsomal lipid peroxidation, but using 14C-Iabelled
CCI4. The incubation was at certain temperatures for 15 min and kept
in the dark. The reaction was terminated with 6 ml ice-cold 100/0 TCA.
Two controls were required. One was for the non-specific covalent
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binding in which microsomes were incubated with reaction stock
solution without' the NADPH generating system and 14C-CCI4. The other
was for CCl4-stimulated lipid peroxidation in which liver microsomes
were incubated in the presence of NADPH but in the absence of CCI4.
After the reaction was terminated, the protein precipitate was
collected by centrifugation at 800 x g for 10 min. The pellet was
suspended in 5 ml of 50/0 TCA and the suspension was heated at 100°C
in open tubes for about 10 min. and then centrifuged to remove 50/0
TCA. The protein pellet was suspended in 7.5 ml of the mixture of
ethanol/ ether / chloroform (2:2: 1, v /v Iv) and allowed to stand at room
temperature for 45 min. with occasional mixing. The protein pellet
was collected and washed with acetone and ether in the same way as it
was washed with the ethanol/ether/chloroform mixture as described
above. The remaining ether was removed by placing the tube in cold
water and gradually warming the water until the ether was completely
removed. The dried protein pellet was weighed and put into a miniscintillation vial. H2 0 (0.1 ml) and Protosol (0.5 ml) were added to
the vial in order to disslove the protein. The mixture was kept at 37°C
until the protein was fully dissolved. Econofluor scintillation liquid 4.5
ml was used to check the radioactivity of the liver microsome protein
on the liqUid SCintillation counter (Cheeseman, 1984).

Determination of NADPH production
NADPH was generated from the system of glucose-6-phosphate,
NADP+ and glucose-6-phosphate dehydrogenase. NADPH production
was checked by recording the changes of absorption at 340nm using a
Cary 219 spectrophotometer. A standard incubation medium was
prepared which contained 36 ml 0.15M KCI, 24 ml O.lM Tris/HCI (pH
7.4). 102 mg glucose-6-phosphate, 3.6 ml H 2 0 and
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6~1

glucose-6-

phosphate dehydrogenase (5 mg protein/ml, 0.26 units/ml). 3 ml of
this stock solution were dispensed into control and test quartz
cuvettes. The cuvettes were put in the spectrophotometer which was
kept at the appropriate temperature as required in the experiments.
Then the baseline was checked to be flat. Afterwards 0.2 ml of
KCI:Tris/HCI (pH 7.4) mixture (0.15M:0.1 M = 3:2) and 0.2 ml of 3
mg/ml (in KCl:Tris/HCI mixture) NADP+ were mixed in to the control
and test cuvettes, respectively. The cuvettes were left in the chamber
of the spectrophotometer for certain times as required in the
experiments, then the spectrum from 450-300 nm was scanned at the
conditions of range=2.0, scan rate=2.0 nm/sec., period=10 sec. and
display=10. The absorption at 340nm was measured.

Isolation of ribonucleotide reductase (RNR'ase): crude extract
The medium for the isolation of RNR'ase contained 0.25M
sucrose, 10 mM potassium chlOride, 5 mM magnesium chloride and 2
mM dithiothreitol (DTT) (final concentrations) in 0.1 MTris/HCI (pH
7.4). The ratio of tissue to medium was 1:4-5 (w/v) when the enzyme
was prepared from livers or solid tumours. If the enzyme was isolated
from Yoshida cells, the medium volume was the same as the volume of
the pelleted cells after centrifugation at 800 x g for 5 min. The
materials (livers, tumours, cells) were homogenized in the medium
using a loose-fitting Potter-Elvehjem (glass-Teflon) homogeniser and
the slurry was centrifuged at 100,000 x g (MSE-65) for 1h. The
preCipitate was discarded and the clear supernatant was kept as the
crude enzyme extract. All procedures were carried out below 4°C
(Youdale and MacManus, 1979). This crude enzyme extract, about 20

mg protein/ml, was usually used for the further partial purification, but
if the material was too small, for example cultured Yoshida cells, the
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crude extract was used directly for determination of the
ribonucleotide reductase activity.

Partial purification of ribonucleotide reductase
A. Precipitation with ammonium sulphate:
Solid ammonium sulphate (0.25 g/ml, corresponding to 45%
saturation) was slowly added to crude extract under stirring at O°C.
After 30 min. of additional stirring at 4°C, the suspension was
centrifuged at 100,000 x g for 20 min. The pellet was dissolved in a
small volume (usually 100/0 of original volume of crude extract) of O.IM
Tris/HCI (pH 7.4) containing 2 mM DTI and 5 mM MgCl2

(Youdale

and MacManus, 1979, Engstrom et aL, 1979). The protein solution was
desalted by either passing through a Sephadex G-25 column (sample
to column 1: 15, v/v) equilibrated with the same buffer or dialysing
overnight against the same buffer with two buffer changes. The
dialysate was centrifuged at 800 x g for 10 min. to remove remaining
preCipitate. The resulting protein solution was used for routine
determination of the enzyme activity and the effect of inhibitor on the
activity.

B. Chromatography on DEAE-cellulose:
If the enzyme preparation was used for further purification, the
protein preCipitate resulting from 45% saturation of ammonium
sulphate was dissolved in a small volume (100/0 of original crude
extract) of 20 mM Tris/HCI (pH7.4) containing 2 roM DTI and 5 roM
MgCl 2 and dialysed overnight against the same buffer with two buffer
changes. Usually 10 ml of dialysate (from 20 g of liver of 7-10 rats aged
three weeks) was adsorbed to a DEAE-cellulose column
(2 x 22 cm) eqUilibrated with 10 mM potassium phosphate buffer
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(pH 7.0) (Engstrom et al., 1979) The protein was eluted in a stepwise
manner with
(1) 10 mM potassium phosphate buffer (pH 7.0),

(2) the same buffer containing 0.08 M KCl,
(3) the same buffer containing 0.16 M KCI
(4) the same buffer containing 0.25 M KCI
at a rate of 1 ml/min until the optical density at 280 nm of the eluate
was less than 0.100 (Mattaliano et al., 1981). The fractions of eluate
containing protein were pooled according to the value of optical
density at 280nm. Proteins were concentrated by adding ammonium
sulphate to 800/0 saturation (0.56 g/ ml). The protein precipitate was
collected by centrifugation and dissolved in O.IM Tris/HCl (pH 7.4)
containing 2 mM DIT and 5 mM MgCl2. The salt in the protein
solution was removed by using a Sephadex-G25 column. The protein
content in this enzyme preparation was about 10 mg/ml.

C. Chromatography on ATP-Agarose column
The enzyme preparation after DEAE-cellulose chromatography
was further purified by using an ATP-agarose column as described by
Spector and Averett (1983). The protein solution (about 105ml, 12.5
mg prot/ml) was applied to a 1x12.5 cm ATP-agarose column
equilibrated with O.IM Tris/HCI (pH 7.4) containing 2 mM DIT and 5
mM MgCI 2 . The column was then washed with the same buffer and the
effluent was collected. This protein solution is referred as the ATPAgarose enzyme preparation. After the absorbance at 280nm of the
eluate from the column was less than 0.100, the washing buffer was
changed to the buffer containing 0.5M KCl. Then the column was
washed with the buffer containing 2 mM ATP and this protein solution
was also collected.
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D. Chromatography on CM-Sephadex
The enzyme preparation after DEAE-cellulose chromatography
(about 2.4 ml of 15.8 mg prot/ml protein solution) was diluted 1: 1 with
H 2 0 and the pH was reduced to 5.2 with acetic acid. The resulting
preCipitate was pelleted by centrifugation at 10,000 x g and the
supernatant (5 ml) was added to CM-Sephadex (6 ml) which was
equilibrated with a solution of 20 mM MES-HCI (pH 6.0) containing 2
mM DIT and 5 mM MgCI2 . The gel was removed and washed by the

same buffer till the protein free. The protein solution was collected
(CM-Sephadex fraction 1). Then the gel was further washed with the
buffer containing 1M NaCl. The resulting solution from the wash with
the buffer plus 1M NaCI was dialysed against two changes of 200 ml of
water containing protease inhibitor (TLCK, 60 mg/L; soybean trypsin
inhibitor, 30 mg/L) and mercaptoethanol (0.1 ml/L) for 15h (CMSephadex fraction 2). After drying with flake polyethylene glycol,
proteins of both CM-Sephadex fractions were resolved in 0.1 M
Tris/HCI containing 2 mM DIT and 5 mM MgCl 2 (Youdale et al., 1982).
The whole scheme of purification of RNR'ase from rat liver is
shown in Fig. 2.1.

Assay of CDP reductase activity
The CDP reductase activity was assayed with the method of
Elford (1974), measuring the reduction of 3H-CDP. The standard
incubation solution contained 5 JlCi 3H-CDP (specific activity 18.4
Ci/mmol, final concentration in the incubation solution 0.787 JlM),
3.3 mM ATP, 1.4 mM MgCI 2 , 10 mM DIT, 20 mM Tris/HCI (pH 7.4)
and enzyme protein 0.5-1 mg in a total volume of 0.345 ml. Incubation
was at 30°C for 1h. The reaction was stopped by the addition of 1 mlof
l.25 M perchloric acid and 2.5 Jlmol of cold (unlabelled) carrier dCMP.
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Rat liver

isolation medium

Crude enzyme extract

ammonium sulphate (45% saturation)

Ammonium sulphate fraction

chromatography on DEAE-cellulose

DEAE-cellulose fraction

chrcmatography on
ATP-agarose

ATP-agarose fraction

CM-Sephadex

CM -Sephadex fraction 1 and 2

Fig. 2.1 Scheme of purification of ribonucleotide reductase
from rat liver

93

The mixture was left on ice for 10 min and denatured protein was
removed by centrifugation. The nucleotide in the deproteinised
supernatant was converted to the monophosphate by 20 min.
incubation in a boiling water bath. Then the solution was neutralised
with 4N KOH and stood on ice for 2-12 hours. Mter removal of
preCipitated potaSSium perchlorate. the solution was transferred to
13.5 x 0.5 cm column of Dowex 50W-(H+) (200-400 mesh) resin and
eluted with 0.2N acetic acid. All CMP was removed in the first 40 ml of
eluant and the dCMP was collected in the next 16-20 ml. The
radioactivity of the eluent which contained dCMP was read on a liquid
SCintillation analyser (Tri-carb 2000CA. United Technologies Packard)
using aqueous Opti-fluor SCintillation liquid. All the radioactivity
determinations were corrected for a small amount of radioactivity that
was present with a control containing no enzyme. One unit of activity of
enzyme was defined as that amount of enzyme that catalyses the
conversion of 1000 DPM (about 0.024 p moles) of CDP to dCDP in 1 h
at 30°C (Richard et al .. 1961; Steeper and Steuart. 1970; Elford.
1974).

Effect of compounds on CDP reductase activity
Unless otherwise stated. the compounds were incubated with
the enzyme under the standard reaction conditions. Then the activity
of the enzyme was determined as normal.

Regeneration of DEAE-cellulose
DEAE-cellulose was first soaked in water (for new cellulose) or in
O.5N NaOH-0.5N NaCl (for used cellulose) for about 12 hours. Mter
drying by using a Buchner funnel fitted with two filter papers, the
cellulose cake was treated as follows:
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(1) Resuspending in IN NaOH for 3 hours with

occasionally mixing,
(2) washing with water,
(3) resuspending in 0.5N HCI for 1 hour,
(4) washing with wa ter,
(5) resuspending in IN NaOH again for 2 hours,
(6) washing with water.
The pH of the suspension should be 7.0 when washing with water. The
pH was checked using pH test paper (pH 1-14 and pH 6-8)
(Himmelhoch, 1971).

Regeneration of Sephadex-G25
Sephadex-G25 was used to remove excess HNE in the HNEenzyme mixture and ammonium sulphate salt when the enzyme was
partially purified. Mter HNE or ammonium sulphate had passed though
the column, 3 volumes of water was passed down the column. The gel
was poured out and washed with water several times. If the gel was not
white and translucent, it was soaked overnight in 0.5N NaOH-0.5N
NaCI, then washed with water.

Regeneration of Dowex 50W-(H+l:
New or used resin was washed 3 times with 2N NaOH, followed
by water, then 3 times with 2N HCI (the last time for 12 hours), fmally
with water. Each time when washing with water the pH of the resin
suspension should be pH 7.0.

SDS gel electrophoresis
Casting separating gel:

7.50/0 acrylamide, 0.10/0 SDS, 0.375M Tris/HCI pH 8.8 separating
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gel was made by combining the reagents as following: 10 ml 300/0
acrylamide/bis (29.20/0 acrylamide and 0.8% N,N - methylene-bisacrylamide), 10 ml 1.5M Tris/HCI (pH 8.8), 0.4 ml 100,.1> sodium
dodecyl sulphate (SDS), 2.0 ml 1.5%) ammonium persulphate and 17.6
ml H 2 0. After degassing the mixture under vacuum for 5 min., 20

~

of

Temed was added and immediately poured into a glass plate sandwich
(16 x 20 cm) to a depth of 13-14 cm. The polymerization mixture was
overlayed with about 2 ml of H 2 0. This mixture was allowed to
polymerize for 1 hour at room temperature, then the water and the
unpolymerized gel mixture were removed from the gel surface.
Casting stacking gel:
4.0% acrylamide, 0.1% SDS, 0.125M Tris/HCI pH 6.8 stacking
gel was prepared as follows: 1.3 ml 300/0 acrylamide/bis, 2.5 ml 0.5M
Tris/HCl (pH 6.8), 0.1 ml 10% SDS, 0.5 ml 1.5 OA> ammonium
persulphate, 5.65 ml H 2 0 were mixed. The mixture was degassed
under vacuum for 5 min and 7.5 Jll Temed was added. The resulting
mixture was immediately added to the glass sandwich to a depth of 2.5
cm. A comb was carefully inserted into the mixture. The gel was
allowed to polymerize for 45 min. at room temperature. The
ammonium persulphate solution for the two gels was freshly prepared
(O'Farrell, 1975, Hames and Rickwood, 1990).
Preparation of the sample:
Protein samples were diluted to 2.5 mg protein/ml with sample
buffer which contained 4.0 ml H 2 0, 1.0 ml 0.5M Tris/HCl (pH 6.8), 0.8
ml glycerol, 1.6 ml 100/0 SDS, 0.4 ml 2-J3-mercaptoethanol and 0.2 ml
0.050/0 Bromophenol blue (sodium salt) in a total volume of 8.0 ml.
Diluted protein solutions were heated at 95°C for 4 min (O'Farrell,
1975, Hames and Richwood, 1990).
After washing the wells of the stacking gel with water, 20
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~

or

10 ~l of samples and 10 ~ of standard protein mixture were loaded
onto the gel. Electrophoresis was carried out at 60 V for stacking gel
and 100 V for separating gel in the running buffer of 4.5g Tris. 21.6g
glyCine and 1.5g SDS in 1.5 L H2 0, cooling with running tap water
(20°C). The time of running in stacking and separating gel were about
1.5h and 12h respectively. When the samples had migrated to a level of
1.5 cm above the bottom of the separating gel, the electrophoresis was
stopped. The gel was carefully taken off the glass and put into fIxing
solution (70/0 acetic acid in 40% methanol v Iv). After 1 hour of fixing,
the gel was transferred to the staining solution and remained in
staining solution for 2 hours. The staining solution was prepared from a
mixture of 200 ml Brilliant Blue G-colloidal and 800 ml deionized H2 0.
Afterwards 120 ml of this mixture was mixed with 30 ml methanol.
The stained gel was destained by washing with 100/0 acetic acid in 25%
methanol for 60 sec and 25% methanol for up 24 hours with several
changes of 250/0 methanol (O'Farrell, 1975. Hames and Rickwood,
1990).

Determination of protein content
Protein content of microsome suspension and enzyme
preparation was determined by the method of Lowry (1951) using
bovine serum albumin as a standard.

Determination of cell viability
Yoshida hepatoma cells' viability was assessed by using Trypan
Blue. 4 volumes of diluted cell suspension was mixed with 1 volume of
0.040/0 Trypan blue. The numbers of viable and non viable cells were
counted using a microscope and haemocytometer.
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No. oj viable cells
Viability =

- - - - - - - - - - - - - - - - - x 100%
No. oj viable cells + No. oj non viable cells

Detennination of the content of acid soluble thiol
The content of acid soluble thiol groups in enzyme preparation,
liver homogenate and DIT solution was determined by the method of
Beutler et al (1963). Precipitation solution which was 1.69g glacial mphosphoric acid, 0.2g EDTA-Na2 and 30g NaCI in 100 ml H 20 (1 mIl
was added to a mixture of 0.2 ml enzyme preparation (about 1.7 mg
protein) and 0.2 ml H20 or drug solution. The resulting mixture was
left on ice for 5 min. Following centrifugation at 800 x g for 10 min, 1
ml supernatant was mixed with 4.0 ml 0.3 M Na2HP0 4 (pH 9.0) and
0.5 ml DTNB-reagent (0.040/0 5,5'-dithiobis-(2-nitrobenzoic acid) and
1% Na3-citrate). The absorption at 412nm of the mixture was read
within 5 min on the Beckman spectrophotometer. The concentration
of SH (mM) was calculated by comparing to a standard curve produced
using GSH as standard. DIT (1 ml) solution was directly mixed with
4.0 ml 0.3M Na2 HP0 4 and 0.5 ml DTNB-reagent. The absorption at
412nm was read within 5 min.

Determination of the content of protein thiol
Liver homogenate or enzyme preparation 0.2 ml was mixed with
2.0 ml TCAjEDTA solution (1 vol. of 5 mM EDTA plus 1 vol. of 50/0
TCA). The mixture was allowed stand on ice for 10 min follOwing
centrifugation at 800 x g for 10 min. The supernatant was discarded
and the protein pellet was washed with TCAjEDTA solution again as
above. Afterwards the protein pellet was resuspended in 5 ml or
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Tris/EDTA/SDS (0.1 M, pH 7.4/5 mM/ 0.50/0). The suspension (l mI)
was mixed with 2 mI Tris/EDTA (0.2 M, pH 8.6/2 mM) and 0.03 mI
DTNB (10 mM in ethanol) and left at room temperature in the dark
for 15 min. Then the absorption at 412nm and 550nm was readed on a
Beckman spectrophotometer. The concentration of thiol was calculated
from the difference of absorption at 412nm and 550nm by comparing
to a standard curve produced using GSH.
Preparation of aqueous 4-hydroxy trans 2,3-nonenal(HNEl
50

~l

of HNE/CH2 CI 2 solution (about 8-10 mg HNE/ml) was

taken and the CH2 Cl2 was almost completely evaporated at room
temperature under N2 . 1 ml H 2 0 was added and shaken for 1 to 2 min.
Traces of CH2 Cl 2 were removed under vacuum and afterwards the
solution was filtered through folded filter paper. The concentration of
this solution was checked by the absorption at 223nm using a Beckman
DU -62 spectrophotometer. The concentration of this aqueous HNE
solution was approximately 3.1 mM and stable for one week if kept at
4°C.

Removal of excess HNE from RNR'ase preparation
In some experiments HNE and the RNR'ase preparation were
pre-incubated together. In order to remove HNE the mixture of
enzyme and HNE was put down a Sephadex G-25 (21 x 1 cm) and the
protein eluted with 0.1 M Tris/HCI (pH 7.4) containing 2 mM DTI at
4°C. Fractions were collected and the fraction containing the protein
was used for the reductase assays.
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3. RESULTS

3.1 CARBON TETRACHLORIDE ACTIVATION IN RAT LIVER
MICROSOMES

3. 1. 1 Effect of temperature on the activation of CCl 4 by rat liver
microsomes
The effect of temperature on the activation of CCl4 in
microsomes from normal rat liver was studied. Spin trapping of CCI3 '
and ESR spectrometry. covalent binding of CCl4 to protein and MDA
formation were used as indices of CCl4 metabolism.

3. 1. 1. 1 Production of CCI3 '
The free radical CCI3 ' can be spin-trapped with phenyl-tbutylnitrone (PBN) to form PBN-CCI3 ' adduct which is a relatively
stable free radical detectable by ESR (Albano. et. al. 1982). The ESR
spectrum obtained from incubating liver microsomes with CCl4 and
PBN in a standard lipid peroxidation reaction mixture (see "Methods")
at 37°C is shown in Fig.3.1.1a. The spectrum showed a triplet of
doublets with g value of 2.006. The effect produced by omitting CCl4 is
shown in Fig. 3.1.1 b. The intensity of signals without CCl4 was much
lower than that with CCI4 . These signals may come from the
background free radicals. It is possible to quantitate production of CCI3 '
by measuring the intensity of the signal due to the PBN-CCI3 ' adduct.
Fig. 3.1.2 demonstrates the effect of temperature on the formation of
PBN-CC13 ' adduct in liver microsomes. The results of the formation of
the PBN adduct produced during the incubation of liver microsomes
100

A

g

= 2.006

10 G

--""-------------

B

Fig. 3.1.1. ESR spectra of PBN-CC1 3 · adduct in rat liver microsomes

This represents a scaled down version of the ESR spectrum of PBNCC1 3 " adduct. Rat liver micro somes were incubated with or without CC14
at 37°C for 15 min in the presence of PBN. Spectrometer setting:
Temperature=213K, Microwave power =10dB (20.5 mW), Modulation
amplitude=2 Gauss, Mod. frequency = 1 00 kHz, Microwave
frequency=9.51 GHZ. gain=1.25 x 106 . A) with CC14 ' B) without CC14 .
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Fig. 3.1.2. Temperature effect on the activation of CC14 in
rat liver microsomes determined as PBN-CC13 ·
adduct formation

Lipid peroxidation was carried out for 15 min. in the dark.
Mean values are given +
S.E.M. for four separate
experiments. ( 0 ) without CCI4 ; ( A ) with CCI 4 . * P<
0.05; ** P< 0.01; *** P < 0.001 (Student's t-test) for
differences between samples with and without CCI4 .
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with or without CC14 in the presence of 3 mM PBN were expressed in
arbitrary units as the height of the middle peak of the PEN adduct ESR
triplet signals. It can be seen that the formation of PBN adducts
increases as the temperature of incubation was increased up to 37°C. It
was shown that only when the temperature was

~

30°C. could a

significant difference of PEN adduct formation above control levels be
stimulated by CCl4 addition. However at 40°C. the formation of PEN
adduct was less than that at 35°C and 37°C (Fig. 3.1.2). This
phenomenon was apparent both with and without CCI4 . Although PEN
adduct signals were observed in the absence of CCI4 • there was no
significant difference in the intensity of signals at different
temperatures except at 40°C. Fig. 3.1.3 shows an Arrhenius plot of
PBN-CCI3 ' adduct formation. It exhibited a discontinuity at 27.5°C. The
energies of activation were calculated by linear regression analysis of
the slopes of the Arrhenius plots and found to be 6.80 and 1.66
kcal/mol below and above the temperature break. respectively.

3.1.1.2 Covalent binding of CCl4 to hepatic microsomal protein

Using 14CCl4 the

amount of covalent binding of 14C-CC14 to

hepatic microsomal protein can be estimated by measuring the
protein-bound radioactivity. Fig. 3.1.4 shows the effect of temperature
on covalent binding of CCl4 to microsomal protein. Throughout the
range of temperature used (20°C-40°C). the binding of 14C-CC14 to the
protein increased gradually in a temperature-dependent fashion. At
lower temperatures (20°C and 25°C), the binding of CCI3 ' derived from
CCl4 activation was not significantly elevated above non-specific
(NADPH-independent) 14C-CC14 covalent binding. The Arrhenius plot
103
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for 14CCl4 covalent binding to microsomal protein was shown in Fig.
3.1.5. It broke at 26.7°C. The activation energies for 14CCl4 binding
were 11.83 kcal/mol and 3.36 kcal/mol at temperatures below and
above 26.7°C.

3. 1. 1. 3 Malondialdehyde production

In microsomal systems, the measurement of MDA by the
thiobarbituric acid reaction has been widely used as an index of CCI4induced lipid peroxidation and, by implication, of the activation of CCI4.
The production of MDA at different temperatures from 15°C to 40°C in
the presence or absence of CCl4 is illustrated in Fig. 3.1.6. It was
demonstrated that when the temperature was higher than 25°C, MDA
was produced even without CCI4, but only when the temperature was
higher than 25°C, did CCl4 show a significant stimulatory effect on
MDA production. The degrees of stimulation as compared to the
control (without CCI.J were 17.5%), 56.5 0/0, 123.50/0 and 145.50/0 at
25°C, 30°C, 35°C, and 40°C respectively. Fig. 3.1.7 showed Arrhenius
plot for CCl4-stimulated MDA fonnation. The break in the Arrhenius
plot occurred at 34.3°C. The activation energies of CCl4-stimulated
MDA fromation was 2.83 kcal/mol at the temperature higher than
34.3°C, and 9.8 kcal/mol at the temperature lower than 34.3°C.

3. 1. 1. 4 Temperature effect on NADPH generation

NADPH is required for the activation of CCI4. In the model used
here, NADPH was generated from a glucose-6-phosphate
dehydrogenase dependent system:
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gZucose-6-phosphate glucose-6-phosphate

+
NADP+

dehydrogenase

6-phospho gZuconate

+
NADPH

It is important therefore to check the effect of temperature on

NADPH generation. The results are shown in Fig. 3. LB. The higher the
temperature, the faster the generation of NADPH, as expressed by
absorbance at 340nm.

3. 1. 2 Effect of selected agents on the activation of CCl 4 by rat
liver microsomes

The effect of two inhibitors of the cytochrome P450 system,
(pyrazole and imidazole), two sulphydryl reagents, (iodoacetamide and
N-ethyl maleimide, NEM) and glutathione (GSH) on the activation of
CCl4 in rat liver microsomes was investigated. The activation of CCl4
was measured by lipid peroxidation as determined by the production
of MDA. The degree of inhibition of MDA production by each
compound was compared to the control samples. The indicated
concentrations of the compounds are the final concentrations used in
the incubation mixture.
The data in Fig. 3.1.9-12 and Table 3.1.1 illustrate the effect of
these selected agents on the formation of MDA. Pyrazole,
iodoacetamide and imidazole are weak inhibitors. Even at the highest
concentrations used, 10 mM or 20 mM, they failed to produce 500/0 of
inhibition (Fig. 3.1.9, 3.1.10 and Table 3.1.1). Pyrazole inhibited lipid
peroxidation by 300/0 at 10 mM and iodoacetamide only inhibited lipid
peroxidation by 15% at 10 or 20 mM. No increase in inhibition
occurred when the concentration of iodoacetamide was increased to
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Fig. 3.1.8 NADPH production rate in NADPH generaing
system at different temperature
NADPH content, as expressed in absorbance at 340nm,
was checked in the NADPH generating system of glucose6-phosphate,

NADPH+

and

glucose-6-phosphate

dehydrogenase at the indicated time at different
temperatures as described in "Materials and Methods."
Mean values are given + S.D. with duplicate. (0) 15°C; ( b.)
20°C; ( • ) 25°C; ( 0 ) 30°C; ( • ) 35°C; ( • ) 40°C.
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Fig. 3.1.9. Effect of pyrazole on lipid peroxidation
stimulated by CC14 in rat liver micro somes

Lipid peroxidation was carried out at 37°C for 15 min. in
the dark and estimated by measuring MDA production.
MDA content in control (without pyrazole) was 257.9
pmol/mg prot./min. Each concentration point represents
the mean of 4 determinations.
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Fig. 3.1.10. Effect of iodoacetamide on lipid peroxidation
stimulated by CC14 in rat liver microsomes.

Lipid peroxidation was carried out at 37°C for 15 min in
the dark and estimated by measuring MDA production.
MDA content in control (without iodoacetamide) was 171.6
pmol/mg prot./min. Each concentration point represents
the mean of 2 determinations.
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Table. 3. 1. 1 Effect of imidazole on lipid peroxidation
stimulated by CCI+ in rat liver microsomes

Concentration
of imidazole
(mM)

Malonaldehyde

Inhibition

( pmollmg prot./min. )

( %

o

267.8 + 28.2

1

259.7 + 36.0

2.9

5

290.4 + 25.5

- 8.6

10

273.7 + 34.6

- 2.7

20

188.0 + 91.6

29

Lipid peroxidation was carried out
described in

"Materials

at 37° C for

and Methods ".

)

15 min. as

Mean values are

given + S.D. for two separate experiments with a total of 4
replicates.
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Fig. 3.1.11. Effect of N-ethyl maleimide (NEM) on lipid
peroxidation stimulated by CC14 in rat liver
microsomes

Lipid peroxidation was caried out at 37°C for 15 min. and
estimated by measuring MDA production. MDA content in
control (without NEM) was 306 pmol/mg prot./min. Each
concentration point represents 4 replicates.
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Fig.3.1.12. Effect of reduced glutathione on lipid peroxidation stimulated by CCl4 in rat liver microsomes

Lipid peroxidation was carried out at 37°C for 15 min and
estimated by measuring MDA production. MDA content in
the control (without GSH) was 187.7 pmol/mg prot/min.
Each concentration point represents the mean of 4
detenninations.
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more than 10 mM. Low concentrations of imidazole had no inhibitory
effect on lipid peroxidation, but increasing the concentration
eventually produced 29%) inhibition at 20 mM (Table 3.1.1). For NEM,
the effect on lipid peroxidation was different. As shown in Fig. 3.1.11,
low concentrations of NEM had a slight inhibitory effect on MDA
production. The highest inhibition extent was about 200/0 at 0.5-1.0
mM of NEM. However, when the concentration of NEM was higher
than 1.0 mM, the inhibition decreased and at 5 mM NEM had a slight
stimulatory effect on MDA production. Fig. 3.1.9 represents the results
obtained for the inhibitory effect of GSH on lipid peroxidation. It can
be seen that GSH strongly inhibits lipid peroxidation in a
concentration-dependent fashion. MDA production was inhibited 500/0
by a concentration of less than 0.2 mM.
Using GSH as the inhibitor, the time course of the inhibitor
effect on lipid peroxidation was studied. An illustration of the effects of
different concentrations of GSH on CC14 -stimulated lipid peroxidation
in liver microsomes at different incubation times is given in Fig. 3.1.13.
It can be seen that throughout the incubation time employed, 3 min.
to 30 min., MDA production was inhibited by 0.08 mM, 0.2 mM, and
0.5 mM GSH. Although CC14 -dependent lipid peroxidation increased
with the incubation time under both conditions of with and without
GSH, the extent and rate of increase above control levels was much
lower when GSH was present, especially at higher concentrations. For
example at 0.5 mM GSH, MDA production no longer increased after 10
min. incubation whilst in the absence of GSH lipid peroxidation
continued to increase for at least another 5 min. GSH prolonged the
initiation period of lipid peroxidation and this effect was
concentration-dependent. In the absence of GSH, a 3 min lag was seen
before MDA production increased at a higher rate. The presence of
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Fig. 3.1.13. Effect of reduced glutathione on the production
of malondialdehyde in rat liver microsomes
stimulated by CCl4 at different incubation times

The temperature of lipid peroxidation incubation was
37°C. GSH concentrations represent final concentrations
in the incubation mixture. Mean values are given ± S.D.
( 0 ) without GSH; ( !J. ) 0.08 mM GSH; (A ) 0.2 mM GSH;
( • ) 0.5 mM GSH.

118

0.08 mM and 0.2 mM GSH increased the lag phase to 5 and 7 min
respectively. No further delay of onset of lipid peroxidation was found
when the highest concentration of GSH (0.5 mM) was present, but the
rate of lipid peroxidation was strongly decreased.

3. 2

RIBONUCLEOTIDE REDUCTASE

3. 2. 1 Purification of ribonucleotide reductase

The purpose of this aspect of the investigation was
(i)

to prepare a partially purified enzyme for determination of

RNR'ase in a variety of tissues and under a variety of conditions, and
(ii) to develop a method of purification for obtaining a pure

preparation of the enzyme with the intention of raising an antibody to

it.
The rats used for the preparation of ribonucleotide reductase
were 3-4 weeks old. The body weight of these rats was generally about
6Sg although values as low as SOg or as high as 92g were observed. The
liver weights were in the range of 2.2-3.Sg. One gram of liver usually
yielded 41 mg of crude extract protein, 11 mg of 4S% ammonium
sulphate fractionation protein and 0.76 mg protein of enzyme
preparation after chromatography on DEAE-cellulose (Table 3.2.1). A
typical purification of the rat liver up to and including chromatography
on DEAE-cellulose column is summarized in Table 3.2.2. The apparent
recovery of total enzyme activity after ammonium sulphate
precipitation step was about 2200/0. This was an inaccurate estimation
probably due to the underestimation of the ribonucleotide reductase
activity in the sample of crude extract, because of RNA and nucleoside
kinase (NDP kinase) activity (Cory, 1973; Spector and Averett, 1983).
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Table 3.2.1 Ribonucleotide reductase yield and activity of different preparations from 3-4 weeks old rat liver
Body Wt. Liver Wt.
( g)

~

I\)

0

( g)

Crude extract

---_._---

mg prot./ml units/mg prot. mg prot./g liver

65±6

3.l±O.3

20.8±O.7

( 7)

(7 )

(7 )

25.5±2.7
( 7)

41.3±lO.5
( 7)

__ Ammonium sulphate fraction
mg prot./ml units/mg prot. mg prot./g liver

D EAE-cellulose
mg prot./ml units/mg prot. mg prot./g liver

40.6±2.8

185.3±26.5

11.5±3.2

12.5±2.8

940±114.2

0.76±O.3

(6 )

(6 )

(6 )

(4 )

(4 )

(4 )

Mean values are given ± S.E.M. with the number of animal groups and enzyme preparations shown in parentheses. Each animal group contained 5-10 rats, and
each enzyme preparation was obtained from 5-10 livers. The value of inhibition extent of crude extract by 4 mM HU was from two separate experiments. The
determination of enzyme activity was performed under standard reaction conditions as described in "Material and Methods". Each assay was carried out in
duplicate.

Table. 3. 2. 2 Purification of rat liver ribonucleotide reductase from 36 g of juvenile normal rat liver.

Volume Total protein Total activity Specific activity Recovery
(0A»
(ml)
(mg)
(units)
(units/mg prot.)

Purification
(fold)

~

I\)
~

Crude extract

38

908.2

29788.4

32.8 + 0.9

100

450/0 ammonium
sulphate precipitate

6.0

260.7

66081.4

253.4 + 5.6

221.7

7.7

DEAE-cellulose

1.5

22.5

23935.5

1063.8 + 96.1

80.3

32.4

The enzyme activity was detennined under standard reaction conditions as described in "Methods".
The mean values of specific activity of enzyme are given + S. D. with each assay was carried out in
triplicate.

This will be discussed later. This is also the reason that the recovery
after chromatography on DEAE-cellulose was so high, about 800/0;
sometimes 100% was observed. However when compared with the
preparation of ammonium sulphate fractionate extract, the recovery of
the enzyme protein after DEAE-cellulose chromatography was
reasonable. This was about 36%.
After precipitation with ammonium sulphate, the resulting
enzyme preparation was chromatographed using a DEAE-cellulose
column. Usually 260 mg protein (6-9 mll in 20 mM Tris-HCI
containing 2 mM DTT and 5 mM MgCl2 was applied to a 2 x 22 cm
DEAE-cellulose column equilibrated with 10 mM potassium phosphate
buffer (pH 7.0). The protein was eluted from the column in a stepwise
manner with 10 mM potassium phosphate containing different
concentrations of KCl. Ribonucleotide reductase activity was eluted
with 10 mM potassium phosphate buffer containing 0.16 M KCI (Fig.
3.2.1). There was a little activity in the fractions of eluate of the buffer
containing 0.25 M KCl. The elution pattern was very reproducible.
The whole procedure, from the homogenising of the liver to a
purified enzyme preparation after chromatography on DEAE-cellulose,
required two and a half days. The activity of three different
preparations of the enzyme were stable for at least one month at
-70°C when stored in O.IM Tris/HCI (pH 7.4) containing 2mM DTT
and 5 mM MgCI 2 .
In Fig. 3.2.2 the results of analysis of the enzyme by sodium
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-page) is
shown. The rat liver enzyme preparation after chromatography on
DEAE-cellulose yielded several major bands on SDS-page and, in
addition, some minor components. The results indicate that this kind
of enzyme preparation was far from homogeneous.
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Fig. 3.2.1. DEAE-cellulose chromatography of rat liver
ribonucleotide reductase
This represents a standard DEAE-chromatography profile
as described in the text. The eluate buffer was 10 mM
potassium phosphate. The volume of the eluate of each
fraction was 6.0 ml. Fractions containing protein( indicated
by the absorption at 280nm) were collected and the CDP
reductase activity was determined under standard reaction
condition as described in .. Materials and Methods." ( - 0- )
A280: ( --- ) enzyme activity.
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Fig. 3.2.2. Sn5-polyacryJamide gel electrophoresis of preparations of ribonucleotide reductase from rat liver
I

Samples from left to right: DEAE-cellulose eluted with
buffer + 0.16M KCl (2 and 3); DEAE-cellulose eluted with
buffer + 0.25M KCl(4 to 7); CM-Sephadex fraction 1 (8 and
9); CM-Sephadex fraction 2 (10 and 11); ATP-agarose
eluted without ATP (12); and ATP-agarose eluted with 2 mM
ATP (13).
Standards (1 and 14) are from the top: j3-Galactosidase
(Mr= 116, OOO), Phosphorylase (Mr=97,4 4 00), Bovine
serum Albumin (Mr=66,000), Egg Albumin (Mr= 4 5 ,00 0),
Carbonic anhydrase (Mr=29,000) .
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Chromatography on an ATP-Agarose affmity column was tried in
an attempt to further purify the protein after chromatography on
DEAE-cellulose. This procedure was not very successful and not
pursued further. The enzymic activity of the resulting enzyme
preparation from the ATP-Agarose column eluting with the same buffer
lost about 80% compared to the enzyme preparation of the DEAEcellulose fraction (see Table 3.2.3). There were still several kinds of
protein in this preparation (Fig. 3.2.2). Attempts were also made to
purify the enzyme preparation resulting from the DEAE-cellulose
column using CM-Sephadex. The yield was very low: 41.9g liver only
gave 1 ml of the resulting preparation with a protein content of lower
than 1.6 mg/ml and specific enzymic activity of 132 units/mg protein.
This enzyme preparation was not homogeneous either (Table 3.2.3 and
Fig. 3.2.2).

3. 2. 2. Ribonucleotide reductase in tissues of different growth
states or rates

Using a partially-purified enzyme preparation, (45% ammonium
sulphate fractionation) as the experimental sample, the CDP reductase
activity in different tissues of different growth rate was determined
and compared.

3. 2. 2. 1 Ribonucleotide reductase activity in juvenile and adult
normal rat liver.

Table 3.2.4 gives a comparison of the ribonucleotide reductase
activity in juvenile (3-4 week-old) and adult 01-12 week-old) rat
liver. It is evident that there was a marked difference between the

125

Table 3.2.3 Rat hepatic ribonucleotide reductase yield and
activity after chromatography on ATP - Agarose
and CM-Sephadex

ATP - Agarose

CM-Sephadex
Fraction 1

Fraction 2

Volume
2

(ml )

Protein content
(mg prot. / ml )
Enzyme activity
(units/mg prot.)

1

2.2
233.3, 181.4

1.5

1.6

undetectable

132.5

undetectable

The data are from a single purification experiment. Fractions 1
and 2 of CM-Sephadex represent, respectively the enzyme
preparations which were obtained by washing the CM -Sephadex
with

buffer only and with buffer plus 1M NaCl. The protein

solutions applied to ATP-Agarose column and CM-Sephadex were
the

enzyme

preparations

chromatography. The specific
units/mg prot.

obtained from

DEAE-cellulose

activity of the enzyme was 1063

prior to being applied to the ATP-Agarose and

973 units/mg prot. prior to being applied to CM-Sephadex.
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Table. 3.2.4 Ribonucleotide reductase activity in juvenile and
adult rat liver

Age
3-4 weeks

11-12 weeks

Body Wt.

(g)

65 + 6 ( 7)

323 + 14 ( 5)

Liver Wt.

(g)

3.1+0.7(7)

12.3 + 1.2 (5)

Enzyme activity
(units/mg prot.)

185 + 26,0 (4)

undetectable

The enzymic activity was determined under standard reaction conditions as described in

"Materials and Methods ".

Mean values are given + S.E.M. with the number of experiments shown in parentheses. For the 3-4 week-old group,
each experimental sample was
11- 12

week-old

from 5-10 rats.

For the

group, each experimental sample was

obtained from an individual rat. All assays of enzyme
activity were performed in duplicate.
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juvenile and adult rat liver in the enzymic activity. In liver of 3-4 weekold rats, the specific activity was 185 units/mg protein. However, no
enzyme activity could be detected in livers of 11-12 week-old rats.

3. 2. 2. 2 Ribonucleotide reductase activity in hepatoma tumours

CDP reduction was detected in Yoshida ascites hepatoma cells
and Morris 5123tc solid tumours carried in Wistar rats. From the
results of Fig. 3.2.3 it is indicated that an ammonium sulphate
fractionation from MorriS 5123tc tumours showed only 130/0 of the
CDP reductase activity as compared to a similar fraction from Yoshida
cells. The range of enzyme activities found in the Yoshida cells under
study was from 1379.5 to 4215.9 units/mg prot. In Morris 5123tc
tumours activities ranged from 255.7 to 452.8 units/mg prot.
The viability of the freshly collected Yoshida cells was generally
greater than 90%. The weight of Morris 5123tc solid tumours ranged
from 2.73 g to 7.02 g. There was no correlation between the CDP
reductase activity and the weight of the solid tumour.

3. 2. 2. 3

Ribonucleotide reductase activity in cultured Yoshida
hepatoma cells

The Yoshida ascites hepatoma cells were collected from the host
rat. After washing with PBS, the cells were cultured in MEM culture
medium at 37°C. At the indicated time, the cells were collected and
washed with PBS by centrifugation and cell-free extracts prepared as
deSCribed in "Methods". CDP reductase was measured directly in the
crude extract. The results are shown in Fig. 3.2.4. For freshly harvested
cells from the host rat, the CDP reductase in crude extract enzyme
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Fig. 3.2.3. Ribonucleotide reductase activity in Yoshida ascites
hepatoma cells and Morris hepatoma 5123 tc solid
twnours

The CDP reductase activity was determined under standard
reaction conditions as described in "Materials and Methods."
Mean values are given + S.E.M. for 5 batches of Yoshida cell
suspensions and 5 Morris hepatoma 5123 tc tumours. Each
assay was carried out in duplicate.
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Fig. 3.2.4. Time course of ribonucleotide reductase activity
in Yoshida ascites hepatoma culture cells

CDP reductase activity was determined under standard
reaction conditions as described in "Materials and
Methods". Mean values are given + S.D.
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preparation was about 149 units/mg prot. During 6 days of culture
period the activity of reductase activity increased over 4 days. At day
two, the enzymic activity was markedly elevated, 9 fold compared to
the activity at day O. At day four, the activity peaked at 2669 units/mg
prot., 17 fold above the day 0 value. Afterwards the activity started to
decline. On day 6, it had returned to a level only slightly above that
found in freshly harvested cells. Since the reductase activity was
measured in the crude extract, the specific activity was lower than in
the ammonium sulphate fraction sample. The enzymic activity at Day 0
was 149 units/mg prot. in the crude extract, but it was 1358 units/mg
prot. in the 450/0 ammonium sulphate fraction.

3. 2. 2. 4 Ribonucleotide reductase activity in regenerating liver

Following partial hepatectomy, the remaining minor lobes of the
liver grow rapidly in order to restore the original mass of the liver. As
shown in Table 3.2.5, the net weight of minor lobes of liver from
partially hepatectomised rats increased compared with sham operated
control livers. The amount of regeneration of liver mass relative to
sham operated liver was increased by 69.70/0 at 36h, 92.7% at 48h,
116% at 60h and 93.60/0 at 72h post operation. In the sham operated
rats the weight of the minor lobes was on average 2.69g during the
period of study.
At intervals of 12 hours, the partially hepatectomized and sham
operated rats were killed and the minor lobes of liver were sampled.
Ammonium sulphate fractions were prepared from the minor lobes for
CDP reductase activity determination. Fig. 3.2.5 illustrates the time
course of the CDP reductase activity in regenerating liver. The enzyme
activity increased in liver tissue following partial hepatectomy. The
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Table 3. 2. 5 Weight of the minor liver lobes following either partial
hepatectomy or sham operations

Time post
operation

-'"

48h

60h

72 h

Weight of minor
lobe of liver ( g )

W

tv

36h

Regenerating
liver

4.26 + 0.33
(4)

5.03

Sham -operated
liver

2.51

± 0.35

2.61

(2)

+ 0.54 5.44 + 0.72 6.06 + 0.51
(2)

(5 )

(4 )

+ 0.37 2.51 + 0.19 3.13 ± 0.54
(2 )

(2)

( 4)

Mean values are given + S.E.M. with the number of animals shown in
parentheses.
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Fig. 3.2.5. Ribonucleotide reductase activity in regenerating

rat liver
Rats were subject to partial hepatectomy at '0 hours' and
liver was sampled for ribonucleotide reductase activity at
the times shown. The CDP reductase activity was
determined under standard reaction conditions as
described in "Materials and Methods". Mean values are
given + S.E.M. The number of rats was 10 at 24h, 9 at 36h,
11 at 48h, and 4 at 72h post operation. Each assay was
carried out in duplicate.
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time course appears to exhibit a periodic cycling with two peaks, one
at 48h post operation and another at 72h post operation. The maximal
reductase activity was observed at 48h post operation which was 4-5
fold higher than the activity at 24h, 36h and 60h post operation. The
enzyme activity of regenerating liver at 72h was 2-3 fold higher than
that at 24h, 36h and 60h post operation. CDP reductase activities were
undetectable in all sham operated livers.
Table 3.2.6 demonstrates the CDP reductase activity of the
mixture of enzyme preparations from 48h and 60h regenerating rat
liver. The activity of the mixture was 292 units/mg protein. This value
was very close to the calculated activity of the enzyme mixture which
was 282 units / mg protein. This result indicated that there was only
additive effect when these enzymes were mixed together.

3. 2. 3 Elevation and inhibition of the activity of ribonucleotide
reductase from juvenile rat liver and regenerating liver

Dithiothreitol (DTI) is necessary for CDP reductase activity as a
reducing agent in this assay system. In this study it was found that
there were differences in the optimal DTI concentration for exerting
the full CDP reduction activity between the enzyme from juvenile
normal rat liver and regenerating liver. Fig. 3.2.6 illustrates the
dependence of the activity of CDP reductase from juvenile normal rat
liver and regenerating rat liver (48h and 60h post operation) on DTI
concentration ranging from ImM to 15 mM. It can be seen that higher
concentration of DTT can elevate regenerating liver's CDP reductase
activity. The enzyme activity of 48h regenerating liver was enhanced
1600/0 when DTI concentration was increased to 5 mM. The
enhancement was not significantly increased when the DTT
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Table 3.2.S CDP reductase activity in the mixture of

enzyme from 48h and SOh regenerating rat
liver

Enzyme

Activity (units/mg prot./h)
calculated

observed

48h

428.8±21.9

60h

136.7±11.2

48h+60h

282.7

292.8+17.8

The activity of CDP reducatse was determined under
standard conditions as described in "Material and
Methods". The DTT concentration in the reaction
solution was 10 mM. The reaction time was 1h. Protein
content in the reaction mixture was 1 mg. For the
measurement of the CDP reductase activity of mixed
enzymes from 48h and 60h regenerating liver, 0.5 mg
protein of each enzyme preparation was added to the
CDP reduction mixture. Mean values are given + S.D.
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Fig. 3.2.6. Dependence of CDP reductase activity on DTT
concentration

The CDP reductase activity of enzyme from juvenile normal
rat liver and regenerating rat liver (48h and 60h) was
determined at different concentrations of DTT. The
enzyme activity at 1 mM DIT was taken as 1000/0. Mean
values are given + S.E.M. Each assay was carried out in
triplicate. (0) juvenile normal rat liver; (.) 48h
regenerating rat liver; ( b. ) 60h regenerating rat liver.
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concentration increased further to 15 mM. For the enzyme from 60h
regenerating liver the degree of activity enhancement by DIT was
lower than for the enzyme from 48h regenerating liver. Comparing to
the activity at ImM DIT, the activity at 5 mM DIT and 10 mM DIT
were increased 270/0 and 81 0/0 respectively. No further enhanced
activity was observed when the DIT concentration was increased to 15
mM. In contrast to the enzyme from regenerating liver, the enzyme
activity of normal juvenile liver did not respond to changing of the DIT
concentration. In the range of 1 mM to 15 mM DIT there was no
significant difference in the reduction activity (Fig. 3.2.6).
To investigate if continual higher DIT concentration was
necessary for the reductase from regenerating rat liver to exert its full
activity, the effect on the CDP reduction by the enzyme from 48h
regenerating liver of addition of higher concentration of DIT (10 mM)
to the enzyme assay mixture which contained lower DIT (1 mM) at
different incubation times was studied (Fig. 3.2.7). At 10 mM DIT the
dCDP formation was 2.2 fold of the value at 1 mM DIT during 60 min.
incubation time. Addition of 10 mM DIT to the 1 mM DIT-containing
enzyme assay mixture 20 min. and 40 min. after the reaction started,
the rate of the dCDP production was completely restored indicating
that the activity of the enzyme had returned to full level.
The function of DIT as an activator of CDP reductase activity was
further studied. First the enzyme protein was preincubated with a
higher concentration of DIT (10 mM) and 8 mM MgCl 2 at 30°C for a
certain time. Then the preincubation mixture was transferred to CDP
reduction mixture for regular activity assay in which the DIT
concentration was diluted to 1 mM. The results are shown in Fig.
3.2.8-10. After preincubation the activity of CDP reductase from 48h
and 60h regenerating liver was enhanced (Fig. 3.2.8 and Fig.3.2.9).

137

200

.

..--..

t::b1-4

o

150

:o~

U'o.O

.gS
0 ........
1-4::;E

~~ 100
~Cl

Cl

()O
"dO

---

0

~

.......

50

+10mMDTf

~
+10mMDTf

0
0

20

40

60

Incubation time ( min )
Fig. 3.2.7. Effect of addition of a high concentration of DTT

on CDP reductase activity from 48h regenerating
rat liver
Enzyme protein from 48h regenerating rat liver was
incubated with CDP reduction mixture containing 1 mM
DIT at 30°C. At the indicated time point (shown by the
arrow in the figure) 3 of the samples were stopped for
dCDP determination, 3 of the samples received 5 ~l 630
mM DIT solution to make the DIT concentration in the
assay 10 roM and incubation was continued to 60 min. The
amount of enzyme protein in assay was 0.39 mg. The mean
values are given + S.D. All assay were carried out in
triplicate. (-------) 1mM DIT; (--) 10 roM DIT.
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Fig. 3.2.B. Effect of preincubation of enzyme protein from

4Bh regenerating liver with DTT /Mg2+
(lOmM/BmM) on CDP reductase activity
The protein (3.7 mg) of enzyme preparation from 48h
regenerating liver was preincubated with 10mM DTT and
8 mM MgCl 2 in total volume of 330 III at 30°C for 20, 40
and 60 min. At the time indicated 34.5 III aliquots of this
incubation mixture were added to the CDP reduction
mixture (310.5 Ill) for the regular activity assay in which
the DTT concentration was diluted to 1 mM. The amount
of enzyme protein in assay was 0.39 mg. Mean values are
given ± S.D. ( [2] ) without preincubation, DTT concentration
in assay was 1 mM; (II) without preincubation, DTT
concentration in assay was 10 mM; ( 0 ) preincubation for
20min.; ( []] ) preincubation for 40 min.; ( • ) preincubation
for 60min.
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Fig. 3.2.9. Effect of preincubation of enzyme protein from
60h regenerating liver with
DTT/Mg2 +
(lOmM/8mM) on CDP reductase activity
The protein (l.8 mg) of enzyme preparation from 60h
regenerating liver was preincubated with 10mM DIT and
8 mM MgCl 2 in total volume of 11 0 ~l at 30°C for 20 min.
Then 34.5 ~l aliquots of this incubation mixture were
added to the CDP reduction mixture (310.5 ~l) for the
regular activity assay in which the DIT concentration was
diluted to 1 mM. The amount of enzyme protein in assay
was 0.58 mg. Mean values are given + S.D. (.) without
preincubation, DIT concentration in assay was 1 mM;
( m) without preincubation, DIT concentration in assay
was 10 mM; (
preincubation for 20min.

m)
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Fig. 3.2.10. Effect of preincubation of enzyme protein
from juvenile normal rat liver with DTT/Mg2+
(10mM/BmM) on CDP reductase activity

The protein (3.9 mg) of enzyme preparation from juvenile
normal rat liver was preincubated with 10mM DTT and 8
mM MgCl 2 in total volume of 110 J.lI at 30°C for 20 min.
Then 34.5 J.lI aliquots of this incubation mixture were
added to the CDP reduction mixture (310.5 J.ll) for the
regular activity assay in which the DTT concentration was
diluted to 1 mM. The amount of enzyme protein in as~ay
was 1.23 mg. Mean values are given + S.D. (m) without
preincubation, DTT concentration in assay was 1 mM; (0)
without preincubation, DTT concentration in assay was 10
mM; ( • ) preincubation for 20min.
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The activity was increased about 29% for 48h regenerating liver
enzyme (Fig. 3.2.8) and 10SCA) for 60h regenerating liver enzyme (Fig.
3.2.9) after 20 min preincubation compared to the enzyme activity
without preincubation. Longer preincubation did not produce more
enhancement of the enzyme activity of 48h regenerating liver (Fig.
3.2.8). In contrast, the activity of CDP reductase from normal juvenile
rat liver was not activated by the preincubation (Fig. 3.2.10).
In an attempt to fmd an explanation for the different responses
of the activity of CDP reductase from regenerating rat liver and normal
juvenile rat liver to DIT concentration, the content of acid soluble
thiols in the 4S% ammonium sulphate fraction and in the homogenate
of the livers and also the protein thiols in the liver homogenates were
measured. The samples prepared for this purpose were made in the
same way as the samples for CDP reductase activity determination but
the buffer was O.lM Tris/HCI (pH 7.4) without 2 mM DIT and S mM
MgCl 2 • The results are shown in Tables 3.2.7. 3.2.8 and Fig. 3.2.11. The
content of acid -soluble thiols in the 4S% ammonium sulphate fraction
of 48h regenerating liver was significantly higher than that from 60h
regenerating liver. There were no significant differences in acid soluble
thiols content between 48h regenerating liver and juvenile normal rat
liver or between juvenile normal rat liver and 60h regenerating liver
(Table 3.2.6). Similarly, there were no differences of the content of
protein thiols in homogenates of normal juvenile rat liver and
regenerating rat livers (Table 3.2.7). However, the content of acid
soluble thiols in homogenates from regenerating liver exhibit a
periodic cycle. The thiol content exhibited maxima at 24h, 48h, and
72h post operation compared to minima at 36h and 60h post
operation (Fig. 3.2.11).
The inhibitory effect of hydroxyurea, a specific inhibitor of
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Table 3.2.7 The content of acid soluble thiols in enzyme
preparation of 45% ammonium sulphate fraction
from juvenile normal rat liver and regenerating rat
liver

Thiols content (nmoles/mg prot.)
Juvenile nonnal liver

5.1 + 0.7 (4)

48h regenerating liver

6.9 + 0.5 (5)

60h regenerating liver

4.2 + 0.5 (5)

The enzyme preparation was prepared as the same as for CDP
reductase activity determination except the buffer was O.lM
Tris/HCI (pH7.4). The content of acid soluble thiols was
measured as described in "Methods". Mean values are
given+S.E.M with the number of animal shown in parentheses.
Thiols content in fraction of 45% ammonium sulphate from 60h
regenerating liver was significantly lower (P < 0.005) compared
to 48h regenerating liver.
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Table 3.2.8 Content of protein thlols in the homogenate from
juvenile normal rat liver and regenerating rat liver
(nmoles/mg protein)

Juvenile normal
liver
94.5 + 1.3

(4)

Regenerating liver
24h
36h
48h
60h
72h
~=-----===-----~=-----~~----~~-94.5+3.7 90.5+2.9 90.3+4.6

(5)

(5)

(5)

89.5+3.0 92.8+3.5

(6)

(5)

Homogenates were made from juvenile normal rat liver and from
regenerating liver at various times post operation with O.lM
TrisjHCl (pH 7.4). The content of protein thiols was measured as
described in "Methods". Mean values are given±S.E.M with the
number of animal shown in parentheses.
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Fig. 3.2.11. Content of acid soluble thiols in homogenate of

regenerating rat liver
Homogenates were made from regenerating liver with
O.lM Tris/Hel (pH 7.4). The content of acid soluble thiols
was measured as described in "Methods". Mean values are
given ± S.E.M. The number of animals was 5 for each point.
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ribonucleotide reductase, on activity of CDP reductase from normal
juvenile rat liver and 48h and 60h regenerating rat liver was also
investigated. All the enzymes investigated displayed a similar sensitivity
to hydroxyurea. The activity was inhibited about 60-700/0 by 4mM
hydroxyurea and 10 mM hydroxyurea nearly completely inhibited the
enzyme activity (Fig. 3.2.12).

3. 3

PROPERTIES OF 4-HYDROXYNONENAL (HNE) AS AN
INHIBITOR OF RIBONUCLEOTIDE REDUCTASE FROM
JUVENILE NORMAL RAT LIVER

Previous work has demonstrated that lipid peroxidation products
damaged DNA or affected DNA synthesis. In rapidly dividing
cells/tissues, for example in tumour cells, the lipid peroxidation levels
are very low. Since ribonucleotide reductase is a critical enzyme for
DNA synthesis, the effect of the lipid peroxidation product 4hydroxynonenal (HNE) on ribonucleotide reductase from normal rat
liver was investigated. The enzyme preparation used for this work was
the 450,,-6 ammonium sulphate fraction stored in O.lM Tris/HCI (pH
7.4) containing 2 mM DTT and 5 mM MgCI 2 .
3. 3. 1 Inhibition of CDP reductase activity by HNE

The data of Fig. 3.3.1 demonstrate that HNE inhibited the activity
of CDP reductase of rat liver when added to the CDP reduction mixture
for enzyme activity assay without pre-incubation under standard
conditions (incubation time 60 min.). HNE (0.1 mM, final
concentration) decreased the activity by 500/0.
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Fig. 3.2.12. Effect of hydroxyurea on activity of CDP reductase
from juvenile normal, 48h and 60h regenerating
rat liver

CDP reductase activity was measured in the absence or
presence of hydroxyurea (4 mM and 10 mM, final
concentration) as described in "Methods". The number
shown in the figure present the inhibition degree by
hydroxyurea compared to control. Mean values are given ±
S.D.
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Fig. 3.3.1. Inhibition of CDP reductase by 4-hydroxynonenal
(HNE)

The CDP reductase activity was measured in the presence
of HNE. The reaction conditions were as described in
"Materials and Methods" except the DTT concentration
was 1 mM. The activity of control was 204.9 units/mg
prot. All assays were carried out in duplicate.
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Further investigation showed that the inhibition was related
to the incubation time. Fig. 3.3.2 shows the extent of inhibition as a
function of the incubation time. Over 60 min. the degree of inhibition
increased. The percentage of inhibition was 30.8% at 15 min., 40.70/0
at 30 min., 480/0 at 45 min. and 51 % at 60 min.
The inhibitory effect of HNE on the enzyme was enhanced by
preincubation of the reductase with HNE before the enzymic reaction
started (Table 3.3.1). When O.lmM HNE was present during a 10 min.
preincubation (resulting in a final concentration of 0.0174 mM during
assay), the enzyme activity was inhibited by 600/0. Without
preincubation, 0.1 mM HNE (final concentration during assay) reduced
the activity by 500/0 and 0.017 mM HNE (final concentration during
assay) inhibited the activity by 15%. When the enzyme was
preincubated with 0.575 mM HNE at 30°C for 30 min, there was no
measurable activity left. In this case the final concentration of HNE
during assay was 0.1 mM. However, the preincubation enhancement of
inhibition was not affected significantly by the time of preincubation
above 10 min. (Table 3.3.1).
In an attempt to determine if the HNE inhibition was reversible,
the enzyme was exposed to HNE at O°C for 1 hour, then excess HNE
was removed using a Sephadex-G25 column. Afterwards the activity of
this "treated" enzyme was tested. Two treatments were carried out for
this purpose.
(0 the original enzyme preparation containing 2 mM DTT and 5

mM MgCl 2 in O.lM Tris/HCI (pH 7.4) was incubated with HNE
(final concentration was 0.1 mM) on ice for 1h. The incubation
mixture contained 10 mg protein in a total volume of 400 J.1l
(equivalent 25 mg protein/mI). After removal of HNE, the CDP
reductase activity was determined. DTT concentration during
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Fig. 3.3.2. The effect of incubation time on inhibition of
CDP reductase by HNE (O.lmM).

The CDP reductase activity was determined as describeed
in "Materials and Methods" except the DIT concentration
was 1 mM. Mean values are given + S.D. ( 0 ) Control; ( • )
+0.1 mM HNE.
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Table 3.3.1 Effect of preincubation of enzyme protein with lINE on the degree of inhibition of CDP
reductase activity

CDP reductase activity (units!mfi! prot.)

~

(J1
~

Preincubation
time
(min)

Control

0
10

204.9+11.0
271.5+1.7
238.3+8.6
174.9±5.9

20

30

O.lmM HNE in
Inhibition
(0/0)
preincubatlon(0.017mM
in assay)

92+0.3
86+3.2
71+0.9

15*
66
63
60

0.575 mM HNE in
preincubatlon(O.lmM
in assay)

Inhibitlon
(0/0)

99.0±4.2

50

2.7+0.5

98

The enzyme protein was incubated with HNE at 30°C. At the time indicated aliquots of this mixture
were added to the CDP reduction mixture to initiate the regular activity assay under standard
reaction conditions except the DIT concentration was 1 mM. Control incubations were carried out
in the presence of H 2 0 during the preincubation. The assays were carried out in triplicate.
* The datum was from Fig. 3.3.1.

assay was 1 mM. The reaction time was 60 min.
(ti) DIT was removed from enzyme preparation firstly by using a

Sephadex-G25 column. Then the DIT -free enzyme preparation
was incubated with 0.25, 0.57 and l.0 mM HNE (fmal
concentration) on ice for 1h. The incubation mixture contained
3.8 mg protein in total volume of 235-267 Jll (equivalent 16.114.2 mg protein/ml). After removal of HNE, the CDP reductase
activity was measured under the condition of 1mM DIT and 15
min reaction time.
The results are shown in Fig. 3.3.3 (for treatment (i)) and Fig. 3.3.4
(for treatment (ti)). As seen in Fig. 3.3.3, the enzyme activity was
reduced by 33% after HNE treatment compared to the control sample
which was incubated with

~O.

Compared with the enzyme without any

incubation, the activity of the control sample (incubated with H2 0) was
not changed. The activities were 204 and 190 units/mg protein
respectively. Fig. 3.3.4 shows that the extent of inhibition of enzyme
activity by HNE was dependent on HNE concentration. CDP reductase
activity was inhibited 750/0 by l.OmM HNE compared to control.
Removal of DIT from the enzyme preparation decreased the enzyme
activity even without HNE addition. The activity of the original enzyme
preparation (without removal of DIT) was 69.3 units/mg protein, the
activity of control sample (removal of DIT and then incubated with
H 20) was 49.7 units/mg protein.
Fig. 3.3.5 shows the separation of enzyme and HNE using the
Sephadex-G25 column. Fraction nos. 4-5 were collected for enzyme
activity assays. In these fractions there was no excess HNE. Thus the
inhibition of the enzyme could not be attributed to an inhibition by free
HNE being carried through to the enzymic reaction mixture.
The inhibitory effect of HNE against CDP reductase activity in
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Fig. 3.3.3. Inhibition of CDP reductase activity by lINE

The enzyme protein (10 mg) was incubated at O°C for
1 hr in the presence or absence (H 2 0 instead) of
O.lmM HNE (final concentration) in total volume of 400 ~l.
Then the mixture was passed down a Sephadex G-25
column (21x1 cm) using O.lM Tris-HCl (pH7.4) containing
2 mM DTI and 5 mM MgCl 2 as an eluant at 4°C. In the
peak fraction of protein eluting from the column, the
CDP reductase activity was determined as described in
"Material and Methods" except the DIT concentration
was 1mM. (m): control, the enzyme was incubated with
H 2 0; ( EM ): the enzyme was incubated with O.lmM HNE;
( D): the enzyme without any incubation. The number in
the figure present the activity left compared to control.
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Fig. 3.3.4. Inhibition of CDP reductase activity by HNE
DTT was removed from the enzyme preparation previously
by using a Sephadex G-25 column. The protein (3.8 mg) of
DTT -free enzyme preparation was incubated at O°C for 1h
with different concentrations of HNE in total volume of
235-267 Ill. Then the mixture was passed down another
Sephadex G-25 column for removal of HNE. The CDP
reductase activity was determined under the condition of
1mM DTT in CDP reduction mixture and 15 min. reaction
time. The number in the figure present the activity left
compared with control. (II) without removal of DTT; (~)
control (incubated with H 2 0); ([£J) incubated with 0,25 mM
HNE; (~) incubated with 0.47mM HNE; (D) incubated
with 1,0 mM HNE,
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Fig. 3.3.5. Chromatography of separation of enzyme and
liNE on Sephadex G-25 column (21x1 em).
( -0-) 200 J,ll enzyme (l1.8mg protein) + 200~1 H 2 0; (-.-)
200 J,ll O. 2mM HNE + 200JlI H 2 0. The mixtures were

passed down the Sephadex G-25 columns (21x1 em) using
0.1 M Tris/HCI as an eluant. The eluted fractions (1 ml)
were collected and 2ml O.02MTris-HCl was added. The
absorbance of this mixture was checked at 280 nm ( 0 )
and 223nm ( • ).
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the crude extract of enzyme was also studied. The results are shown in
Fig. 3.3.6. HNE had a very weak inhibitory effect on the crude extract
of enzyme compared to partially purified enzyme preparation (45%
ammonium sulphate fraction). 1 mM HNE inhibited the activity by
500/0, 10 times weaker than its effect on the ammonium sulphate

fraction.

3. 3. 2 Effect of dithiothreitol

(DTI)

on the inhibition by HNE

The functions of DIT were as a reducing agent for the reductase
activity assay and an activator of the enzyme from regenerating liver
(see 3. 2. 3). In this study DTI was also found to influence the
inhibition of CDP reduction by HNE. Table 3.3.2 indicated that when
the DIT concentration was increased to 15 mM in the reaction
solution, the enzyme activity was only inhibited about 240/0 by 0.2 mM
HNE and no significant inhibition was observed by 0.05 mM HNE.
However when the DIT concentration was 1 mM, the enzyme activity
was inhibited by 300/0 and 800/0 at 0.05 mM and 0.2 mM HNE,
respectively. To ensure that this decrease of inhibition was due to the
direct effect of DTT, and not because of the change of basal reductase
activity when a high concentration of DTT was present during assay,
the enzyme activities at different concentrations of DTT were studied.
The results are shown in Fig. 3.2.6. Using a concentration range of 1
mM to 15 mM DIT, there was no significant difference in the
reduction activity.
If HNE was incubated with DIT before exposure to the enzyme,
HNE did not inhibit the activity of the enzyme (Table 3.3.3). It can be
seen that without preincubation with DTf (preincubation with H20
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Fig. 3.3.6. Inhibitory effect of lINE on the activity of crude
extract of ribonucleotide reductase from rat liver

In the absence or presence of HNE, the CDP reductase
activity of crude enzyme extract was measured under
standard reaction conditions as described in "Materials
and Methods". The activity of the control was 22.8
units/mg protein. Each assay was carried out in at least
duplicate.
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Table. 3. 3. 2 lINE effect on RNR activity in the presence of a
high concentration of DIT
Concentration of DTI
1mM
Treatment

Control

Activity

15mM
inhibition

(units/mg prot.)

(0/0)

Activity
(units/mg prot.)

inhibition
( 0/0)

283.9+5.8

204.9+11.0

+HNE

0.05 mM 140.3+15.0
0.2 mM
In the

38.7+7.0

presence

or

31.5

274.1+0.1

3.5

81.1

213.9+2.4

24.7

absence of HNE the activity of enzyme

was measured under standard reaction conditions as described
in " Material and Methods ". The concentration of

DTT during

the reaction was 1 mM or 15 mM as indicated. Mean values are
given + S. D.
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Table 3.3.3 Effect of preincubation of lINE with DTT on the
inhibition of lINE

Treatment

CDP reductase activity
(units Im~ protein)

-HNE

205.1±19.4

+0.1 mM HNE (f/ c)
without preincubation with DTT
preincubated with DTT
0.287mM/2.87mM
(HNE/DTT)
0.575mM/5.75mM
(HNE/DTT)

99.014.2

186.1±25.8

179.7±17.9

HNE was preincubated with DTT (0.287 mM HNE with 2.87mM
DIT in one experiment and 0.575 mM HNE with 5.75 mM DIT
in another experiment) at 30°C for 30 min. and then the aliquots
of this mixture were added to the CDP reduction mixture and the
enzyme protein to determine the activity of the enzyme. The final
concentration of HNE and DTT in this assay mixture were 0.1
mM and 1 mM respectively. Mean values are given ± S.D.
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instead) 0.1 mM (final concentration) HNE inhibited the enzyme
activity by about 500/0. However, after incubation with DTf at ratio of
1:10 for 30 min at 30°C (0.287 mM HNE with 2.87 mM DIT in one
experiment and 0.575 mM HNE with 5.75 mM DTT in another
experiments), HNE did not significantly inhibit the activity. If HNE was
incubated with enzyme protein in the presence of additional DIT,
HNE failed to inhibit the enzyme activity (Fig. 3.3.7). In this
experiment the enzyme protein was incubated with 0.1 mM HNE (final
concentration) and 2 mM additional DTT together at O°C for 1h. Then
the excess HNE and DIT were removed by using Sephadex-G25
column and the CDP reductase activity was checked. It can be seen in
Fig. 3.3.7 that if HNE was incubated with enzyme protein only 0.1 mM
HNE produced 330/0 inhibition; but if HNE was incubated with enzyme
protein in the presence of 2 mM DIT, HNE did not damage the
enzyme.
In order to study if a high concentration of DIT could reactivate
the enzyme activity after the enzyme was damaged by HNE, two
treatments were carried out as outlined below,
(i) DIT was removed from the enzyme preparation by using a
Sephadex-G25 column. Then the protein of this DTT-free
enzyme preparation was incubated with 1 mM HNE at O°C for 1h.
After removal of HNE, the enzyme protein was incubated with
5.4 mM DIT (final concentration) at 30°C for 0.5, 1 and 2h.
Afterwards the CDP reductase activity was checked. The DIT
concentration in the activity assay was 1 mM and the reaction
time was 15 min.
(ii) The original enzyme preparation (without removal of DTI)

was incubated with 0.1 roM HNE (final concentration) at O°C for
1h. CDP reductase activity of this treated enzyme was
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Fig. 3.3.7. Effect of preincubation of lINE with DTT and
enzyme protein together on the inhibition of
HNE

The protein (10 mg) of original enzyme preparation was
incubated at O°C for Ih with (1) H 2 0, as control ( ~ ); (2)
0.1 mM HNE (E2]) and (3) 0.1 mM HNE and 2 mM
additional DTT (mn) in a total volume of 400 ~l. Then the
mixture was passed down a Sephadex G-2S columns for
removal of HNE and additional DTT. CDP reductase activity
was determined under standard conditions except that the
DTT concentration was 1 mM. The number in the figure
represents the activity left compared to control.
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determined following the removal of excess HNE using a
Sephadex-G25 column. The concentration of DIT in the activity
assay were 1 mM for control and half the HNE-treated samples
and 10 mM for the other half of the HNE-treated samples. The
assay reaction time was 60 min.
The results are presented in Table 3.3.4 and Fig. 3.3.8. For the first
treatment, preincubation of HNE-treated enzyme protein with a higher
concentration of DIT (5.4 mM) up to 1h did not reactivate enzyme
activity. When the preincubation was for 2h, the enzyme activity was
totally lost (Table 3.3.4). A Similar result was observed from the second
treatment. Incubation of HNE-treated enzyme protein with the higher
concentration of DIT during enzymic reaction did not reverse the
inhibition either. With exposure of HNE-treated enzyme protein to 10
mM DIT during 60 min. enzyme reaction for the activity assay the
enzyme activity was reduced to the same extent as when the enzyme
activity was tested at 1 mM DIT during assay (Fig. 3.3.8).
The mechanism of HNE effect on the enzyme activity was also
investigated. The results in Fig 3.3.9 shows that after incubation with
HNE, the SH content of the enzyme preparation was decreased. The
decrease was dependent on the HNE concentration. However
incubation time above 5 min did not affect this decrease.
It seems that DIT had a modulating effect on HNE inhibition and

afforded protection of the enzyme against HNE. Fig. 3.3.10-12 show
that these two compounds can interact. DIT influenced the spectrum
of HNE, such that there was decreased absorbance at 223nm(Fig
3.3.10). At the same time HNE decreased the reactive SH content of
DIT. The higher the concentration of HNE and the longer the time of
incubation, the more the decrease of SH content (Figs 3.3.11,12).
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Table 3.3.4 Effect of DTT on CDP reductase activity of lINEtreated enzyme
Treatment

Control

CDP reductase activity
( units/mg prot.)

0/0

of control

49.7 + 3.4

100

12.0±1.0

24

11.3±1.1
12.2+1.2
undetectable

22
24

1mM HNE treatment
~thoutincubation
~th

5.4mM DTI

incubated with DIT
30 min.
60 min.
120 min.

o

DTI was removed from the enzyme preparation first using a
Sephadex G-25 column. The protein of the DTT -free enzyme
preparation (3.8 mg protein) was incubated with 1 mM HNE at
O°C for 1h in a total volume of 267 ~l. Then this incubation
mixture was passed down another Sephadex G-25 column for
removal of HNE. The HNE-free enzyme protein solution was then
incubated with 5.4 mM DTT. At the time indicated aliquots of
this incubation mixture were added to the CDP reduction
mixture to initiate the regular activity assay. The DTT
concentration in the assay was 1 mM. The reaction time was 15
min.
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Fig. 3.3.8. Effect of higher concentration of DTT on CDP
reductase activity of HNE-treated enzyme

The enzyme protein (10 mg) was incubated at oce for 1h in
the presence or absence (H2 0 instead) of 0.1 mM HNE in
total volume of 400 ,.l.l. Then the mixture was passed down
a Sephadex G-25 column for removal of HNE and eDP
reductase activity was determined. (
control, the
enzyme protein was incubated with H 2 0. DTT
concentration in assay was ImM; ( [[] ) the enzyme protein
was incubated with 0.1 mM HNE. Then DTI concentration
in assay was ImM; ( ELl ) the enzyme protein was incubated
with 0.1 mM HNE. DTI concentration in assay was 10 mM.
The numbers in the figure present the enzyme activity left

m)

compared to control.
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Fig. 3.3.9. Effect of incubation with HNE for various times
on the SH content crude extract of the enzyme.

The enzyme was extracted with O.lM Tris-HC1(pH7.4)
containing only 0.25M sucrose. After centrifugation at
100,000 g at 4°C for 30 min, 200 III supernatant (1.68 mg
protein) was incubated with 200 III HNE or H 2 0 (as
control) at 30°C. The SH content of enzyme was checked
as described in "Materials and Methods". Mean values are
given + S.D. ( 0) control; (.) 0.05 mM HNE; ( Il ) 0.1 mM
HNE; ( • ) 0.2 mM HNE; ( [J ) 0.5 mM HNE.
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Fig. 3.3.10. Reaction of FINE with DTT in Tris/HCl (36.5 mM pH 7.4)
"

(A) The spectrum of 0.1 mM HNE after at 30°C for 10 min. in presence
of different concentration of DTI. (1) Control: 0.1 mM HNE in Tris
buffer; (2) 0.1 mM HNE in Tris buffer at 30°C for 10 min.; (3) + 0.02
mM DTI; (4) + 0.04 mM DIT; (5) + 0.1 mM DTT; 6) + 0.2 mM DIT.
(B) The spectrum of 0.1 mM HNE in presence of 0.04 mM DTI after at
30°C for different time (1) 0; (2) 10 min.; (3) 30 min.; (4) 60 min.
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Fig. 3. 3.11. The effect of lINE on the SH content of DTT
0.1 mM DIT was incubated with HNE in 36.5 mM
Tris/HCl (pH 7.4) in total volume of 1ml at 30°C for 10
min. The SH content of DIT was measured as described in
"Materials and Methods" using GSH as standard. Mean
values are given + S.D.
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Fig. 3. 3.12. The effect of incubation time of HNE with
DTT on the reduction of SH content of
DTT

0.1 mM DIT was incubated with 0.5 mM HNE in 36.5 mM
Tris/HCl (pH 7.4) in total volume of 1 ml at 30°C. The
method of determination of SH content as described in
"Materials and Methods". Mean values are given + S.D.
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4. DISCUSSION

4. 1.

ACTIVATION OF CCl4 IN RAT LIVER MICRO SOMES

4. 1. 1. Effect of temperature on the activation of CCl 4 in rat liver
microsomes

Carbon tetrachloride (CCl.J can be metabolically activated in liver
endoplasmic reticulum to form a reactive intermediate, that was first
proposed to be the trichloromethyl free radical (CCI3 ') by Slater (1966).
A number of reactions including covalent binding of CCI3 ' to microsomal
macromolecules and CCl4 -induced lipid peroxidation are able to show
indirectly the activation of CCl4 (Fig. 1.1.2). Additionally, CCI3 ' can be
spin-trapped with phenyl-t-butylnitrone (PBN) to form the PBN-CCI3 '
adduct, which is a relatively stable free radical detectable by ESR
(Tomasi, et al., 1980; Albano, et

al~,

1982). The spin trapping of CCI3 ' by

PBN, covalent binding of radiolabelled CCl4 to microsomal protein and
CCl4 -dependent MDA formation are all indirect methods for measuring
the activation of CCl4 (Cheeseman et al., 1985).
In the present study the temperature (range from 15-40°C) effect
on the activation of CCl4 by rat liver microsomes was studied.
Determinations of PBN-CCl3 ' formation, CCl4 covalent binding to protein
and CCl4 -dependent MDA production have been used to follow the
course of the activation of CCl4 ,
The ESR spectrum obtained from incubating liver microsomes
with CCl4 and PBN was a triplet of doublets (Fig, 3.1.1 a), The spectrum
was identical with those of the PBN-CCl3 ' adduct detected in liver
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microsomes observed by Tomasi et al. (1980) and Albano et al. (1982).
Although there was a PBN-CC13 ' adduct-like signals in samples incubated
without CC14 (Fig. 3.1.1. b), the intensity of signals was much lower than
that of the samples with CC14. These signals may arise from the
background free radicals. These free radicals may be lipid free radicals
produced during the incubation of microsomes. These radicals can be
trapped by PBN to form the lipid-type radical-PBN adduct (Tomasi et al.,
1980; Albano et al., 1982).
The incubation temperature was very important for the formation
of PBN-CC13 ' adduct. It can be seen from Fig. 3.1.2 that only when the
temperature was

~

30°C was the level of formation of PBN adduct

stimulated by CC14 significantly higher than in the control. This result
indicated that PBN -CC13 ' was significantly formed in microsomes only
when the temperature was

~

30°C. Similarly, the production of MDA

was only stimulated above baseline values by CC14 when the temperature
was

~

30°C (Fig. 3.1.6). For the covalent binding of CC14 to microsomal

protein, temperatures higher than 25°C were required to produce
specific 14C-CC14-protein (Fig. 3.1.4). Taken together, these results
indicate that only when the temperature reaches 25-30°C can the
activation of CC14 start. Figs. 3.1.2, 3.1.4, 3.1.6 also showed that
formation of PBN-CC13 ', specific covalent binding of 14CC14 and
production of MDA stimulated by CC14 were increased as the incubation
temperature was increased up to 37-40°C.
The metabolic activation of CC14 in rat liver microsomes occurs
through the NADPH-cytochrome P450 system (Slater, 1984; Slater et al.,
1985; Cheeseman et al., 1985). It is possible that any factor which
enhances the ability of this system will increase the activation of CC14·
This point has been demonstrated by the fact that induction of the
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microsomal cytochrome P450 activity by drugs enhances the activation of
CCl4 (see Introduction 1.1.1.2). Since NADPH:cytochrome P450
reductase and cytochrome P450 are both involved in the activation it can
be considered that the activation of CCl4 is an enzymic process.
Temperature is an important factor in enzymic reactions, so it is
understandable that the activation of CCl4 is increased as the
temperature increases and starts only at a certain temperature.
However, the temperature effect on the activation of CCl4 is more
complicated than this simple explanation. Cytochrome P450 and
NADPH:cytochrome P450 reductase are membrane-bound enzymes. Most
investigations of the effect of temperature on membrane-bound enzymes
have shown that there is a break in the Arrhenius plot (Peterson et al.,
1976). The results presented in this thesis are consistent with this

statement. It can be seen from Figs 3.1.3, 3.1.5, 3.1. 7 that breaks
appeared in the Arrhenius plots for the activation of CCl4. Previous
studies have reported the P450-system-dependent metabolism of drugs,
like stearic acid nitroxide (Stier and Sackmann, 1973), hexobarbital.
ethylmorphine (Peterson et al., 1976), benzphetamine, aminopyrine and
ethanol (Puntarulo and Cederbaum, 1989) were dependent on
temperature and had breaks in the Arrhenius plots. The break in
Arrhenius plot has been assumed to be associated with a phase
transition of the lipids in the membrane. In rat liver microsomes the
number of P450 molecules is about 20-30 times greater than that of the
NADPH:cytochrome P450 reductase (Depierre and Dallner, 1975). It has
been suggested that the whole enzyme system is enclosed by a rather
rigid phospholipid halo which undergoes a crystalline-liquid phase
transition (Stier and Sackmann, 1973). Cytochrome P450 molecules are
clustered around the reductase which is envisioned to randomly reduce
the cytochrome P450 molecules immediately adjacent to it (Peterson et

171

al., 1976). If P450 molecules are not directly associated with the
reductase, a translational motion of the reductase or P450 molecules
through the microsomal membrane is required. In this case the
Arrhenius plot will exhibit a break. Below the transition temperature the
membrane is presumably in the gel state, the molecule of drug has to
penetrate a rigid barrier to reach the reductase and a high activation
energy will be needed for the activation. Above the transition
temperature, the membrane is in a rather fluid state, therefore the
activation energy will decrease (Stier and Sackmann, 1973). Stier and
Sackmann reported that transition temperature of the rabbit liver
microsomal membrane was 32°C. The transition temperature for aniline
and aminopyrine oxidation was 34-36°C and 27 -29°C respectively (Stier
and Sackmann, 1973). and for P450-dependent ethanol metabolism in
liver microsomes it was about 20.3°C (Puntarulo and Cederbaum, 1989).
The results in the present study showed the transition temperature was
about 26.7-27.5°C or 34.3°C (Fig. 3.1.3; 3.1.5; 3.1.7). Below the
transition temperature the energies for PBN-CCl3 · adduct formation,
specific 14CCl4 binding to protein and CCl4-dependent MDA production
were 6.8 kcal/mol, 11.83 kcal/mol and 9.8 kcal/mol respectively. Above
the transition temperature the energies were changed to 1.66 kcal/mol,
3.36 kcal/mol and 2.83 kcal/mol respectively.
Using these different methods to measure the activation of CCl4
obtained different transition temperatures, it was apparent that the data
were very close when PBN-CCI3 · adduct formation and 14CCl4 covalent
binding to protein were employed as the indices, giving values of 27.5°C
and 26.7°C respectively ~ However, the apparent tranSition temperature
was much higher when CCl4 metabolism was measured by lipid
peroxidation, with a value of 34.3°C being obtained. This phenomenon
was consistent with the conclusion that misleading results can be
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obtained using only one parameter of CCl4 metabolism, especially if that
parameter is CCl4-dependent lipid peroxidation (Cheeseman 1982 a, b).
Spin trapping of CCl3 ', the covalent binding of radiolabelled CCl4 to
microsomal macromolecules and CCl4-induced lipid peroxidation are all
indirect indices of CCl4 metabolism. Cheeseman (1982 a, b) suggested
that the measurement of covalent binding was a better index being more
direct than CCl4-induced lipid peroxidation assay. Using these two
methods Cheeseman studied the differences between CCl4 metabolism
and P450-dependent drug metabolism as exemplified by aminopyrene
demethylation in response to inhibitors. He found that a better
correlation existed between aminopyrene metabolism and 14CCl4
binding than with aminopyrene metabolism and CCl4-induced MDA
production.
There are two processes from CCI3 ' production to PBN -CCI3 '
adduct formation and CCl4 covalent binding. However there are three
processes from CCI3 ' production to CCl4-induced lipid peroxidation (see
Fig. 1.1.2) and even more processes to MDA production. Temperature
will affect all of these processes. Therefore, the apparent effect of the
temperature on CCl4 activation measured by these three methods is the
sum results of the influence of the temperature on these processes
together. If there are less indirect processes, the result of the influence
of the temperature will be closer to the net effect of temperature on
CCl activation. From this point it was suggested that PBN spin trapping
4
of CCI

3

'

and the covalent binding are the better parameters than CCl4 -

induced MDA production. This can explain why the results of the
transition temperature were very close when CCl4 metabolism was
measured by PBN-CCl ' formation and 14CCl4 covalent binding whilst the
3
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datum of the transition temperature obtained by CCl4 -dependent MDA
assay was very different to the previous two.
In this study the activation of CCl4 was initiated in vitro by using
the artificial lipid peroxidation model in which the NADPH was
generated from reaction of glucose-6-phosphate with NADP+. The effect
of temperature on NADPH generation was also investigated. It can be see
from Fig. 3. 1.8 that higher temperature enhanced the generation of
NADPH.
The activation of CCl4 in microsomes is found to be absolutely
dependent on the addition of NADPH (Slater and Sawyer 1971a; 1977;
Kornbrust and Mavis, 1980). Tortoriello et al. (1991) reported that a
high concentration of NADPH (300-500

~M)

was required for activation

of CCl4 at maximum rate in liver microsomes. An NADPH generator was
provided for optimal CCl4 metabolism. The presence of an NADPH
generator in the reaction system increased the rate and extent of CCl4
metabolism by two-fold compared to the reaction without a NADPH
generator system. The NADPH generator can maintain more NADPH in
its reduced form and therefore preserves a higher concentration of
NADPH for cytochrome P450 catalyzed metabolism (Tortoriello et al.,
1991).
Therefore, an enhancement of the activity of the electrontransport chain through the changing of membrane lipid phase and an
increase in the amount of electron donor (NADPH) may both contribute
to the stimulation of the activation of CCl4 by increasing temperature.
It was observed that the formation of PBN-adduct decreased after

the temperature reached 37°C (Fig. 3.l.2) under conditions of both with
and with<?ut CCI4 . This was probably due to the PBN-spin adduct being
unstable at higher temperatures. It has been reported that the PBNCCI3 · spectrum changes markedly during warming of the sample from
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-196°C to room temperature. Unstable species appear during the
warming up (Tomasi. et al.. 1980). The instability of PBN-adduct at the
high temperature will lead to the underestimation of the activation of
CCl4 · Increase in the temperature will increase the rate of CCI4
activation but also decrease the stability of the PBN-adduct. Therefore.
there is a limit to the use of PBN-adduct formation as an index of CCl4
activation.

4. 1. 2 Effect of selected agents on the activation of CCl 4 in rat liver
micro somes

Several agents have been chosen for investigation of their effect on
the activation of CCl4 as evidenced by determination of lipid
peroxidation which was measured by MDA production. Two inhibitors of
cytochrome P450 (pyrazole and imidazole). two sulphydryl reagents.
Uodoacetamide and N-ethyl maleimide) and glutathione have been used
for this purpose.
This was a continuation and completion of the studies initiated by
Slater and Sawyer (1971 a. b. c) and continued by Cheeseman (1982 a.
b). In those studies CCl4 -induced lipid peroxidation and 14CCl4 covalent
binding to microsomal protein were taken as the indices of CC14
activation and used to compared with typical mixed-function oxidase
(MFO) activity in terms of the effects produced by inhibitors of MFO.
The typical MFO activity was exemplified by aminopyrene
demethylation. The type of inhibitors used in those studies were classiC
P 450 inhibitors. SH reagents. metal-chelating agents and free radical
scavengers. It was found in those studies that there were apparent
differences between aminopyrene demethylation and CCl4 metabolism.
For instance. the SH reagent pCMB at 0.1 roM moderately inhibited
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14CC14

binding, strongly stimulated CC14 -dependent MDA production

while aminopyrene demethylation was strongly reduced (Cheeseman,
1982 a, b; Slater and Sawyer, 1971 b). CC14 is not a typical MFO

substance, therefore, it is expected that CC14 metabolism respond to
inhibitory agents in a different way from aminopyrene demethylation
(Cheeseman et al., 1985).
Pyrazole is classically used as a inhibitor of alcohol dehydrogenase
(ADH) , the principal enzyme responsible for the oxidation of ethanol in
liver (Goldberg and Rydberg, 1969). Imidazole, an isomer of pyrazole, is
a inhibitor of ADH too (Boiwe and Branden, 1977). Both of these two
agents can inhibit P450 enzyme activity (Ingelman-Sundberg and Jomvall
1977) as exemplified by aminopyrene demethylase (Cheeseman, 1982

b) and amine oxidase (Terelius and Ingelman-Sundberg, 1986). Pyrazole
and imidazole can induce isoenzymes of liver microsomal cytochrome
P 450 and therefore enhance the CC14 -stimulated lipid peroxidation (see
Introduction) but this property is not relevant to investigations in vitro.
Pyrazole and imidazole have been used as protective agents in vivo.
For instance, administration of pyrazole to rats partially prevents the
CC14 -induced loss of microsomal P450 (Toranzo et al., 1975).
Pretreatment of rats with pyrazole almost completely abolished the
ultrastructural effects of CC14 on the liver endoplasmic reticulum at 3h
after its administration (Bernacchi et al., 1980). Pyrazole protects the
animal or hepatocytes against glutathione depletion, lipid peroxidation
and cell damage induced by allyl alcohol (Jaeschke et al., 1987; Silva
and O'Brien, 1989). Pretreatment of rats with imidazole inhibit the
metabolic activation of N-nitrosopyrrolidine (NPYR) resulting in the
reduction of NPYR-derived DNA adduct formation. NPYR is a acute
hepatoxic and carcinogenic agent to rat liver (Hunt and Shank, 1991).
The effect of pyrazole and imidazole on activation of CC14 in vitro
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has been studied by Cheeseman (1982 b) ten years ago. He found that at
5 mM, pyrazole and imidazole had modest effects on CC14-dependent
lipid peroxidation and covalent binding of 14CC14 to microsomal protein,
although aminopyrene demethylase was strongly inhibited by these two
agents at the same concentration.
Since pyrazole and imidazole have protective roles against damage
induced by drug metabolism, and particularly as they have been tested
as hepatoprotective agents in the CC14 model in vivo and they can inhibit
p 450 enzyme activity in vitro, their effect on CC14-dependent lipid
peroxidation in liver micro$omes at higher concentrations (10-20 mM)
was investigated. The results were shown in Fig. 3.l.9 and Table 1.1.1. It
can be seen that at the relatively high concentrations these two agents
eventually produced small inhibitory effects on the lipid peroxidation
stimulated by CC14. At 10 mM pyrazole inhibited CC14-dependent MDA
formation by 300/0. Imidazole showed 29% inhibition at 20 mM. These
results indicated that the activation of CC14 was inhibited by these two
compounds at a relatively higher concentration. The mechanism of the
inhibition may be attributed to their ability to inhibit of P450 enzyme
activity.
Iodoacetamide (I DAM) and N-ethyl maleimide (NEM) are
sulphydryl reagents that can interact with SH groups of a protein
resulting in alkylation of the protein (Haenen, et al., 1987; Chen and
Stevens, 1991). In the present study IDAM and NEM had little effect on
CC1 4-dependent lipid peroxidation in liver microsomes. IDAM inhibited
MDA production by 150/0 at 10 mM. No increase in inhibition occurred
when the concentration of IDAM was increased to more than 10mM
(Fig. 3.1.10). NEM exerted biphasic effects on CC14-stimulated MDA
formation (Fig. 3.l.11). At 0.5-1.0 mM NEM inhibited MDA production
by 20 0/0, but higher concentrations of NEM stimulated the lipid
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perOxidation slightly.
These results were similar to those obtained by Cheeseman (1982
b). He observed that IDAM at 10 mM had little effect on MDA
production whereas the covalent binding of 14CCl4 was inhibited by 290/0
and aminopyrene demethylase was inhibited to a similar degree. He also
found that at 3 mM NEM aminopyrene demethylase was inhibited by
340/0 whereas 10 mM NEM was required to inhibit covalent binding to a

similar degree. At 10 mM NEM CCl4-dependent MDA production was
enhanced.
The effect on CCl4 metabolism of other SH reagents, pCMB,
mersalyl and dithiobisnitrobenzoate (DTNB) have been studied by Slater
and Sawyer (1971 b) and Chesseman (1982 a; b). pCMB at the range of
50-300 ~M inhibited 14CCl4 binding to the microsomal protein. The

effect of pCMB on CCl4-dependent MDA production showed a biphasic
effect but this biphasic pattern was different from NEM. At the lower
concentration (1 00

~M)

production. At 200

~M

pCMB stimulated CC14-dependent MDA
pCMB strongly inhibited CC14-induced lipid

peroxidation. Mersalyl and DTNB showed the Similar pattern of effects
to that found with pCMB (Cheeseman, 1982 b).
SH reagents are believed to inhibit drug metabolism by blocking
electron transfer to cytochrome P450 and also by denatUring the
cytochrome (Franklin and Estabrook, 1971). Since CCl4 is activated at
cytochrome P450 it is understandable that IDAM and NEM inhibit CCl4mediated lipid peroxidation. However the biphasic effects of NEM is
difficult to explain. This effect seems to demonstrate the problem of
using MDA production as an indicator of CCl4 metabolism since,
simultaneous with enhanced MDA production, decreased covalent
binding occurs (Cheeseman, 1982 b).
GSH is a very important and an effective inhibitor of lipid
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peroxidation. In this study, GSH showed inhibitory effects on lipid
peroxidation in a concentration-dependent manner. A 500/0 inhibition
was observed at a concentration of GSH less than 0.2 mM and 1mM GSH
nearly completely diminished the MDA production (Fig. 3.1.12). GSH
not only inhibited the extent and rate of CCl4 -dependent MDA
formation, but also prolonged the initiation period of lipid peroxidation,
and this effect was concentration-dependent too. In the absence of GSH
a 3 min. lag phase was seen before the lipid peroxidation started (see
Fig. 3.1.13). GSH prolonged this lag phase. In the presence of 0.08 mM
GSH, the induction time of the lipid peroxidation was prolonged to 5
min. The period of induction of lipid peroxidation was further increased
to 7 min. when the concentration of GSH was increased to 0.2 mM.
These results are in agreement with previous work. It has been
observed that GSH protect hepatocytes (Poli and Gravela, 1982), liver
mitochondria (Yonaha and Tampo, 1987), nuclei (Tirmenstein and
Reed, 1989) and microsomes (McCay et al., 1981; Burk, 1982, 1983;
Burk et al., 1983; Haenen and Bast, 1983; Nagasaka et al., 1989; Wefers
and Sies, 1989; Palamanda and Kehrer, 1992) against lipid peroxidation.
GSH delays the onset of lipid peroxidation in liver micro somes induced
by ascorbate/ADP /Fe 3 + , NADPH and CCl4 . It also decreases the rate and
extent of CCl4 -induced lipid peroxidation in micro somes (Burk et al.,
1983).
It was observed that GSH effect on the onset of lipid peroxidation

in liver microsomes was dependent on a heat-labile protein (Burk,
1983). Burk (1983) suggested that the GSH-dependent protection
against lipid peroxidation was a result of free radical scavenging. Later it
was revealed that the protein factor perhaps was vitamin E reductase
and the protection by GSH against microsomal lipid peroxidation
through a vitamin E-dependent mechanism (Haenen and Bast, 1983;
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Wefers and Sies, 1988; Bast and Haenen, 1990). In this mechanism
vitamin E radicals in the membrane produced by scavenging of a free
radical by vitamin E are regenerated to vitamin E by a free radical
reductase at the expense of GSH (Haenen and Bast, 1983; Bast and
Haenen, 1990; Shan et al., 1990).
However, these conclusions come from the results obtained by
using the non-enzymic dependent lipid peroxidation system. So far
there is no evidence to suggest that the inhibitory effect of GSH on CC14induced lipid peroxidation also depends upon a heat-labile factor. This is
because CCl4-induced lipid peroxidation is P450 system-dependent and
requires the native microsomes. Cheeseman (1982 b) and Burk et al.
(1983) reported that GSH inhibited 14CCl4 covalent binding to

microsomal protein. These observations are consistent with the
suggestion that free radical scavenging as the mechanism of protection
of GSH (Burk, 1983) since covalent binding is produced by CCl3 · radical.
Based on these observations it could be conSidered that GSH inhibits
lipid peroxidation induced by CCl4 in microsomes through the same
mechanism as the GSH dependent inhibition of lipid peroxidation
induced by the non-enzymic system.
More evidence is required to determine the mechanism of GSH
function in CCl4 -induced lipid peroxidation system, such as
a) the time and concentration courses of GSH effect on 14CC14
covalent binding and PBN -CCl3 · formation for determination of the
ability of GSH scavenging CCI3 ·;
b) requirement of vitamin E for GSH function to check if the
inhibitory effect of GSH is vitamin E dependent (for this research
vitamin E deficiency microsomes can be employed);
c) the effect of SH reagents on GSH function to test if there is a
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protein factor involved in the GSH protection effect;
d) the effect of addition of GSH peroxidase on GSH function.

4. 2. RIBONUCLEOTIDE REDUCTASE

4. 2. 1. Purification of ribonucleotide reductase from 1uvenile normal
rat liver

Mammalian ribonucleotide reductase ( RNRase ) contains two
components, M 1 and M2. The two components are easily separated and
it is difficult to purify the mammalian RNRase due to its instability
(Wright, et al., 1989). So far only subunit M1 of the enzyme from calf
thymus and regenerating rat liver has been highly purified (Enstrom, et
al.,1979; Thelander et aI., 1980; Youdale et al., 1982). In these studies
dATP-affinity chromatography was employed as a last or important step
since dATP specifically binds the M 1 subunit. The liver enzyme is
completely dissociated by binding to the dATP-affinity column (Youdale,
et al., 1982). A number of reports describe the separation of the
mammalian enzyme into two subunits. However, in all cases attempts to
recombine the subunits or to pUrify the subunits separately resulted in
very low yields of enzyme activity (Thelander, et aI., 1980).
An attempt to pUrify the intact rat liver enzyme was made in the

present work. The purpose was to develop a method of purification for
obtaining a protein preparation in which the separation of the two
subunits was minimal and the enzyme preparation was pure enough for
raising an antibody. Ammonium sulphate fractionation (45% saturation),
DEAE-cellulose chromatography, ATP-Agarose affinity chromatography.
pH 5.2 precipitation, CM-Sephadex chromatography have all been
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utilised for the purification.
Apart from its stability another maj or problem of purification of
the enzyme is the low level of reductase present in most eucaryotic
cells. Here the livers of 3-4 week-old rats have been chosen as the
source of the enzyme since it is active in the liver at this stage of
development and it is available in large quantities.
The protein content and the enzyme activity in different
preparations of the enzyme from liver are shown in Table 3.2.1.
Up to the step of chromatography on DEAE-cellulose the enzyme
protein was purified some 30-fold (Table 3.2.2). This enzyme
preparation, however, showed more than 10 bands of protein when it
was analysized by sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-page) (Fig. 3.2.2).
Chromatography on ATP-Agarose affinity and pH 5.2 precipitation
followed by chromatography on CM-Sephadex were employed in an
attempt to further purify the enzyme preparation after chromatography
on DEAE-cellulose.
ATP-affinity Sepharose has previously been used for purification of
the phage T 4 induced ribonucleotide reductase in

'E.

coG.. but apart from

ribonucleotide reductase several other proteins which can interact with
ATP were bound to the ATP-Sepharose column (Berglund and Eckstein,
1972). ATP-affinity chromatogtaphy has also been used for a simple
purification of ribonucleotide reductase from human cells (Spector and
Averett, 1983). In that work the ATP-Agarose column is used for
removal of nucleoside diphosphate kinase from the enzyme preparation
without binding ribonucleotide reductase. The aim of using ATP-Agarose
affinity column in the present purification was to see whether the
column could remove other proteins which bind to ATP whilst leaving
the intact ribonucleotide reductase to pass through the column under
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the experimental conditions. However. this procedure was not
successful. The resulting enzyme preparation which was eluted from
ATP-Agarose column with buffer containing no ATP lost 80% of the
enzyme activity compared to the activity of the DEAE-cellulose fraction
(Table 3.2.3). The dissociation of the enzyme may be responsible for this
loss of activity. It was impossible that the intact enzyme was bound to
the column. like phage T4 -induced ribonucleotide reductase since the
protein fraction eluted with 2 mM ATP showed only one band on SDSpage (Fig 3.2.2. line 13). This ATP-Agarose-bound protein was unlikely
to be the protein Ml or M2. Comparing the SDS-page of the protein
fraction(s) eluted without and with 2 mM ATP (line 12 and line 13 in
Fig. 3.2.2) it can be seen that there was no this protein left in the
protein fraction eluted without ATP. however. there still 20% of the
enzyme activity left in this fraction indicating that the protein which
tightly bound to the ATP-Agarose column was not essential for the
enzyme activity.
DEAE-cellulose is an anion exchanger; CM -Sephadex is a cation
exchanger. The separation of the enzyme on CM -Sephadex after DEAEcellulose chromatography was not successful either. The resulting
enzyme preparation after chromatography on CM-Sephadex had 282
units/mg prot. left compared to a starting activity of 973 units/mg prot.
and the purification was not improved (Table 3.2.3 and Fig. 3.2.2).
There was an inaccurate estimation of the recovery of total
enzyme activity after the ammonium sulphate precipitation step (Table
3.2.2). This was most probably due to the underestimation of the
enzyme activity of the crude enzyme extract. '!\vo factors contributed to
this underestimation:
i) RNA RNA inhibits ribonucleotide reductase activity (Cory. et al ..

1973) and the crude extract contains a lot of nucleic acids. RNA can be
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removed after salt precipitation;
ii) nucleoside kinase (NDP kinase) In the presence of Mg2+. NDP kinase

catalyzes the transfer of phosphate from nucleoside triphosphates (NTP)
to nucleoside diphosphates (NDP). NDP are the substrates of
ribonucleotide reductase and the assay for the activity of ribonucleotide
reductase requires Mg2+. Thus the substrate and requirement of Mg2+
for NDP kinase are satisfied in the RNR assay mixture and since NDP
kinase activity is much higher than RNR in mammalian cells, NDP
kinase will quickly convert the radiolabelled NDP (3H-CDP) to NTP (3HCTP) resulting in the reduction of substrate for RNR. Most of the NDP
kinase activity (900/0) can be removed from the crude extract by
ammonium sulphate precipitation (Spector and Averett 1983).
It is readily apparent that the development of a method for

obtaining a highly purified and minimally separated ribonucleotide
reductase preparation from juvenile normal rat liver was not successful.
Chromatography on DEAE-cellulose is a common method of protein
purification, but it is not specific for separation of ribonucleotide
reductase from the bulk of proteins, like dATP affinity chromatography
for the M 1 subunit. ATP-affinity Agarose column did not specifically bind
M1 or M2 and caused the loss of the enzyme activity probably due to the
separation of the two subunits. Chromatography on CM-Sephadex caused
the loss of the enzyme activity too and did not improve the purification
situation. It seems that it is impossible to purify both subunits of
ribonucleotide reductase together to a very high purity. Purification of
M1 and M2 separately perhaps is a better way. In the future it would be
worth trying to use monoclonal antibody technique to obtain the M2 or
M1 antibody. This protocol includes administration of an M1 or M2containing preparation to an appropriate recipient animal, production of
hybridoma cell lines, cloning of hybrid cell mixtures and screening for
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M1 or M2 antibody production (Liddell and Cryer, 1991). This
technology has been applied to prepare antibodies against a vast range of
antigens including serum proteins, enzymes, cell surface receptors,
hormones, drugs, tumour specific antigens and differentiation antigens
(Wilson and Goulding, 1986). A major advantage of using monoclonal
antibody technology is the extreme confidence with which M 1 or M2
antibody can be made. A major disadvantage of using this technology is
that it relies on the random fusion of a heterogeneous population of B
lymphocytes with myeloma cells, resulting in much time being spent

in

growing and testing hybrids which secrete M 1 or M2 antibody. The
other disadvantage is the intensive cost of producing the monoclonal
antibodies (Wilson and Goulding, 1986).

4. 2. 2. Activity of ribonucleotide reductase in tissues of different
flrowth states

Ribonucleotide reductase is a key enzyme for DNA synthesis. It
catalyzes the conversion of four ribonucleotides into the corresponding
deoxyribonucleotides that are the precursors of DNA. The reductase
activity is closely related to the growth rate of normal and neoplastic
tissues (Thelander and Reichard, 1979; Lammer and Follm ann , 1983;
Cory, 1989). In the present study, the reductase activity was checked in
normal dividing and resting rat liver and hepatomas. The results
demonstrated that the activity of the enzyme was higher in proliferating
cells. An activity of 215 units/mg prot. existed in juvenile (3-4 weeks
old) rat livers while no activity was observed in adult (11-12 weeks old)
rat livers (Table 3.2.4). Similarly, an elevated enzyme activity appeared
in regenerating liver whilst the enzyme activity was undetectable in
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livers from sham-operated animals (Fig. 3.2.5). Hepatomas possessed
higher enzymatic activity (Fig. 3.2.3. 3.2.4) and furthermore. the level of
the enzyme activity was related to the growth rate of the tissue. The
activity of the enzyme in the rapid-growing Yoshida hepatoma was
significantly higher than that in the slower-growing MorriS tumour (Fig.
3.2.3). All of these results are in agreement with the previous work
(King and van Lancker. 1969; Elford et al.. 1970; 1972; 1974; Takeda
and Weber. 1981; Youdale. et al .. 1982).
The time course of the enzyme activity was investigated in
cultured Yoshida ascites hepatoma cells during 6 days of culture. The
enzyme activity was very low at day O. It began to increase after day 1
and continued to increase over 4 days. The highest activity was found at
day 4. then the activity decreased abruptly (Fig. 3.2.4).
Ribonucleotide reductase is related to cell cycle. The enzyme
activity is very high in S phase and very low in GO / G 1 phase (see
Introduction). When cultured cells are in the exponential phase, there is
a large amount of cells in S phase. Therefore. it is expected that
ribonucleotide reductase activity is increased. When cultured cells are
in the plateau phase, the portion of cells which are in S phase
decreases and the portion of cells in GO / G 1 phase increases, thus the
ribonucleotide reductase activity will decline. According to Carrie
(personal communication). the exponential growth phase of cultured
Yoshida cells was beginning at day 1 and lasts for 4 days. This growth
pattern parallelled the pattern of changes in the activity of CDP
reductase (Fig. 3.2.4).
These results are similar to the observation of Chevanne and
Caldini (1986). They reported that after the Yoshida cells were
transferred from host rats to the culture medium the enzyme activity
increased after 2-3h and continued to increase throughout the 18h
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period. They concluded that this elevated activity was related to the
transition of the cells from GO-G 1 to S phase. Takeda and Weber (1981)
also observed that when hepatoma cells (3924A) were freshly plated
and allowed to grow in lag, log and plateau phases for a 96-hr period the
CDP reductase increased at 6 hr. The enzyme activity remained at the
increased level (5.5-6 fold) for 48 hours and then declined to a lower
level.
For studying changes in the enzyme activity in regenerating liver.
the entrained rat model was used here. When the rats are entrained to a
12h light/12h dark regime, with access to food during the first 8h of
darkness, liver regeneration is marked by cycles of DNA synthesis and
cell division at approx. 24h intervals (Hopkins et aI., 1973; Slater et al.,
1990). Using this model to study processes of liver regeneration
associated with CDP reductase activity, it was found that the enzyme
activity in regenerating liver exhibits a periodic cycling in time course
following partial hepatectomy (Fig. 3.2.5). There were two peaks of the
enzyme activity. one at 48h post operation and another at 72 h post
operation. This cyclical change in the reductase activity closely
parallelled the time course of thymidine kinase activity in regenerating
liver. It has been reported that thymidine kinase activity in regenerating
liver is high at 24, 48, and 72h post operation, but very low at 12, 36.
60 and 84h post operation (Cheeseman. et aI .. 1986; Slater et al .. 1990).
Several previous studies have reported that the ribonucleotide reductase
activity is increased in regenerating liver (King and Lancker. 1969;
Elford. 1974; Cory and Fleischerm 1982 b; Takeda and Weber. 1981).
but none has been with the entrained rat model used here, therefore
neither showed changes in the ribonucleotide reductase activity with
cyclical variations. Use of the entrained rat schedule of Hopkins et aI.
(1973) is better to show the close relationship between DNA synthesis
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and ribonucleotide reductase activity and investigate the mechanism of
regulation of the enzyme activity in regenerating liver.
What is the mechanism of regulation of ribonucleotide reductase
activity in regenerating liver? Earlier work of Cory and Fleischer (1982
b) showed that two components of ribonucleotide reductase, M 1 and
M2 were not co-ordinately regulated in regenerating liver. M2 increased
more rapidly and remains at a high level for a longer period, while the
M 1 increased later. Cory and Fleischer asked the question: does the
non -coordinate increase of the two components result from the noncoordinate synthesis of the protein component or the non-coordinate
activation of the newly synthesised components?
Whitfield et al. (1989) believe that non-coordinate synthesis of the
protein components is involved in the enzyme activity's regulation. They
suggested that one subunit of the enzyme, MI, controls the enzyme
activity in regenerating liver. Before the onset of DNA replication, the
cells start accumulating a large pool of functional ribonucleotide
reductase M2 subunit. When M2 subunits reach a certain level (when
the cell is near the end of the G I phase), the cell begins M I gene
expression, stops inactivating and reduces the degradation of the M I
products. Then MI and M2 combine to form the active holoenzyme. At
the end of the S phase, the cell reduces MI gene expression and
resumes degrading MI subunits.
The results of this study could not indicate if M I and M2 were
regulated coordinately or not during periodiC cycling changes in the
enzyme activity. However, the changes in the enzyme activity in the
model of regenerating liver used here was the result of the regulation of
the enzyme activity in vivo and the mechanism of regulation was probably
through changing the level of the enzyme protein and/or in- and reactivation of the enzyme activity. This conclusion was from the results
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shown in Fig. 3.2.5 and Table 3.2.6. The CDP reductase in regenerating
liver had declined at 60h post operation (Fig. 3.2.5). This phenomenon
could be explained by three possibilities:
(i) changing the protein level of the enzyme in vivo,
(ii) inactivation of the enzyme in vivo,

(iii) inhibition of the enzyme activity by inhibitors produced in vivo

or in vitro.
However, it can be seen from Table 3.2.6 that there was only an additive
effect when enzymes from 60h and 48h regenerating liver were mixed
together. This result indicated that there were no inhibitors in the
enzyme preparation from 60h regenerating liver. Therefore, only
possibilities of (i) and (ii) would be responsible for the decrease of the
enzyme activity in 60h regenerating liver. Of course more direct
evidence is required to make the final conclusion about the regulation
mechanism in the ribonucleotide reductase activity in the regenerating
liver model used here. Examination of the activity and the protein level
of Ml and M2 separately at different time of post operation is required
for this purpose.
In the present study, it was found that there were differences
between the enzyme from juvenile normal rat liver and regenerating
liver in the optimal DIT concentration for exerting the full CDP
reduction activity (Fig. 3.2.6). A higher concentration of DIT (10 mM)
was required for the enzyme from 48h and 60h regenerating rat liver to
exert the full CDP reductase activity, while 1 mM DIT was enough for
the CDP reductase from juvenile rat liver to express the activity. The
enzyme activity of 48h and 60h regenerating liver at 10 mM DTI was
about 2600/0 and 181 0/ 0 of the activity at 1 mM DIT, respectively.
The differences in the optimal DTI concentration for the full
activity between enzyme preparations from normal and regenerating
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liver may due to
(i) different content of low molecular weight thiols in
enzyme preparations i.e. higher content of thiols in the
enzyme preparation from juvenile normal rat liver and lower
content of thiols in the enzyme preparations from
regenerating rat liver;
(ii) the enzymes from normal rat liver and regenerating rat

liver are different;
(iii) different rate of consumption of the DTI.
The results shown in Table 3.2.6 allow one to rule out the first
possibility. There were no significant differences in acid-soluble thiol
content between enzyme preparation from 48h regenerating liver and
normal rat liver or between 60h regenerating liver and normal rat liver.
The content of acid-soluble thiols in enzyme preparations from 48h
regenerating liver was significantly higher than that from 60h
regenerating liver. However, this difference cannot explain the results
that the enzyme activity from both of 48h and 60h regenerating liver
was dependent on DTT concentration. In fact, the enzyme from 48h
regenerating liver required higher DTI concentration for exerting the
full activity than that the enzyme from 60h regenerating liver did.
For the second possibility, it is unlikely that the enzymes from
normal and regenerating rat liver have big differences in their
properties. Whitfield et ale (1989) reported that both normal and
regenerating rat liver contained functional protein M 1, 88-90 kDa
protein and non-functional fragments of Ml, 40 kDa protein; however,
normal liver contained only faint traces of the 88-90 kDa protein. This
result indicates that normal and regenerating liver contain the same M 1
subunit. The experiment here demonstrated that the enzyme from
normal and regenerating liver had the same sensitivity to the specifiC
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inhibitor. hydroxyurea. It can be seen from Fig. 3.2.12 that 4 mM
hydroxyurea inhibited the enzyme activity form three sources by 60700/0. At 10 mM hydroxyurea the activity of all the enzymes was nearly
inhibited by 1000/0. Hydroxyurea destroys the tyrosine free radical of M2.
Therefore. the M2 of normal and regenerating liver have the same
properties.
DTI is necessary for CDP reductase activity as a reducing agent in
this assay system. As a reducing agent, it would be consumed during the
enzymic reaction. The higher the enzyme activity. the more the CDP
reduction and the more the DTI consumption. Therefore, the third
possibility could explain the results that the enzyme activity from 48h
regenerating liver required a higher DTI concentration than the
enzyme from normal rat liver was not (Fig. 3.2.6). The CDP reductase
activity in 48h regenerating liver was much higher (723 units/mg proL)
than that in normal juvenile rat liver (185 units/mg prot.) (Fig. 3.2.5,
Table 3.2.4). It is therefore understandable that 48h regenerating liver
enzyme needs more DTI for reducing the CDP. This explanation is
supported by the results shown in Fig 3.2.7. The continual presence of a
higher DTI concentration was needed to maintain the high activity of
the enzyme from 48h regenerating liver (Fig. 3.2.7). At 1 mM DTI, the
level of reduction of CDP was lower compared to that at 10 mM DTI.
Addition of 10 mM DTI immediately restored the rate of CDP reduction
even after the reaction had been going for 20 and 40min. (Fig. 3.2.7).
Since the enzyme activity in normal juvenile liver was only 185
units/mg prot., 1 mM DTI was a saturating concentration for the
enzyme to catalyse the CDP reduction. Thus there was no significant
difference in the normal liver's enzyme activity at the range of 1 mM to
15 mM DTI.
However, the third possibility cannot explain the dependence of
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the enzyme activity from 60h regenerating liver on the DIT
concentration. The level of the CDP reductase activity in 60h
regenerating liver was Similar to that in juvenile normal rat liver, that
was about 110 units/mg prot. There is another explanation. In this
study, it was found that the higher concentration of DIT had the ability
to activate the CDP reductase from 48h and 60h regenerating liver (Fig.
3.2.8, 3.2.9). Preincubation of the enzyme protein from 48h and 60h
regenerating liver with 10 mM DIT for 20 min enhanced the CDP
reductase activity by 29% and 1050/0, respectively. However, the activity
of CDP reductase from normal juvenile rat liver was not activated by high
concentration of the DIT (Fig. 3.2.10).
Therefore, DIT had two functions under the present
experimental conditions, as a reducing agent that would be continuously
consumed in the reaction and as an initial activator of the enzyme
activity. The dependence of enzyme activity from 48h regenerating liver
on DTT concentration may have been due to these two roles of DIT,
reducing agent and activator. The dependence of enzyme activity from
60h regenerating liver on DIT concentration, on the other hand, may
have been only due to the function of DIT of activation.
What is the mechanism of the activation of ribonucleotide
reductase by DTf? Previous work has been shown that the tyrosine free
radical of M2 can be regenerated by DIT and 02. Under the high
concentration of DIT (5-10 mM) and air, tyrosine radical-free M2 can
be reactivated to an active M2 containing a M2-specific tyrosine free
radical (Thelander, et al., 1983; Graslund et al., 1982; Lassmann, et al.,
1989).
From the discussion above and the results shown in Fig. 3.2.8,
3.2.9, it can be suggested that some inactive M2 (specific radical-free
M2) exists in regenerating liver. These inactive M2 subunits can be
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reactivated by a high concentration of DTT in vitro.
Does this phenomenon have some physiological meaning in
regenerating liver? A tentative hypothesis for this phenomenon
connecting to the regulation of the ribonucleotide reductase activity in
regenerating liver is given below. As mentioned already. Whitfield et al.
(1989) suggested that in regenerating liver before the onset of DNA
replication, the cells start to accumulate a large pool of M2. According
to the results of this present study it is supposed that these M2
subunits, all or part, are inactive. When M2 reach a certain level, the
cells start to synthesis Ml. Then M1 and M2 combine to form a
holoenzyme. Before or after the combination. the inactive M2 is
reactivated through regeneration of free radicals and the holoenzyme
becomes functional. How are these inactive M2 subunits reactivated in
vivo? They could be reactivated by intracellular thiols, like low molecular

weight thiols. Fig. 3.2.11 showed that acid-soluble thiol in homogenates
from regenerating liver exhibit a periodic cycle which is the same as the
cycle of CDP reductase (Fig. 3.2.5). Possibly. in 48h and 72h
regenerating liver there are more M2 subunits than in 36h and 60h
regenerating liver, therefore a higher concentration of thiols is required
in 48h and 72h regenerating liver for activation of the M2.

It has been suggested that cells may have a mechanism for

controlling ribonucleotide reductase activity by generating the free
radical of M2 (see Introduction 1. 3. 3. 2).
The activity of CDP reductase from 48h regenerating liver in Figs.
3.2.6-8 was lower, only 170-250 units/mg prot., compared to that in Fig.
3.2.5 which was about 700 units/mg prot .. This was because in the
experiments shown in Fig. 3.2.6-8 the content of enzyme in the assay
mixture was low, about 0.39 mg in the CDP reduction mixture. Low
content of enzyme protein will underestimate the enzyme activity since
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the two subunits of the enzyme are easily separated at low protein
content. Usually 1 mg enzyme protein is needed for determination of
the enzyme activity.
Thymidine kinase is very active in 24h regenerating liver
(Cheeseman, et al., 1986). However, no peak of the activity of
ribonucleotide reductase was shown at 24h post operation. Perhaps at
this time, the dNTP pools in liver is large enough to support the first
burst of DNA synthesis. Therefore ae novo synthesis of Ml and M2
subunits is not necessary.
The present work has confirmed the previous results that
ribonucleotide reductase activity is very closely related to the tissue
growth and cell division. The CDP reductase activity can only be
detected in tissues in which intense cell proliferation occurs, like
juvenile rat liver, regenerating rat liver and hepatoma cells.
Furthennore, the level of enzyme activity is closely related to the
growth rate of these tissues and cells. The enzyme activity in
regenerating liver exhibits a periodic cycling in time course following
partial hepatectomy. This phenomenon has been found in thymidine
kinase. The results in the present study suggested that regulation of M2
activity through the way of regenerating M2 specific free radical in the
regenerating liver may play a role in regulation of ribonucleotide
reductase activity in regenerating liver. However, more detail and
advanced research on this possible regulation mechanism are required
in the future. For this purpose M2 subunit from regenerating liver must

be highly purified in order to be able to check the amount of M2specific free radical using ESR spectra and to raise the M2 antibody.
Then the time courses of the amount of M2-specific free radical, the
protein level of M2 and M2 activity need to be performed.
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4. 3. INHIBITORY EFFECT OF HNE ON RIBONUCLEDTIDE REDUCTASE

HNE is one of the most important products of lipid
peroxidation having effects at the enzyme, subcellular, and cellular
level. HNE has the property of inhibition of cell proliferation, but the
mechanism of this inhibition is still not clear. In the present study,
the effect of HNE on the activity of ribonucleotide reductase from rat
liver and the mechanism of the effect have been investigated.
In this study it was demonstrated the HNE inhibited the
activity of rat liver CDP ribonucleotide reductase. This inhibition was
related to the concentration of HNE and the time of incubation (Fig.
3.3.1 and 3.3.2). High concentrations of HNE and long incubation
produced more inhibition of the activity of the reductase. HNE at 0.1
mM produced 50 0/0 inhibition. Preincubation of HNE with the enzyme
protein at 30°C for some time before the enzymic reaction started
increased the extent of inhibition (Table 3.3.1). The preincubation
time had no significant effect on the enhancement of inhibition. If
the enzyme protein was exposed to HNE at O°C for 1 hr, the enzyme
activity could not be recovered after removal of HNE by gel filtration
(Fig. 3.3.3 and 3.3.4). Since the enzyme preparation contained 2mM
DTI and DTI had a protective effect on the enzyme protein against
HNE (see below), so two treatments were carried out for this
experiment. One was using original enzyme preparation (without
removal of 2 mM DTI) and standard enzyme reaction condition (Fig.
3.3.3). Another was using the DTI -free enzyme preparation and
employed 15 min of the enzymic reaction time. However, the results
from these two treatments were essentially the same. The activity of
the HNE-treated enzyme was inhibited and the extent of inhibition
was dependent on HNE concentration (Fig. 3.3.3 and 3.3.4). All of
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these results indicate that HNE can inhibit the enzyme activity
during the enzymic reaction, also it can affect the enzyme protein
itself and this effect is irreversible.
Several enzymes have been reported to be inhibited by HNE
(see Table 1.2.1). HNE possess high reactivity with SH groups. All
inhibitory effects of HNE can be explained by the inactivation of
functional SH groups (Benedetti and Comportl, 1987; Esterbauer et
al., 1988). Ribonucleotide reductase contains several SH groups
which are essential for the enzyme function (see Introduction).
Therefore HNE inhibition of CDP reductase activity may be due to the
blockage of SH groups on the enzyme protein by the aldehyde.
In this study the following pieces of evidence for this
explanation have been given:
(i) DTI has a modulating effect on HNE inhibition and protection of

enzyme against HNE
DIT is a reducing agent in the assay for activity in this study.
The structure of DTI is as below:

The results show that DTI has a modulating effect on HNE inhibition
and protection of the enzyme against HNE. In the presence of a high
concentration of DTT, the degree of inhibition by HNE was decreased
. significantly (Table 3.3.2). If HNE was incubated with DTT before
exposure to the enzyme, HNE had no inhibitory effect on the CDP
reduction (Table 3.3.3). If HNE was incubated with enzyme protein in
the presence of DTI, HNE did not damage the protein (Fig. 3.3.7).
These results are consistent with previous work that reported that most
inhibitory effects of HNE are prevented by the prior addition of thiols
(Schauenstein, 1982). It is reported that a 0.1 mM solution of HNE is
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completely consumed by 1 mM glutathione within 30 min. (Esterbauer,
1982). Therefore, it is understandable that HNE incubated with DIT
(HNE:DIT = 1: 10) for 30 min. at 30°C lost the ability to inhibit the
enzyme activity (Table 3.3.3). HNE can discriminate between different
types of thiols (Schauenstein, 1982), reacting with non-protein thiols
most avidly. This fact can explain the result that if HNE was incubated
with enzyme protein and DTT together, HNE failed to inhibit the
enzyme activity (Fig. 3.3.7). However, DTT did not reactivate the enzyme
activity after the enzyme was damaged by HNE. Incubation of HNEtreated enzyme (enzyme exposed to HNE at O°C for 1 h then the HNE
was removal by gel filtration) with higher concentration of DTT pre- or
during enzyme reaction, no enzyme activity was recovered (Table 3.3.4,
Fig. 3.3.8).

The reaction of HNE with SH is an alkylation. The end

product of the reaction is a very stable cyclic hemiacetal (see
Introduction 1. 2. 1). DIT can reduce S-S bridges. The results here
showed that DIT cannot reverse HNE-SH binding.
(ii) HNE decreases the SH content of the enzyme preparation and

DTT
As shown in Fig. 3.3.9 HNE decreased the SH content of the
enzyme. This effect was dependent on HNE concentration, but
independent of the incubation time. As indicated in Fig. 3.3.10 DTT
influenced the spectrum of HNE, decreasing the absorbance at 223nm.
Fig.3.3.11 and 3.3.12 showed that in presence of HNE the SH content of
DIT decreased. The effect of HNE on the content of SH on DIT was
proportional to both the HNE concentration and the incubation time.
(iii)

The presence of thiols in the enzyme preparation decreases the

effect of HNE
Another piece of evidence is from the result of the inhibitory
effect of HNE on the enzyme activity of the crude extract. It can be seen
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from Fig. 3.3. land Fig. 3.3.6 that the effect of HNE on crude extract is
10 times weaker than it was on the partially purified enzyme. The
explanation is that there is a large amount of thiol in the crude extract
enzyme. These thiols react with HNE preferentially and protect the
enzyme against HNE (Dianzani et al., 1990).
Therefore, under the present experimental conditions, HNE
inhibits the CDP ribonucleotide reductase in two ways. One was that
HNE directly affected the enzyme protein. This was the result of
blocking the essential SH group of enzyme by HNE. This damage was
irreversible (Fig.3.3.3 and 3.3.4). The concentration of HNE influenced
this effect (Fig. 3.3.4), but the time of HNE incubation with the enzyme
protein was not very important since (a) the preincubation time had no
significant effect on the enhancement of inhibition induced by
preincubation of HNE with enzyme (Table 3.3.1), and (b) the reduction
of the content of SH of enzyme by HNE only related to HNE
concentration, the reaction time had no effect (Fig. 3.3.9). The second
way was through the interaction of HNE with the reducing agent DIT.
HNE reacted with DIT and consumed the amount of the DIT. Finally
this effect affected the enzyme activity. This kind of effect of HNE was
indirect. It was not only related to the HNE concentration, but was also
related to the incubation time (Fig. 3.3.11, and 3.3.12). Therefore,
when HNE was present during the enzymic reaction the overall
inhibitory effect of HNE on the enzyme activity was related to the
incubation time (Fig. 3.3.2).
Ribonucleotide reductase is a key enzyme for DNA syntheSiS.
Its activity is very closely related to growth rate of tissue and cell
cycle. HNE is one of the most important products of lipid
peroxidation. It has been suggested that HNE has a role for regulation
of cell proliferation (see Introduction). It would be very interesting
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and worthwhile to investigate the HNE effect on the expression and
activity of ribonucleotide reductase in vivo. Such research could employ
cultured cells for studying the relationship between ribonucleotide
reductase activity and cell proliferation in terms of the effects
produced by HNE. The effect of HNE on M 1 or M2 gene expression
and amplification could be investigated by addition of a lower
concentration of HNE to the cultured cells at different stages of the
cell cycle.
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5. CONCLUSION

1. Temperature is very important for CC14 metabolism. CC1 was
4

activated in rat liver microsomes in a temperature-dependent fashion.
The transition temperature for CC14 activation was 26.7-27.5°C when
the metabolism was measured by PBN-CC13 · formation and specific
14CC14 covalent binding to protein. However, the transition temperature

was shown to be at 34.3°C when CC14 -dependent MDA production was
taken as an index of CC14 metabolism. CC1 4 -dependent lipid peroxidation
is not a good parameter for the activation of CC14 .
Two P450 inhibitors (pyrazole and imidazole) and one SH reagent
(iodoacetamide) had inhibitory effects on CC1 4 -stimulated MDA
production only at a relatively high concentrations (10-20 mM). At this
concentration level they produced 15-300/0 inhibition. GSH strongly
inhibited lipid peroxidation induced by CC14 in a concentrationdependent manner. At 0.2 mM it reduced MDA formation by 500/0. GSH
also delayed the onset of the lipid peroxidation and this effect was also
dependent on the concentration of GSH. The results suggested that
GSH inhibited lipid peroxidation possibly by the way of scavenging and
interaction with intermediates of the activation of CC1 4 . Another SH
reagent, N -ethyl maleimide (NEM) showed biphasic effects on CC14 stimulated MDA production. NEM at 0.5-1.0 mM inhibited MDA
formation, but higher concentrations of NEM stimulated the lipid
peroxidation. This phenomenon may be attributed to the fact that CC1 4 dependent lipid peroxidation is a poor index for the activation of CC1 4 ·

2. It was not possible to successfully purify Ml and M2 subunit of
ribonucleotide reductase together to a highly purified state. It was
concluded that it would be better to pUrify Ml and M2 separately.
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Ribonucleotide reductase activity was very closely related to growth
state and rate of the tissues. The enzyme activity can only be detected in
the dividing tissues, such as juvenile normal rat liver, regenerating liver,
liver tumour and hepatoma cells. The level of the enzyme activity in fastgrowing tissue (hepatoma Yoshida cells) was higher than that in slowgrowing tissue (Morris 5123tc tumour). These results have confirmed
the previous work. The enzyme activity in regenerating liver exhibits a
periodic cycling in time course follOwing partial hepatectomy. This
phenomenon has been found in thymidine kinase. The activity of CDP
reductase from 48h and 60h regenerating liver could be activated by
higher concentration of DTT (10 mM). It is assumed that the
regenerating liver's enzyme activity was activated by DTT by
regenerating the specific free radical of the M2 subunit. The content of
low molecular weight thiols in regenerating liver exhibited the same
periodic cycle as the CDP reductase. From these results a possible
mechanism of regulation of the ribonucleotide reductase activity in
regenerating liver was tentatively suggested. In regenerating liver,
before the onset of DNA replication, the cells start to accumulate a large
pool of ribonucleotide reductase M2 subunit. These M2, all or part, are
inactive. When M2 reach a certain level, the cells start to synthesis Ml.
Then M 1 and M2 combine to form holoenzyme. Before or after the
combination, the inactive M2 is reactivated through regeneration of free
radicals. Then the holoenzyme becomes functional. It is further
suggested that low molecular weight thiols in the regenerating liver may
play the role of regenerating free radicals.

3. 4-Hydroxynonenal (HNE) inhibited the CDP reductase activity from
juvenile nonnal rat liver. The inhibition was dependent on the
concentration of HNE and incubation time. Under the experimental
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conditions used in the present study. HNE achieved its inhibitory effect
in two ways. One is direct damage to the enzyme protein by blockage of
the functional SH groups in the enzyme protein. This effect was
irreversible and only dependent on HNE concentration. The other one
is indirect by consuming the DIT in assay mixture through the
interaction of HNE with SH groups on DIT. and eventually affected the
enzyme activity. This effect was dependent on both the concentration of
HNE and the incubation time. Therefore. the overall effect of HNE on
CDP reductase activity was dependent on both parameters.
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